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Abstract 
Antimicrobial resistance in Escherichia coli isolates from organic and 
conventional dairy farms; phenotypic and genotypic perspectives 
by 
Omega Yaw Amoafo 
The use of antimicrobials has been the main weapon against infectious diseases for over a century. 
However, the persistent use/abuse of antimicrobials has resulted in resistant strains, and 
antimicrobial resistance (AMR) is a key health problem for health authorities and governments 
worldwide. This study aimed to shed light on the impact of antimicrobial usage and AMR 
development and prevalence by comparing the AMR status of Escherichia coli from the soils of 
conventional dairy farms to their organic counterparts in the Geraldine area of South Canterbury, 
New Zealand. Dairy farm soil E. coli (DfSEC) isolates (n=814) were phylogenetically typed and 
antimicrobial susceptibility tested (AST) against cefoxitin, cefpodoxime, chloramphenicol, 
ciprofloxacin, gentamicin, meropenem, nalidixic acid, and tetracycline. Twenty of the DfSEC isolates 
were selected based on their absolute resistance to cefoxitin 30 mg for bioinformatics analysis. 
The 814 DfSEC isolates were classified into seven main E.coli phylogenetic groups. The phylogeny 
group B1 was most prevalent at 73.7%. The E group was next at 9.6% while the A was 5.8%, C was 
5.3% and the D and B2 groups were 0.5% each. When classified under the newer E. coli phylogeny 
nomenclature, the cladeI+II and cladeIII+IV+V phylogroups were found to be less than 1%. There was 
no F phylogeny group member identified in this study and 3.1% of the isolates were placed as 
 iii 
unknowns. The AST results indicated 3.7% of the DfSEC isolates were resistant to at least one of the 
eight selected antimicrobials.  
Of the selected 20 DfSEC isolates, each carried at least two resistant gene variants. Three isolates 
from a conventional farm carried up to six resistant gene variants. Each of the 20 isolates may 
encode nucleotide sequences of either the blaACT-1, blaBIL-1, blaCMY-2, or the blaMIR-1 gene 
variants for extended-spectrum β-lactamase (ESBL) production and the multi-drug transporter gene 
mdfA1 for the efflux pump. Two isolates from different farms showed close relatedness (≤ 1 locus 
difference apart). Statistical analysis indicated that there was no significant difference (P > 0.05) 
between the effect of the two dairy farming systems on the AMR of the DfSEC isolates but isolates 
from the conventional dairy farm possessed more resistance gene variants per organism than those 
from the organic dairy farms. DfSEC isolates commonly associated with humans and their companion 
animals may be transferred into the dairy farm soil and there is the possibility of farm-to-farm 
transfer of DfSEC isolates. Virulent mastitis and/or metritis causing E. coli of phylogeny group A may 
be found in the dairy farm soil.  
This study archived over 800 dairy farm soil E. coli isolates for future comparative studies and laid a 
foundation for a future study of the trend of antimicrobial resistance development and their spread 
in the central region of the South Island of New Zealand.  
Keywords: antimicrobial, cefoxitin, extended-spectrum, genomic, isolates, lactamase, multi-drug, 
phylogenetic, virulent, variant. 
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Antimicrobial resistance (AMR) threatens to push modern civilization back into the pre-antimicrobial 
era of high morbidity and mortality rates of infections due to bacterial diseases (Brown & Nettleton, 
2017; Venkat, 2019). Such a scenario would inevitably lead to harsh socio-economic difficulties 
caused by loss of trillions of dollars as a result of the loss of human and agricultural output and 
wastage of resources used to combat the effects of lack of therapeutic options in the face of bacterial 
infections (Jasovský, Littmann, Zorzet, & Cars, 2016; Naylor et al., 2018; Tacconelli & Pezzani, 2019). 
Friedman et al. (2016) summed up these negative impacts of AMR in terms of morbidity and 
mortality as; increased resource utilization and cost, alterations in guidelines in terms of loss of 
narrow-spectrum antimicrobial classes, and changes in established therapeutic regimes. The closures 
of wards in hospitals and cancellation of surgical procedures as chemo- and radiotherapy result in 
immune-compromised individuals are also some of the negative aspects of AMR (Teillant, Gandra, 
Barter, Morgan, & Laxminarayan, 2015; Willyard, 2017; Woolhouse, Waugh, Perry, & Nair, 2016).  
New Zealand (NZ) has not escaped bacterial resistance to antimicrobials which pose a threat to 
humans and animals (Heffernan, Bakker, & Williamson, 2014; Heffernan, Dyet, Munroe, et al., 2014; 
McMullan et al., 2016; Rademaker et al., 2020).  
NZ is an agricultural country with dairy farming as one of the major contributors to its GDP and NZ’s 
dairy industry contributes 3% of global dairy production with 21.2 billion litres of milk processed by 
dairy companies in 2018-2019 (DairyNZ, 2020). Conventional dairy farming, as opposed to organic 
dairy farming, contributes a significant amount of chemicals and their metabolites directly or 
indirectly to the environment (Chobtang, Ledgard, McLaren, & Donaghy, 2017; Mandal et al., 2020; 
Oliver et al., 2020; Singh et al., 2020). These two farming systems may therefore impact the 
microbiome in the soils differently (Groot & van’t Hooft, 2016; Mandal et al., 2020; Zhang et al., 
2020). The recent surge in AMR prevalence has been attributed to the exposure of soil microbes to 
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factors that cause evolutionary pressures for them to mutate and acquire resistance to survive, as 
they have done for millions of years (Allen et al., 2010; Finley et al., 2013; Gillings, 2013; Kim, Jensen, 
Aga, & Weber, 2007; von Wintersdorff et al., 2016). 
It is prudent to monitor the population of microorganisms with broad resistance to antimicrobials in 
an environment, especially if they are closely associated with human and livestock activities (Argudín 
et al., 2017; Oliver, Murinda, & Jayarao, 2011; Wang, McEntire, Zhang, Li, & Doyle, 2012). In the case 
of E. coli found in dairy farm soils (DfSEC), it may be possible to evaluate the prevalence (Chee-
Sanford, Aminov, Krapac, Garrigues-Jeanjean, & Mackie, 2001; Popowska et al., 2012) and the mode 
of transfer of antimicrobial-resistant strains or their genes horizontally or vertically (Geue et al., 
2002; Lupo, Coyne, & Berendonk, 2012; Nesme & Simonet, 2015; Rivera et al., 2012). Bacteria strains 
carrying antimicrobial resistance genes (ARGs) may be transmitted from the livestock directly, by 
their products or through other environmental factors such as the soil, waterways, flooding, or 
insects as demonstrated in a study by Rybaříková, Dolejská, Materna, Literák, and Čížek (2010) to 
humans and vice versa (Collis et al., 2019; Hartmann et al., 2012; Heuer, Schmitt, & Smalla, 2011; 
Marti et al., 2013; van den Bogaard & Stobberingh, 2000)  
1.1 Origins of antimicrobials 
Raaijmakers and Mazzola (2012) citing Thomashow (2002) defined antimicrobials as heterogeneous, 
low molecular-weight compounds produced by microorganisms that inhibit the growth or 
metabolism of other microorganisms. This definition is similar to the definition of antimicrobials by 
Waksman (1947) who, by quoting Vuillemin (1889) on ‘one creature destroying the life of another to 
sustain its own’, defined antimicrobials as chemical substances produced by microorganisms that can 
kill or inhibit the growth of other microorganisms (Waksman, 1947). Lietman (1986) expanded this 
definition to include semisynthetic and synthetic antimicrobials with the term antibiotic, replaced by 
antimicrobial (Kourkouta et al., 2018).  
It is widely accepted that ancient Chinese, Egyptians, Greeks, and Romans used extracts from fungi to 
cure various infections (Aminov, 2010; Gould, 2016; Kourkouta et al., 2018). The pioneering work of 
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Louis Pasteur and Robert Koch to link microorganisms to the cause of infectious diseases that had 
plagued humankind since the dawn of time (Gould, 2016), accelerated the search for a ‘magic bullet’ 
to cure infectious diseases (Aminov, 2010; Zaffiri, Gardner, & Toledo-Pereyra, 2012). Until the 
discovery of antiseptics in 1867, the reliance was mainly on the use of hygiene and sanitation for the 
prevention and spread of diseases (Jeśman, Młudzik, & Cybulska, 2011).  
The discovery of mycophenolic acid secreted by Penicillium brevicompactum and used against 
Bacillus anthracis by the Italian physician and microbiologist, Bartolomeo Gosio in 1893 has been 
cited as the earliest antimicrobial discovered (Nicolaou & Rigol, 2018). Later in 1911, Paul Erlich 
discovered salvarsan for the cure of syphilis (Yazdankhah, Lassen, Midtvedt, & Solberg, 2013; Zaffiri 
et al., 2012). This was before the discovery of penicillin by Alexander Fleming in 1928 (Adedeji, 2016; 
Jeśman et al., 2011) with the period from 1950-1965 being described as the golden age of 
antimicrobial discovery (Gould, 2016; Kumazawa & Yagisawa, 2002). 
The commercial production of antimicrobials in 1943 and the discovery of various other 
antimicrobials over time, to the present cephalosporins (Mohr, 2016; Patait et al., 2015; Zaffiri et al., 
2012; Zaffiri, Gardner, & Toledo-Pereyra, 2013), have resulted in a huge improvement in dealing with 






Figure 1.1 Timeline of antimicrobial discovery.  
A modified version of chronology of antibiotic discovery and their introduction into clinics by (Patait et al., 2015). 
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1.2 The advent of antimicrobial resistance  
According to The World Health Organisation (WHO), AMR develops when a microbe such as a 
bacterium, fungus, virus, or parasite can no longer be destroyed, or its growth is limited by a drug 
that the microbe was previously sensitive to. Such that, standard treatments no longer work. This 
leads to difficulties in treating or control of infections with prolonged hospital stays and increased 
risk of disease transmission, increased socioeconomic costs, and greater risks of deaths (World 
Health Organization, 2014). AMR, according to the WHO (2018) causes a 50% increase in risks 
compared to diseases caused by non-resistant microbes. 
Bacterial AMR was predicted before the start of commercial antimicrobial production and usage 
because the genes that encode for AMR have been in existence long before their discovery and 
commercial production (D’Costa et al., 2011; Li et al., 2015; Martínez, 2012; Perry, Waglechner, & 
Wright, 2016; van Hoek et al., 2011; Wright & Poinar, 2012). In most cases, the discovery of 
resistance genes and their phenotypic expression occurred before or immediately following the mass 
production of a particular antimicrobial (Friedman et al., 2016). Aside from this, antimicrobial genes 
have also been found in regions and locations with little or no human interactions (Allen, Moe, 
Rodbumrer, Gaarder, & Handelsman, 2009; Lang et al., 2010; Ushida et al., 2010; Van Goethem et al., 
2018). For example, Lee et al. (2019), citing earlier work carried out with Park et al. (2018), identified 
antimicrobial-resistant genes PNGM-1 in deep-sea sediments that are tens of thousands of years old. 
These two phenomena suggest that antimicrobials and resistance to antimicrobials have always been 
part of bacteria populations. Although, other studies have also indicated that the number of AMR 
genes found at these remote and pristine places suggests the role of wind and water currents and 
wildlife activities (Allen et al., 2010; Lang et al., 2010; Segawa et al., 2013; Ushida et al., 2010). 
Antimicrobial resistance to a wide range of infectious agents is a huge public health threat (Aslam et 
al., 2018; Ferri, Ranucci, Romagnoli, & Giaccone, 2017; Frieri, Kumar, & Boutin, 2017; Laxminarayan, 
Duse, Wattal, Zaidi, Wertheim, Sumpradit, Vlieghe, Hara, Gould, Goossens, et al., 2013; World Health 
Organization, 2014). There has been a plateau in the discovery and emergence of effective 
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pharmaceuticals to combat microbial pathogens during the past couple of decades (Coates, Halls, & 
Hu, 2011; Hollis & Ahmed, 2014; Kalkreuter, Pan, Cepeda, & Shen, 2020; Lewis, 2013). For the past 
50 years only one antimicrobial belonging to a new class, the narrow spectrum daptomycin, has been 
discovered and used in clinical settings (Fernandes & Martens, 2017; Lewis, 2012; Piddock, 2012).  
Globally, the ever-increasing human population means agriculture has to keep up with food 
production (crop and animal) to sustain the various populations (Gilland, 2002; Laurance, Sayer, & 
Cassman, 2014). In most developed countries the call is for the elimination of highly intensive 
farming where animals are held indoors under controlled conditions (factory farming), as a source of 
food for human consumption (Foley et al., 2011; Garcia, Osburn, & Cullor, 2019; McMichael, Powles, 
Butler, & Uauy, 2007; Tilman, 1999). However most developing nations in Asia, Africa, and South 
America are urged to intensify their farming systems to produce enough food for local consumption 
or export (Carvalho, 2006; Duncan et al., 2013; Jayne, Chamberlin, & Headey, 2014). The use of 
antimicrobials is beneficial to animal factory farmers as there is an increase in productivity of the 
animals by the elimination of neonatal diseases and energy waste in fighting against pathogens 
(Angelakis, 2017; Gelbrand et al., 2015; Gorden & Plummer, 2010; Landers, Cohen, Wittum, & 
Larson, 2012). This, however, is the major way that humans have contributed to the present state of 
widespread resistance to clinical antimicrobials (Davies & Davies, 2010; Martin, Thottathil, & 
Newman, 2015; Mehdi et al., 2018; Sarmah, Meyer, & Boxall, 2006a; Watkins & Bonomo, 2016). 
A Mexican study, however, found that the short-term deposition of sulphonamide and quinolone 
antimicrobials in the soil did not increase the relative number of sulphonamide (sul) and quinolone 
(qnr) resistance genes but long-term deposition increases the absolute concentration of these 
resistance genes in the soil (Dalkmann et al., 2012). A USA study of the metagenomics of AMR in the 
soils with a 14-year application of poultry and bovine manure containing antimicrobials and their 
metabolites found increased amounts of AMR genes in the soil compared to soils without 
antimicrobials (Yang et al., 2020). A Chinese study of the effect of antimicrobial and heavy metal 
usage in feed supplements and for disease control in the swine industry heavily correlated with the 
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abundance of antibiotic resistance genes (ARGs) in the soil of the swine farms (Zhu et al., 2013). 
Similarly, a Portuguese study into the effect of excreted antimicrobials, their derivatives, and 
metabolites on the occurrence and abundance of ARGs in wastewater indicated that the 
anthropological effect of antimicrobial release into the environment is to blame for the relative 
abundances of ARGs in the environment (Amador, Fernandes, Prudêncio, Barreto, & Duarte, 2015). A 
gradient study of a riverbed to ascertain the magnitude and effect of human activities on the 
occurrence and abundance of ARGs in the riverbed and suspended sediments indicated that the 
more antimicrobials, heavy metals, and other products of human activity that are deposited into the 
river at the various stations, the greater the occurrence of ARGs at the station (Pruden, Arabi, & 
Storteboom, 2012). A British Columbian study on the effect of the use of poultry litters heavily laden 
with antimicrobials and other agrochemicals as fertilizer for crop production farms correlated with 
the amount and occurrence of ARG in these soils (Furtula et al., 2010). Thus, the assessment that the 
development and prevalence of AMR and the spread of ARGs are due to the deposition of 
antimicrobials and their metabolites is well-founded. 
Since bacteria have continually evolved to resist environmental stressors and pressures to preserve 
their existence for billions of years (Brockhurst, 2013; Durão, Balbontín, & Gordo, 2018; Esbelin, 
Santos, & Hébraud, 2018; Rodríguez-Rojas, Rodríguez-Beltrán, Couce, & Blázquez, 2013; van 
Heerwaarden, Kellermann, & Hoffmann, 2014), their adaptations to subvert antimicrobial therapy 
are not entirely surprising. The fronts of pressures that bacteria face are twofold; natural 
antimicrobials as indicated by the original definition of antibiotics. Secondly, the unquantifiable 
hundreds of millions of tons of antimicrobials and other pharmaceuticals that have been produced 
(Davies & Davies, 2010), eventually end up in the environment such as agricultural fields and water 
bodies as whole compounds or their metabolites (Angeles et al., 2020; Ghirardini, Grillini, & Verlicchi, 
2020; Serra-Compte, Álvarez-Muñoz, Rodríguez-Mozaz, & Barceló, 2017; Yuan et al., 2019). 
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1.3 The extent of antimicrobial resistance 
The global reduction in the discovery of new potent antimicrobials to deal with the rise and spread of 
AMR bacteria (Piddock, 2012; Roca et al., 2015) has been attributed to years of lack of global 
coordinated research and investment into the pharmaceuticals for new antimicrobials as well as 
actions to stop antimicrobial abuse (Hoffman et al., 2015; Inoue & Minghui, 2017; Laxminarayan, 
Sridhar, Blaser, Wang, & Woolhouse, 2016). Across the world, different organisations and 
governments have set up systems to deal with the threat that this situation poses (Chaudhary, 2016).  
In as much as the AMR patterns differ from country to country across the different regions of the 
world (Goossens, Ferech, Vander Stichele, Elseviers, & Group, 2005; O'Brien et al., 1978; Tacconelli et 
al., 2018; Tacconelli et al., 2019; Tandogdu et al., 2014), it is noted that the best way would be for a 
coordinated effort by all nations. This is because the problem is ever-increasing, and AMR does not 
restrict itself to political or geographical borders (Carlet et al., 2012; Chaudhary, 2016; Klein et al., 
2018; Laxminarayan, Duse, Wattal, Zaidi, Wertheim, Sumpradit, Vlieghe, Hara, Gould, & Goossens, 
2013; Tacconelli et al., 2018; Ventola, 2015).  
The WHO global action plan on AMR (Hoffman et al., 2015; World Health Organization, 2018) is a 
step in a direction to find some coordination amongst member states. Secondly, the USA federal 
government’s Center for Disease Control (CDC) One Health Office, is one of the major organisations 
which has been set up across different regions, sectors, and disciplines to combat the global AMR 
problem (Cipolla, Bonizzi, & Zecconi, 2015; Frieden, 2010). In Europe, the European Centre for 
Disease Prevention and Control (ECDC) (Mazińska, Strużycka, & Hryniewicz, 2017; Weist & Högberg, 
2016), in North America, USA CDC and the Canadian government (Parmley et al., 2013; Zhanel et al., 
2010), in Africa, the South Africa government (Osei Sekyere, 2016; Rweyemamu et al., 2013) have set 
up bodies that survey and regulate the use of antimicrobials and facilitate communication between 
the various antimicrobial stakeholders. These bodies collect data, set up surveillance networks, share 
information, educate, and liaise with lawmakers, medical, veterinary, and agricultural bodies to help 
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control the threat that AMR poses globally (Asokan & Vanitha, 2018; Mitchell et al., 2020; Purohit et 
al., 2017; Robinson et al., 2016; Rousham, Unicomb, & Islam, 2018; Wegener).  
In NZ, the control of antimicrobial usage in agriculture and veterinary is by the Ministry for Primary 
Industries with advice from the NZ Veterinary Council, Agricultural Compounds and Veterinary 
Medicines group, and other crown and academic research institutions (Anon, 2020). To promote NZ’s 
contribution to global antimicrobial stewardship, NZ is a member of the World Health Assembly’s 
Tripartite Action Plan to tackle AMR formed by the WHO and the Food and Agriculture Organization 
(FAO) (Iossa & White, 2018). This assembly aims to ensure the treatment of infectious diseases 
successfully for as long as possible with effective and safe medicines that are quality assured, 
responsibly used, and easily accessible in times of need (Ministry of Health and Ministry for Primary 
Industries, 2017). This is an important undertaking for NZ because according to Harrison et al. (2020), 
despite the island nation's status of NZ which gives its ecosystem some isolation, the relatively high 
reliance of the nation’s economy on agriculture causes a high incidence of infectious diseases. 
Notwithstanding the tight controls to prevent indiscriminate use of antimicrobials (Ministry of 
Agriculture and Fisheries, 2011), microbial resistance to antimicrobials continues to occur and 
present a danger to animals and humans in NZ (Heffernan, Bakker, et al., 2014; Heffernan, 
Woodhouse, Pope, & Blackmore, 2009; Loh, Vukcevic, & Bastos Gomes, 2020). For example, a report 
released by The NZ Institute of Environmental Science and Research (ESR) indicated that extended-
spectrum β-lactamase E. coli (ESBL) isolated from human blood cultures increased from 2.6% during 
the period 2006-2008 to 3.8% in the period 2009-2011, an increase of 46% (ESR, 2012) and the 
prevalence rate of methicillin-resistant Staphylococcus aureus (MRSA) has increased by 78% from 
13.4 to 23.9 per 100 000 persons over 10 years (2004-2013) (ESR, 2014). 
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1.4 Antimicrobial resistance mechanisms and their transfer 
1.4.1 Penicillins 
The contribution of penicillin to health and well-being, especially during and after WWII was 
immense and the tag of a wonder drug was not an overstatement at the time. However, even in 
1940, before the mass production of penicillin, Abraham and Chain (1940) confirmed the observation 
made by Alexander Fleming in 1929 that certain bacteria can grow in the presence of penicillin. 
Penicillin belongs to the group of antimicrobials with a β-lactam ring at the centre of their structure. 
The β-lactam binds to a serine site of the penicillin-binding protein (PBP) (Brem et al., 2016; Yeats, 
Finn, & Bateman, 2002; Zervosen, Sauvage, Frère, Charlier, & Luxen, 2012) of bacteria belonging to 
the Ambler classes A, C, and D (Etemadi, Ebrahimzadeh Leylabadlo, & Ghotaslou, 2020). The ease of 
binding is because of the close resemblance to the D-alanyl-D-alanine substrate of transpeptidases 
involved in peptidoglycan synthesis. The ability of β-lactam to bind to the PBPs, disrupts the synthesis 
of peptidoglycan (Nordmann, Dortet, & Poirel, 2012a; Strominger, Blumberg, Suginaka, Umbreit, & 
Wickus, 1971; Sullivan, Delgado, Maharjan, & Cain, 2020; Tomasz, 1979), the key component of a 
bacteria cell wall, leading to cell lysis (Cavallari, Lamers, Scheurwater, Matos, & Burrows, 2013; Cho, 
Uehara, & Bernhardt, 2014; Tomasz, 1979; Zeng & Lin, 2013).  
Resistance to β-lactam antimicrobials is mainly by the breakdown of the lactam ring by an enzyme β-
lactamase to the biologically harmless penicilloic acids (Chakraborty, 2016; Fisher, Meroueh, & 
Mobashery, 2005; Ohalete, 2016; Peterson, Petrasky, Seymour, Burkhart, & Schuiling, 2012). Other 
mechanisms include a) pumping the drug out of its cell (Das, Verma, Kumar, Ghosh, & Ramamurthy, 
2020; Levy, 2002; Mahamoud, Chevalier, Alibert-Franco, Kern, & Pagès, 2007), b) change in the 
structure of the target site of the drug (Lingzhi et al., 2018) or c) reduced permeability of the bacteria 
cell to the drug (Bryan, 1988; Masi, Réfregiers, Pos, & Pagès, 2017; Neu, 1982; Neu, 1992; Pagès, 
James, & Winterhalter, 2008).  
Most Gram-negative bacteria, including opportunistic pathogens like Escherichia coli and other 
Enterobacteriaceae, have mobile genetic elements to produce β-lactamase for the breakdown of β-
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lactam antimicrobial to ineffectiveness (Tooke et al., 2019). The ability of the β-lactam antimicrobial 
to disrupt the cell wall synthesis of a bacteria may also be reduced if the targeted site is modified in 
the bacteria (Singh, Sripada, & Singh, 2014; Todar, 2011; Yao & Rock, 2016). As suggested by 
Fontana, Ligozzi, and Satta (1996) and Duezt et al. (2001), mutation at sites on resistant bacteria’s 
genetic elements causes the over-production of low-affinity penicillin-binding proteins (PBP2x, 
PBP2b, or PBP1a). These low-affinity membrane-bound serine transferases of PBPs prevent the 
antimicrobial from disrupting the peptidoglycan formation so the bacterial cell wall’s integrity is not 
compromised (Engel et al., 2014; Łeski & Tomasz, 2005).  
4.1.1 Forms of penicillin 
The realisation that penicillin in its natural and original structure has limitations, led to more studies 
and efforts into the chemistry and biochemistry of the compound which resulted in the discovery of 
different forms and groups of the antimicrobial (Clark, 2011; Clarke, 2015; Kardos & Demain, 2011). 
Different forms of penicillin such as benzylpenicillin, penicillamine, penaldic acid, 2-
pentenylpenicillin, and other chemical formulations that varied in stability, solubility, and their acid-
base properties (Clarke, 2015) were discovered/or developed. Other groups of antimicrobials that 
have this β-lactam ring in their structure include carbapenems, monobactams, and cephalosporins 
(Lingzhi et al., 2018).  
Carbapenem antimicrobials are forms of bicyclic β-lactam antimicrobials that differ from the 
penicillins in having a carbon atom replacing sulphur in the β-lactam ring (Berks, 1996; Karaiskos & 
Giamarellou, 2020; Mori, Takahashi, & Mizutani, 2007; Pham et al., 2020). The various carbapenems 
vary in their solubility, stability in solution or solid form, level of toxicity (Liang, Chen, & Macy, 2019) 
to mammals, and also in spectra of effectiveness (Moellering Jr, Eliopoulos, & Sentochnik, 1989; Park 
et al., 2014; Singh, Young, & Silver, 2017). Due to the variation in their toxicity such as allergic 
seizures and nephrotoxicity and stability, not all carbapenems discovered are clinically available 
(Salmon-Rousseau et al., 2020). Clinically available ones include imipenem and meropenem 
(Fernandes, Amador, & Prudêncio, 2013; Moellering Jr et al., 1989; Singh et al., 2017). Although 
carbapenems are stable against β-lactamases, and, even broad-spectrum β-lactamases (ESBLs), 
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resistance was discovered in 1993 and spread fast due to easy acquisition and transfer of 
carbapenemase genes through plasmids (Carattoli, 2011; Kim et al., 2020). The genetically and 
biochemically diverse inducible carbapenem hydrolysing β-lactamases are responsible for the 
resistance observed in this group of antimicrobials (Hu, Zhang, & Gu, 2020; Queenan & Bush, 2007; 
Rasmussen & Bush, 1997; Streling et al., 2018). This group of enzymes may even hydrolyse other β-
lactams such as cephalosporins and penicillins even more efficiently than they do carbapenems 
(Amjad et al., 2011; Baxter & Lambert, 1994; Lee, Lu, et al., 2019; Mehta, Rice, & Palzkill, 2015; 
Rasmussen & Bush, 1997).  
Monobactams are monocyclic β-lactam antimicrobials whose chemical structure mimics the iron-
chelating siderophores that bacteria use to chelate iron from their host into their cells (Li, Oliver, & 
Townsend, 2017; Sykes, Bonner, Bush, Georgopapadakou, & Wells, 1981). The monobactams thus 
have easier penetration by the Trojan-horse mechanism into the bacteria cell to bind to the PBPs in 
the periplasm of the bacteria cell and disrupt protein synthesis (Kou et al., 2018; Mitton-Fry et al., 
2012; Scorciapino et al., 2017). They are also the only group of β-lactam antimicrobial-resistant 
against metallo-β-lactamases antimicrobial inhibitors (Page et al., 2011). The wide use of the less 
toxic monobactam, aztreonam was followed by the development of resistance, especially the CTX-M-
15 type cefotaxime hydrolysing β-lactamases (Fernandes et al., 2013; Maryam & Khan, 2018).  
The cephalosporins are bactericidal β-lactam antimicrobials of different generations, first isolated 
from the fungus Acremonium (Cephalosporium) (Braga & Lackner, 2017; Shahbaz, 2017). Most 
cephalosporins in use presently are synthetic or semisynthetic. The effectiveness of first-generation 
cephalosporins is towards aerobic Gram-positive organisms (Curtis, Boley, Walls, Hamory, & 
Schmaltz, 1993; Zaffiri et al., 2012). Higher generations cephalosporins had improved and wider 
spectra of activity (Alexopoulou et al., 2013) and even used for the treatment of typhoid fever, a 
Gram-negative bacterial disease (Klemm et al., 2018; Soe & Overturf, 1987). Cephalosporins are well 
tolerated by human cells and show little toxicity (Vigliotta et al., 2020). The fifth-generation 
cephalosporins such as aztreonam, ceftaroline (Corey et al., 2010; File Jr et al., 2010; Lin et al., 2013), 
ceftobiprole (Nisha, Vanishree, & Mahesh, 2017; Selvan & Ganapathy, 2016), and cefoxitin 
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(Fernandes et al., 2013) on their own are effective against MRSA with relatively fewer side effects 
compared to other drugs and drug cocktails (Lin et al., 2013; Nisha et al., 2017; Selvan & Ganapathy, 
2016). 
1.4.2 Aminoglycosides 
The aminoglycosides of which streptomycin (1944), kanamycin (1958), gentamicin (1963), and 
amikacin (semi-synthetic, 1972) are commonly known (Davies, 2007). They act by restricting protein 
synthesis for the growth of sensitive bacteria (Hancock, 1981; Wilton, Charron-Mazenod, Moore, & 
Lewenza, 2016). The antimicrobial binds to the 30S ribosomal subunit (Ribeiro da Cunha, Fonseca, & 
Calado, 2019) of the bacteria and stops the process of translation during protein synthesis (Jana & 
Deb, 2006). The wider use and importance of the aminoglycosides is explained by their broad-
spectrum in being active against aerobic Gram-negative bacilli and Gram-positive cocci, ability to kill 
bacteria quickly and synergise with other drugs (Davies, 2007; Gunics, Motohashi, Amaral, Farkas, & 
Molnár, 2000; Hu et al., 2015; Jana & Deb, 2006; Krause, Serio, Kane, & Connolly, 2016).  
Bacteria become resistant to gentamicin and other aminoglycosides by phosphorylation (Muir & 
Wallace, 1979), acetylation (Ishigaki et al., 2017), methylation (Reis, Kolvenbach, Nunes, & Corvini, 
2020; Sun et al., 2016), changing antimicrobial cleavage site by nucleotide mutation of the16S rRNA 
(Pantel et al., 2018; Wong, Hendrix, Scott Priestley, & Greenberg, 1998), or efflux pump (Calvopiña, 
Dulyayangkul, & Avison, 2020; Hocquet et al., 2003). Bacteria may also acquire resistance by gene 
transfer as a transposon (Davies & Davies, 2010; Fenton, Harsch, & Klein, 1973; Honoré & Cole, 1994; 
Reis et al., 2020). The existence of both plasmid (Acar, Bulut, Stasiewicz, & Soyer, 2019; Guerra, Soto, 
Helmuth, & Mendoza, 2002; Oliva et al., 2018) and chromosomal genes (Miriagou, Carattoli, & 
Fanning, 2006; Sun et al., 2018) encoding for the resistance to aminoglycosides makes for easy 
transfer of these genetic materials between bacteria by both horizontal and vertical means. Some of 
the genes that encode for aminoglycoside modification enzymes (AMEs) secreted by resistant 
bacteria include aac(3)-Ia, aac(6′)-Ib, ant(4′)-IIa, ant(2”)-Ia, and aph(3”)-Ib (Ojdana et al., 2018).  
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According to Salih & Gibree (2019), gentamicin is the best antimicrobial for the treatment of cow 
mastitis caused by bacteria, and Sato, Bartlett, Kaneene, & Downes (2004) showed that out of 332 
strains of Campylobacter spp., all were susceptible to gentamicin but not to ciprofloxacin or 
tetracycline. An Argentinian study found only 0-2.1% of S. aureus strains from cows with clinical and 
non-clinical mastitis to be resistant to a group of aminoglycosides but 48.4 % of them were resistant 
to penicillin-based antimicrobials (Russi, Bantar, & Calvinho, 2008). In a Turkish study on bacteria 
found in dairy products, 0%, 42%, and 55% of Bacillus cereus, S. aureus, and E. coli isolates were 
resistant to gentamicin, compared to 91%, 93%, and 90% to ampicillin and 0%, 54% and 66% to 
tetracycline, respectively (Gundogan & Avci, 2014). While in a surveillance study of 132 E. coli isolates 
from 110 dairy cows from 10 farms in New York State, 98.45% were resistant to ampicillin, 34.1% to 
streptomycin, 24.8% to tetracycline, and < 20% to gentamicin (Srinivasan et al., 2007). 
In the NZ conventional dairy industry, aminoglycosides are rarely used (Ministry for Primary 
Industries, 2019). Aminoglycosides together with tetracyclines, macrolides/lincosamides or clavulanic 
acid made up less than 1% of the total intramammary veterinary antimicrobial sales in 2017 
compared to 83% for penicillin and 14% of cephalosporin–based antimicrobials (Ministry for Primary 
Industries, 2019). The sales of aminoglycosides had reduced by 17% from 1 870 kg in 2016 to 1 557 
kg in 2017. Data over five years indicated that sales of aminoglycosides increased to 2 611 kg in 2015, 
but declined annually following that period (Ministry for Primary Industries, 2019).  
1.4.3 Quinolones 
Nalidixic acid, the first of the quinolone group of antimicrobials, was serendipitously discovered in 
1962 during the production of the antimalarial drug, chloroquine (Andersson & MacGowan, 2003; 
Bisacchi, 2015; Kuhlmann, Dalhoff, & Zeiler, 2012). The comparative ease of manipulation of the 
chemical structure of the quinolones has led to the discovery of many more antimicrobials of the 
group, which includes ciprofloxacin (Andersson & MacGowan, 2003; Appelbaum & Hunter, 2000). 
These changes in the chemical structure led to improvements in their potency against Gram-positive 
and Gram-negative bacteria, most notably Enterobacteriaceae such as E. coli and Klebsiella spp., and 
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atypical bacteria such as Mycoplasma pneumoniae. These changes also improved the tolerance of 
the drug by macro-organisms (Andersson & MacGowan, 2003; Appelbaum & Hunter, 2000). 
Quinolones were licensed for therapeutic use in1967 as drugs for the treatment of urinary tract 
infection caused by Gram-negative bacteria apart from Pseudomonas aeruginosa (Emmerson & 
Jones, 2003; Kuhlmann et al., 2012).  
Quinolones are synthetic, meaning naturally occurring resistant genes did not exist in soils and the 
environment as is the case of other groups of antimicrobials (Hernández, Sanchez, & Martínez, 2011). 
However, a multidrug resistance efflux pump, inherent in most bacteria species (Blair & Piddock, 
2016; Piddock, 2006) accounts for intrinsic resistance displayed by bacteria species and for the initial 
resistance to nalidixic acid demonstrated by Gram-positive bacteria such as S. aureus and 
Streptococcus spp. (Hernández et al., 2011).  
Additional resistance mechanisms to the quinolones include target protecting proteins, and 
quinolone modifying enzymes. Genes encoding these proteins and enzymes are found on plasmids 
making them horizontally transferable (Hernández et al., 2011). The plasmid encoding the qnr gene 
protects the bacteria from DNA gyrase (Hernández et al., 2011) and reduces drug accumulation due 
to the efflux pump (Martínez-Martínez, Pascual, & Jacoby, 1998). The DNA gyrase prevents the 
supercoiling replication, transcription, recombination, and repair of DNA (Emmerson & Jones, 2003; 
Loganathan et al., 2017), which leads to cell death (Hernández et al., 2011). 
The quinolones have been widely used in human medicine for the treatment of urinary tract 
infections caused by enteric bacteria (Aldred, Kerns, & Osheroff, 2014; Emmerson & Jones, 2003; 
Smithson et al., 2012; Stuck et al., 2012) and other therapeutic manipulations (Berning, Krasz, & 
Miehlke, 2011; Harris, Elhassan, & Flook, 2016), in veterinary medicine (Teuber, 2001; Wegner & 
Engberg, 2003) and other agricultural industries (Hou et al., 2015; Li et al., 2012; Quesada, Paschoal, 
& Reyes, 2013). These human activities have led to various amounts of the quinolones being found in 
various environmental niches (Oliveira, Nunes, Barreto Crespo, & Silva, 2020; Watkinson, Murby, 
Kolpin, & Costanzo, 2009). Up to 22 µg/kg of nalidixic acid was found in agricultural soils in a French 
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surveillance study (Tamtam et al., 2011). The incidence in resistance to nalidixic acid in veterinary 
sourced Salmonella strains in Germany increased from 0.2% in 1986 to 14.4% in 1996 (Malorny, 
Schroeter, & Helmuth, 1999). A similar study looking at the incidence in Campylobacter strains in the 
Netherlands found an increase in prevalence from 0% to 14% in seven a year from 1982 to 1989 
(Endtz et al., 1991).  
1.4.4 Tetracyclines 
The tetracyclines were discovered, patented, and commercialised from the late 1940s to the early 
1950s (Nelson & Levy, 2011b). Since then, modifications and derivatives have been 
developed/identified to overcome the bacterial resistance that was observed to earlier tetracyclines 
(Liu & Myers, 2016; Nelson & Levy, 2011a). Tetracyclines are widely used in humans (Daghrir & 
Drogui, 2013; Gu, Walker, Ryan, Payne, & Golub, 2012; Swamy, Sanivarapu, Moogla, & Kapalavai, 
2015) and veterinary (Chantziaras, Boyen, Callens, & Dewulf, 2014; Eliopoulos, Eliopoulos, & Roberts, 
2003; Jones, Woolfson, Djokic, & Coulter, 1996; Margolis, Fanelli, Hoffstad, & Lewis, 2010; Prescott, 
2017) medicine, in agriculture for the treatment of diseases of plants, such as Mycoplasma spp. 
infection in palm trees (Maramorosch, 2012; McCoy, 2012), Xanthomonas campestris of seeds 
(Yemata & Fetene, 2017) and black rot in crucifers (Schaad & Dianese, 1981; Singh, Rathaur, & 
Vicente, 2016) and in aquaculture (Pereira, Silva, Meisel, & Pena, 2015; Tuševljak et al., 2013). 
Tetracyclines are classified as broad-spectrum, bacteriostatic antimicrobials of both natural and 
semisynthetic origins (Nelson & Levy, 2011b; Tariq, Rizvi, & Anwar, 2018). Tetracyclines, in human 
medication, have been widely used in periodontal disease management and treatment (Bokor-Bratić 
& Brkanić, 2000; Jones et al., 1996; Masoumi, Andisheh-tadbir, Firozabadi, Bahmanpour, & Tanideh, 
2017; Rosenstein, Kushner, & Kramer, 2015), for control of gastritis and peptic ulcer and more 
recently, for the prevention for malaria (Gaillard, Madamet, & Pradines, 2015; Tan, Magill, Parise, & 
Arguin, 2011). In veterinary medicine, they are mostly used for treating bacterial infectious diseases 
and also as a growth promoter (Chopra & Roberts, 2001; Jamal, Shareef, & Sajid, 2017; Mathers, 
Flick, & Cox Jr, 2011). The first group of tetracyclines to be discovered – chlortetracycline, 
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oxytetracycline, and demethylchlortetracycline were of Streptomyces sp. origin. Later semisynthetic 
ones – methacycline, doxycycline, and minocycline were manufactured (Michalova, Novotna, & 
Schlegelova, 2004). By 1953, however, isolates of Shigella dysenteriae with resistance to the first 
group of tetracyclines had been discovered (Michalova et al., 2004; Nelson & Levy, 2011a).  
Tetracyclines prevent the growth of bacterial cells by binding to the high-affinity binding 30S subunit 
site of protein 7 (Li et al., 2013; Tritton, 1977) on the bacterial ribosome and thus blocking the 
binding of an aminoacyl–tRNA. (Brodersen et al., 2000; Connell, Tracz, Nierhaus, & Taylor, 2003; 
Goldman, Hasan, Hall, Strycharz, & Cooperman, 1983). This disrupts bacterial protein synthesis for 
cell division. The tetracyclines are highly lipophilic and this enhances their ability to enter bacteria 
cells to exert their effect (Bryskier, 2005; Nikaido, 2003). Bacteria become resistant to tetracycline by 
being able to, in an energy dependant manner, flush it out of their cells using an efflux protein 
located in the lipid bilayer of its cell wall (Li, Livermore, & Nikaido, 1994; Skočková, Cupáková, 
Karpíšková, & Janštová, 2020; Thaker, Spanogiannopoulos, & Wright, 2010). Bacteria also use 
ribosomal protection proteins to prevent tetracycline from inserting onto their ribosomes (Velhner & 
Milanov, 2015) or produce proteins that can modify the chemical structure of tetracycline and 
prevent them from latching onto their ribosomes (Chopra & Roberts, 2001).  
1.4.5 Amphenicols 
Chloramphenicol was the first of the amphenicols to be discovered and was isolated from 
Streptomyces venezualae in 1947 as a natural antimicrobial (Aminov, 2017). It contains nitrobenzene 
and a derivative of dicloroacetic acid (Dowling, 2013). Chloramphenicol is the first natural 
antimicrobial to be fully synthesized for commercial purposes (Brock, 1961; Ingebrigtsen, Didriksen, 
Johannessen, Škalko-Basnet, & Holsæter, 2017). It is a broad-spectrum antimicrobial, effective 
against both Gram-positive and Gram-negative bacteria, Mycoplasma, Chlamydia, Rickettsia, and 
MRSA (Dowling, 2013). Being fat-soluble (Dowling, 2013; Ingebrigtsen et al., 2017), chloramphenicol 
crosses most physiological barriers in the mammalian body and can be used for treating bacterial 
infections in the brain, mammary gland, and the placenta (Aminov, 2017). However, due to aplastic 
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anaemia and bone marrow suppression toxicity during a systemic application, its use has been 
limited to topical application for eye and ear infections (Ingebrigtsen et al., 2017; Yunis, 1988).  
Chloramphenicol is a bacteriostatic antimicrobial that interferes with peptidyl transferase and 
inhibits peptide bond synthesis at the 50S ribosomal subunit (Tereshchenkov et al., 2018; Weber & 
DeMoss, 1969; Yunis, 1988). Easily transferred by conjugation, large (> 100 kbp) plasmids carrying 
the cmlA gene confers resistance to chloramphenicol (Bischoff, White, Hume, Poole, & Nisbet, 2005; 
Kehrenberg & Schwarz, 2006). Bacterial resistance to chloramphenicol and its derivative florfenicol is 
mainly by permeability barriers, mutation of the target site, use of acetyltransferases to inactivate 
the drug, and use of efflux pumps (Fernández et al., 2012; Schwarz, Kehrenberg, Doublet, & 
Cloeckaert, 2004; Trivedi, Patil, Shettigar, & Bairwa, 2015). 
1.5 Soil microbes and the resistome 
The term ‘antimicrobial resistome’ has been coined to indicate the bacterial ARG pool (Crofts, 
Gasparrini, & Dantas, 2017; Forsberg et al., 2012; Keen & Montforts, 2011). The presence of both 
natural and artificial antimicrobials, their metabolites, agrochemicals, industrial chemicals, and other 
toxins, as well as the variation in physical conditions of the soil due to weather patterns and climatic 
changes, causes soil microbes to behave differently from microbes in the largely homeostatic 
environment of living organisms, especially the mammal (Fierer, 2017; Nakatsu, 2007; Prosser, 2015). 
This is pertinent for the dairy farm soils’ microbes, including E. coli, as the microbes encounter these 
wide varieties of synthetic chemicals and their metabolites, (Curutiu, Lazar, & Chifiriuc, 2017; Kalia & 
Gosal, 2011; Paul, Chakraborty, & Mandal, 2019; Thiele‐Bruhn, 2003; Verma, Jaiswal, & Sagar, 2014). 
Secondly, the variations in physical features like temperature, ultraviolet (UV) and visible light 
exposure, chemical (water availability, pH, salinity), coupled with the cyclic manner of being ingested 
(Cooper, Morby, Gunn, & Schneider, 2006; Marles-Wright & Lewis, 2007) into the homeostatic 
systems of livestock to be later deposited into the farm soil, aggravates the stress on the farm soil 
microbial population and push them towards adaptations resulting in different phenotypical (Foster, 
2007; Walk, Alm, Calhoun, Mladonicky, & Whittam, 2007; Walk et al., 2009) and genetic (Diard et al., 
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2010; Landini, Egli, Wolf, & Lacour, 2014) changes. These may result in the development of resistant 
genes to antimicrobials (Almakki, Jumas-Bilak, Marchandin, & Licznar-Fajardo, 2019; Pal et al., 2017; 
Ramakrishnan, Venkateswarlu, Sethunathan, & Megharaj, 2019).  
1.6 E. coli: a model organism for the study of antimicrobial resistance in the 
environment 
From its first discovery by Theodor Escherich (Minodier, 2011), Escherichia coli has been found in the 
gastroenteric system of birds, mammals (Keestra & Bäumler, 2014; Lofton, Morrison, & Leiby, 1962; 
Mackie, 1997; Nordmann et al., 2012a), reptiles (Cushing, Pinborough, & Stanford, 2011; Gopee, 
Adesiyun, & Caesar, 2000; Ramos et al., 2019; Wheeler, Hong, Bedon, & Mackie, 2012) and 
amphibians (Hacioglu & Tosunoglu, 2014; Portis & Coe, 1975). E. coli is a Gram-negative, aerobic, 
facultative anaerobic exhibiting a mutualistic, commensal, and opportunistic pathogenic relationship 
with its host (Blount, 2015; Luo et al., 2011; Tenaillon, Skurnik, Picard, & Denamur, 2010). E. coli is 
also commonly found in other environmental niches like water bodies (Fujioka, Sian‐Denton, Borja, 
Castro, & Morphew, 1998; Solo-Gabriele, Wolfert, Desmarais, & Palmer, 2000), soil (Bottomley, 
Angle, & Weaver, 2020; Frankenberger Jr & Arshad, 2020; Fujioka et al., 1998; Solo-Gabriele et al., 
2000), and plants (Cooley et al., 2013; Sekizuka et al., 2011).  
The vast variation in strain characteristics and adaptations of the genus Escherichia has made E. coli 
one of the most studied organisms in biological sciences (Agrimonti, Bottari, Sardaro, & Marmiroli, 
2019; Arita, 2004; Frazao, 2018). It has been described as a “classic” organism for studies because of 
its versatility as a pathogenic or commensal organism (Hornef, 2015; Luo et al., 2011; Nolan, 
Vaillancourt, Barbieri, & Logue, 2020). It is involved in the physiology and pathophysiology of 
gastrointestinal, respiratory, urogenital, and other mammalian body systems (Confer & Ayalew, 
2013; Heintz & Mair, 2014; Hughes et al., 2010; Macpherson, de Agüero, & Ganal-Vonarburg, 2017; 
Smith, Fratamico, & Gunther, 2007).  
The increase in spread and occurrence of AMR has caused a surge in studies and research into AMR 
with E. coli as the model organism (Blount, 2015; Han & Lee, 2006; Kolisnychenko et al., 2002; Saka 
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et al., 2005; Stokes et al., 2020; Taj et al., 2014; Vijayendran et al., 2007). E. coli has been studied as 
the organism in whom AMR has been widely monitored (Mellata, 2013; Roca et al., 2015; Skočková 
et al., 2020). E. coli resistant to third-generation cephalosporins, ESBLs, and carbapenems 
(Chaudhary, 2016) are included in the World Health Organisation’s (WHO) list of bacteria that require 
urgent action to combat its burden on the health and economy of all nations (Gnanou & Sanders, 
2000; Hawser et al., 2009; Kumarasamy et al., 2010; Martel et al., 2000). 
E. coli has also been found, in numerous cases, to carry various AMR genes (Burow et al., 2019; 
EUCAST, 2013; European Food Safety Authority, 2015; Sun, Chen, Jiang, Chen, & Lin, 2019; Tadesse et 
al., 2012). However, because of the huge variation and characteristics within the species (Agarwal, 
Srivastava, & Singh, 2012; Blattner et al., 1997), there can arguably never be enough information on 
them. The present advances in molecular biology together with computerisation, and the widespread 
use of the internet, has also helped to improved methods of studying, sharing, and storing 
information about microbes (Cardinale, Joachimiak, & Arkin, 2013; Lee, Esa, Wee, & Soo, 2020; 
Steurbaut et al., 2010; Willard, Johnson, & Connelly, 1996), and E. coli in particular (Kühn, 1985; 
Rawson et al., 2020; Staropoli & Alon, 2000; Watz et al., 2019).  
1.7 E. coli and the dairy industry 
In the dairy farming industry, the importance of E. coli varies from its use as an indicator organism for 
faecal contamination of milk and other dairy food products (Carlos et al., 2010; Oliver et al., 2020; 
Salaheen et al., 2019; Stenkamp‐Strahm, McConnel, Magzamen, Abdo, & Reynolds, 2018), to an 
agent of diseases of cows (Bicalho, Machado, Oikonomou, Gilbert, & Bicalho, 2012; Cui, Wang, Lin, et 
al., 2020; Cui, Wang, Wang, et al., 2020; Edgell, 2020; García, Fox, & Besser, 2010; Low et al., 2005; 
Sheldon et al., 2010a; Tadesse et al., 2012; Torres Luque et al., 2017), in particular mastitis (Liu et al., 
2014) and diseases of calves (Bhullar et al., 2012; Fuenzalida & Ruegg, 2019; Gay, 1965; Jamali, 
Krylova, & Aïder, 2018; Kolenda, Burdukiewicz, & Schierack, 2015; Rigobelo et al., 2006). In the USA 
the development of mastitis in a cow costs up to 14.50 USD (LeJeune, Homan, Linz, & Pearl, 2008), 
 21 
and its treatment range between 224-275 USD/cow, resulting in up to 1.5-2 billion in total cost/year 
in the USA (Hoffmann, Maculloch, & Batz, 2015).  
In the dairy industry, E. coli is also implicated in AMR genes (ARGs) carriage and spread (Awosile et 
al., 2018; Awosile et al., 2020; Barry, 1986; Palmeira & Ferreira, 2020) through the environment by 
either horizontal or vertical gene transfer (Hammerum & Heuer, 2009; Harrison & Brockhurst, 2012; 
Oikarainen, Pohjola, Pietola, & Heikinheimo, 2019; Volkova, Lanzas, Lu, & Gröhn, 2012). Apart from 
bacteria consumed while grazing and drinking, soil microbes may enter the body systems of cows by 
the teat canal (Derakhshani et al., 2018; Oliver & Mitchell, 1983; Rainard, 2017), as the teat often 
comes into contact with faecal and soil material which contains bacteria. These could be transmitted 
to humans through milk as they could be present in the mammary gland before the onset of clinical 
symptoms (Alharbi et al., 2018; Godziszewska, Pogorzelska-Nowicka, Brodowska, Jagura-Burdzy, & 
Wierzbicka, 2018; Rainard, 2017).  
In the face of the spread of antimicrobial-resistant bacteria, it is important to identify their routes 
and speed of transmission (Ghosh & Zurek, 2015), to assist with the management of diseases 
(Chomicz et al., 2014; Stringer, Beard, Miller, & Wakefield, 2002) especially in the presence of 
widespread antimicrobial resistance (Bergonier et al., 2014). Epidemiologically, the DNA based 
identification of individual bacterial strains enables the identification of the source(s) of bacteria and 
the pattern of spread of the bacteria (Winkworth, 2013), which would help to evaluate transmission 
routes and identify how best to control the spread of these bacteria through the human food chain 
(Albesharat, Ehrmann, Korakli, Yazaji, & Vogel, 2011; Henriques, Silva, Lemsaddek, Lopes-da-Costa, & 
Mateus, 2014). 
1.8 Antimicrobials in the dairy industry 
The main use of antimicrobials in the dairy industry globally is for the treatment and prevention of 
mastitis (Garcia et al., 2019; Middleton et al., 2014; Sharif & Muhammad, 2009; Tiwari et al., 2013) 
where bacterium(-ia) is (are) generally the causative agent(s) (Hogeveen et al., 2011; Middleton et 
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al., 2014; Ruegg, 2017). In the UK, the government has been proactive in promoting the reduction of 
the use of antimicrobials. In the livestock industry, the UK government managed to reduce the 
average use of antimicrobials by 19% from 2014 to 2018 at 50 mg/kg across all livestock sectors 
(Hyde et al., 2017; Mills et al., 2018) with a median of 15.97-20.62 mg/kg in the dairy sector alone 
(Hyde et al., 2017). Similar to the rest of the world, the NZ dairy industry’s use of antimicrobials is 
mainly for mastitis prevention or cure for non-lactating (dry) (11% of the national total) and lactating 
cow therapy (1% of the national total) (Agricultural Compounds and Veterinary Medicines Team, 
2019).  
The majority of the antimicrobials used in the dairy industry are of the intra-mammary route of 
administration for mastitis control with the occasional use via the injectable form for foot injuries, 
urogenital infections, or neonatal respiratory and enteric diseases (Garcia et al., 2019; Redding, 
Bender, & Baker, 2019). In NZ and the rest of the world, the β-lactams of penicillin (cloxacillin with or 
without ampicillin) remains the main active ingredient (86%) and first-generation cephalosporins 
(13%) with tetracyclines and aminoglycosides (1%) accounting for the rest of the total antimicrobials 
used in the dairy industry (Agricultural Compounds and Veterinary Medicines Team, 2019; Fischer, 
Sjöström, Stiernström, & Emanuelson, 2019; Sawant, Sordillo, & Jayarao, 2005). While most dairy 
farms in NZ would use antimicrobials based on the advice of a veterinarian, others rely on experience 
in regards to antimicrobial usage on farms (Fischer et al., 2019; Jones et al., 2015; McDougall, 
Compton, & Botha, 2017).  
There is a good awareness of AMR in bacteria amongst dairy farmers in NZ but the main issues that 
the farmers concern themselves with are the therapeutic outcomes and the withholding period of 
the type of antimicrobial used (Jones et al., 2015; McDougall et al., 2017; Mills et al., 2018). Most 
researchers have indicated poor antimicrobial recording amongst most dairy farmers around the 
world (González, Steiner, Gassner, & Regula, 2010; Jones et al., 2015; Kayitsinga, Schewe, Contreras, 
& Erskine, 2017). Most farms would complete an antimicrobial regime at the right dose, and most 
farmers, instead of veterinarians, administer the antimicrobial regimes (Hyde et al., 2017; Jones et 
al., 2015; McDougall et al., 2017).  
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The majority of dairy farms discard milk from cows undergoing antimicrobial treatment within the 
antimicrobial withholding period, others feed the milk to beef cattle or calves (Brunton, Duncan, 
Coldham, Snow, & Jones, 2012; Higham et al., 2018). Feeding of milk with traces of antimicrobials as 
is the case with milk from cows undergoing antimicrobial treatment (De Ruyck & De Ridder, 2007; 
Han et al., 2015; Meara, 1958; Riediker, Diserens, & Stadler, 2001; Sisodia, Gupta, Dunlop, & 
Radostits, 1973; Soledad-Rodríguez, Fernández-Hernando, Garcinuño-Martínez, & Durand-Alegría, 
2017) has been strongly linked to the development of antimicrobial-resistant strains of bacteria from 
calves (Aust et al., 2013; Brunton et al., 2012; Langford, Weary, & Fisher, 2003). The appearance of 
resistant strains of bacteria and other microbes in the environment, especially agricultural lands pose 
a significant threat not only to persons directly involved in the agricultural industry but also to the 
population at large due to the transmission of these strains of microbes through the food chain 
(Allen, 2014; Rebecchi, Pisacane, Callegari, Puglisi, & Morelli, 2015; Wellington et al., 2013). At 
present, bacteria have developed resistance to most natural and synthetic antimicrobials (Brown & 
Wright, 2016; D'Costa, McGrann, Hughes, & Wright, 2006). This phenomenon is similar in Europe 
(Liebana et al., 2012; Tang et al., 2017), America (Allen, Levine, Looft, Bandrick, & Casey, 2013; 
Michael et al., 2015), and in NZ (Hill, Yung, & Rademaker, 2011; Priest et al., 2017; Ravi, Zhu, Luey, & 
Young, 2016; Toombs-Ruane et al., 2017). In NZ, the main veterinary uses of antimicrobials (57% of 
the total of 93 000 kg/year) are for growth promotion and prophylaxis across cattle, poultry, and pig 
farming (Harrison et al., 2020; Sarmah, Meyer, & Boxall, 2006b).  
1.9 Conventional versus organic dairy farming in NZ 
In NZ, a predominantly agricultural nation, the number, and intensity of dairy farming have been 
increasing since the turn of the century (Foote, Joy, & Death, 2015). Dairy farming is one of the major 
farming practices in NZ and produces 3.5% (17 b NZD) (DairyNZ, 2019) of the gross domestic product 
of the country whiles contributing 3.3% of total global milk production (Baskaran, Cullen, & Colombo, 
2009; Livestock Improvement Corporation Limited & DairyNZ Limited, 2019).  
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The total number of milking cows in NZ is about 4.9 million from 11 559 herds at an average of 431 
cows/herd. Of these, 932 363 cows from 191 herds are found in the Canterbury district of the South 
Island (DairyNZ, 2019). Dairy farming in NZ is mainly pastoral all year round (Chobtang et al., 2017; 
Chobtang, Ledgard, McLaren, Zonderland-Thomassen, & Donaghy, 2016; Compton, McDougall, 
Young, & Bryan, 2014), unlike most other members of the Organisation for Economic and 
Cooperation Development (OECD) countries. Dairy cows are fed mainly on different cultivars of 
ryegrass (Lolium spp.) and legume foliage of clover (Trifolium spp.) (Beukes et al., 2014; Ledgard, 
Schils, Eriksen, & Luo, 2009; Moot, 2013; Thom, Popay, Waugh, & Minneé, 2014), with the occasional 
crops of kale (Brassica oleracea spp. acephala), turnips (Brassica rapa subspp.), chicory (Cichorium 
intybus), and fodder beet (Beta vulgaris subsp.) during the autumn and winter months (Beukes et al., 
2014; Beukes et al., 2012; Doole, 2014). Irrigation on dairy farms is mainly by rivers, streams, creeks, 
and wells around the farms as well as rainwater collected into tanks and dams (Flemmer & Flemmer, 
2007; Martin et al., 2006; Zonderland-Thomassen & Ledgard, 2012). The NZ dairy farming system 
causes circulation and close interaction between the livestock, the soil microbiome, nutritional 
elements, other chemicals, their residues, and metabolites (Chobtang et al., 2017; Loganathan et al., 
2003; Williams & Haynes, 1990), especially on a conventional dairy farm. The organic dairy farms, 
however, do not use any chemically formulated nutritional supplements.  
The forage-based feed has a lower energy content/kg than grain-based feed, meaning the grass need 
to be of high quality (Chobtang et al., 2017; Monaghan et al., 2007). Therefore, the use of fertilizers, 
herbicides, and other agrochemicals is common in the NZ conventional dairy farming industry 
(Bahmani, Thom, Matthew, Hooper, & Lemaire, 2003; Bouton, 2007; Eerens & Lane, 2004; 
Ghanizadeh & Harrington, 2019; Laidlaw & Frame, 2013; Rahman, Thompson, & Nicholson, 1990). 
Some of the common herbicides used on NZ farms such as phenoxy, benzoic acid, dicamba, and the 
pyridine groups have long residual activity in the soil (Ghanizadeh & Harrington, 2019). Therefore, it 
is plausible that these substances have some effect on the microbiome of the conventional dairy 
farm soils. Apart from these, the conventional dairy farming industry uses about 93 000 kg of the 
active ingredient of commercial antimicrobials annually (Harrison et al., 2020; Ministry for Primary 
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Industries, 2019; Sarmah et al., 2006a), residues and or metabolites of which get deposited in the soil 
and or water bodies on the farm. Organic dairy farms, however, do not use agrochemicals, fertilizers, 
and commercial antimicrobials (Organics Aotearoa New Zealand, 2016). 
The total land area of NZ used for dairy farming is about 1.74 million ha. Of this, 2.45% is used for 
organic dairy farming while the remaining 97.45% is for conventional farming (DairyNZ, 2019; Massey 
University, 2006; Organics Aotearoa New Zealand, 2016). Organic dairy farming in NZ is attractive 
because of the perception of ecological friendliness (Mzoughi, 2014; Tuck et al., 2014), the better 
environmental aspect of nitrogen balance (Anglade et al., 2015; Hansen et al., 2000; Kumar, Patel, 
Bahadur, & Meena, 2016) and decreased potential of eutrophication due to non-use of fertilizers 
(Halberg, 2012; Rosati & Aumaitre, 2004; Shah, Bansal, & Singh, 2018). These conditions improve soil 
and water health (Amin, Karsten, Veith, Beegle, & Kleinman, 2018) and reduce resource intensity and 
greenhouse gas emissions (Squalli & Adamkiewicz, 2018). This was indicated in long-term studies by 
Fließbach, Oberholzer, Gunst, & Mäder (2007) and Hartmann, Frey, Mayer, Mäder, & Widmer, 
(2015).  
A four-year NZ study initiated by Massey University, in NZ, compared organic dairy farming to 
conventional dairy farming and did not find any significant differences in the overall productivity of 
the two systems (Kelly et al., 2005). However, the cost of the NZ pastoral dairy organic farming was 
found to be less than the cost of their counterparts in the European Union (EU) and the USA systems 
(Shadbolt, Kelly, & Holmes, 2005). Although the rules governing organic farming may vary from 
country to country, in NZ, Australia, and most European countries, an organic farm needs to be 
accredited by a recognised certifying body (Fouilleux & Loconto, 2017). The European organic 
definition of holistic production systems based on cultural, biological, and mechanic instead of 
artificial means has set the standard for organic farming in other parts of the world (Dabbert, Haring, 
& Zanoli, 2004) and is strictly adhered to by NZ organic dairy farmers. The restricted (or zero) use of 
antimicrobials, herbicides, pesticides, and synthetic fertilizers in organic farming helps in combating 
the rise in AMR microbes from the soil because exposure to, and subsequent development of 
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resistance by microbes to pesticides, leads to the development of resistance to antimicrobials 
(Kurenbach et al., 2017; Ramakrishnan et al., 2019; Shafiani & Malik, 2003). 
1.10 Background to the study 
There is a positive correlation between the increased use of an antimicrobial group and the 
development of resistance against that group of antimicrobials (Korpela et al., 2016; Megraud et al., 
2013; Seppälä et al., 1995). This is because the development of resistance by bacteria is mainly due 
to evolutionary pressure created when bacteria are exposed to sub-doses of antimicrobials, their 
metabolites, and other chemicals (AliAbadi & Lees, 2000; Andersson & Hughes, 2014; Cassidy, 
Donnelly, & Tunney, 2010; Grenni, Ancona, & Caracciolo, 2018). This occurs, especially when 
antimicrobials are used as growth promoters, with the continuous exposure of bacteria to low doses 
of antimicrobials (Grenni et al., 2018; Van Boeckel et al., 2015). Other authors include the deposition 
of agrochemicals and their metabolites as well as heavy metals from the industry as factors that 
cause these evolutionary pressures to the soil microbiome (Coutinho et al., 2013).  
The livestock on a dairy farm has constant interaction with the soil microbes due to the amount of 
soil cattle consume whilst grazing (Cunha & McDowell, 2012; Mayland, Shewmaker, & Bull, 1977), 
maybe about 0.6% of total dry matter of feed intake (Fries, Marrow, & Snow, 1982) approximately 
180-320 kg/animal/year (Healy, 1968). The cattle pass out large amounts of E. coli in their faeces 
(Dargatz et al., 2013; Maule, 2000; Söderlund et al., 2016), which assimilate into the soil and grass, 
only to be taken up later by the cows. So the cycle continues, with possibilities of transmission to 
humans (Alharbi et al., 2018; Godziszewska et al., 2018; Muloi et al., 2018; Rainard, 2017). Several 
studies have shown that pathogenic microbes such as E. coli O157:H7, Salmonella spp., Listeria 
monocytogenes, Mycobacterium paratuberculosis, several enteric viruses and protozoans, traced to 
livestock have caused disease outbreaks in human populations (Aijuka & Buys, 2019; European Food 
Safety Authority, 2015; Gagliardi & Karns, 2000; Goberna et al., 2011; Li, Subbiah, & Dvorak, 2019; 
Spencer & Guan, 2004). NZ is all too familiar with this phenomenon (Baker, Thornley, Lopez, Garrett, 
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& Nicol, 2007; Baker, Lopez, Cannon, De Lisle, & Collins, 2006; Jaros et al., 2013; Moore, Drew, 
Davies, & Rippon, 2017; Nugent, 2011). 
The NZ dairy industry is a big player in the global dairy market by contributing 3.3% of the total dairy 
product consumption in the world (DairyNZ, 2019, 2020). The industry is predominantly of cattle 
contributing approximately 15.1 billion NZD to the economy as of 2017-18, forecast to rise by 5.5 % 
to 17.6 billion by the year ending June 2019 (Ministry for Primary Industries, 2020). A total of  
7 604 kg, 11% of the national total antimicrobial sold was to the industry in 2017 and the trend had 
increased in the subsequent years (Ministry for Primary Industries, 2019).  
The use of antimicrobials in the conventional dairy farming system compared to the highly restricted 
to none-usage in the organic dairy farming system in NZ may create conditions that drive the changes 
in the AMR status of E. coli in their soils differently.  
1.11 Aims  
This study aimed to: 
• Adopt a method for antimicrobial susceptibility/resistance analysis that would isolate a 
diverse range of E. coli isolates from the soil of organic and conventional dairy farm soils. 
Such a method may not show bias towards any particular antimicrobial group by the E. coli 
isolates and analyse the diversity by quadruplex PCR phylogenetic typing (Clermont, 
Christenson, Denamur, & Gordon, 2013). 
• Analyse the phylogeny of the DfSEC isolates to determine whether E. coli strains commonly 
associated with animal species other than bovine may be found in the bovine environment, 
which may indicate possible transfer from other domestic animals. 
• Assess the antimicrobial susceptibility of the dairy farm E. coli (DfSEC) isolates from organic 
and conventional dairy farming systems by the Kirby-Bauer method (Hudzicki, 2009) for the 
comparison of the effect of the two systems on the antimicrobial susceptibility/resistance of 
the isolated E. coli strains. 
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• Assess the genetic properties of the DfSEC using whole-genome sequenced (WGS) 
information analysed by bioinformatics software packages of the DfSEC isolates to compare 
the effect of the two dairy farming systems on resistance and virulence genes encoded by E. 
coli isolates from the two dairy farming systems. 
• Analyse the relatedness of the DfSEC isolates from the four farms located in the same 
district, within a 20-25 km radius of each other using whole genome multi-locus sequence 
typing (wgMLST) of E. coli (Clermont, Gordon, & Denamur, 2015) for the possibility of 
transfer of E. coli between the farms. 
This information would assist in addressing issues that have earlier been raised by different 
researchers regarding AMR in E. coli from the dairy farm environment: 
• Antimicrobial resistance threatens the continuous use of antimicrobials to deal with 
infectious bacteria diseases in medicine, veterinary, and plants. 
• The use of antimicrobials in agriculture adds to the development and spread of AMR globally. 
• The transfer of antimicrobial-resistant bacteria from agricultural soils to humans is plausible.  
• E. coli is one of the most important bacteria regarding AMR and this poses problems in the 
Geraldine district of South Canterbury of the South Island of NZ as it does globally. 
Such information could be relied upon by the various AMR controlling stakeholders to make 
substantiated decisions on the use of antimicrobials in NZ. Data from this study could also be used 
for future studies on the topic. 
 
.   
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Chapter 2 
Isolation and identification of dairy farm soil E. coli for antimicrobial 
resistance studies 
2.1 Introduction 
Improvements made in culture media and techniques have advanced microbiological research 
(Bonnet, Lagier, Raoult, & Khelaifia, 2020; Fairfax, Bluth, & Salimnia, 2018; Lagier et al., 2015). The 
isolation of any particular species of bacteria has traditionally been based on culture techniques (Das 
et al., 2019; Haruta et al., 2006; Lagier et al., 2015; Lazcka, Campo, & Muñoz, 2007), using an array of 
specific and/or selective media as a tool to identify and isolate different bacteria (Apostolakos, 
Mughini-Gras, Fasolato, & Piccirillo, 2020; Hinenoya et al., 2020; Oyeniran et al., 2020; Pagès, Ogier, 
& Gaudriault, 2020). Since soils contain a very wide variety of bacteria the use of selective media 
seldom yields a single species (Bonnet et al., 2020; Patel, 2016) and contamination is bound to make 
such an approach tedious and time-consuming (Ohtsuka et al., 2019). Most researchers have 
countered this problem by including antimicrobial(s) in the selection media (Bennett, MacPhee, & 
Betts, 1995; Bonnet et al., 2020; Hustá, Ducatelle, Haesebrouck, Van Immerseel, & Goossens, 2020; 
Ibekwe & Grieve, 2003; Zadik, Chapman, & Siddons, 1993). However, if the resulting isolated E. coli is 
to be used for an AMR study, the chance of biasing the study by obtaining E. coli with specific AMR 
genes exists. 
E. coli isolates from the soil environment are stressed (Evans & Wallenstein, 2012; Manzoni, Schimel, 
& Porporato, 2012; Moll & Engelberg-Kulka, 2012; Rangel, 2011) and the presence of an energy 
source may help to repair bacteria strains when culturing them in vitro (Aldsworth, Sharman, & 
Dodd, 1999; Hecker & Völker, 2001; Samson & Cairns, 1977). Escherichia coli (EC) broth contains 
tryptone (0.02 g/mL) and lactose (0.005 g/mL) as an energy source to help the recovery of stressed E. 
coli isolates by contributing to the repair of damaged organelles (Chou & Cheng, 2000; Michel, 2005; 
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Shafiei, Zarmehrkhorshid, Mounir, Thonart, & Delvigne, 2017). Phosphate buffered saline (PBS) on 
the other hand, does not contain energy sources and would neither cause the multiplication of cells 
during incubation nor contribute to the repair of stressed cells.  
All E. coli strains share the ability to be cultivated on commonly used selective MacConkey agar 
(MacConkey, 1905; MacConkey, 1900), eosin methylene blue (EMB) (Neidhardt, Bloch, & Smith, 
1974), nutrient agar with 4-Methylumbelliferyl ß-D-Glucuronide (NMUG) (Rice, Baird, Eaton, & 
Clesceri, 2012; Rice, Covert, Johnson, Johnson, & Reasoner, 1995), EC broth (Bordner, 1991; Brenner 
et al., 1993; Paul, 1980) and tryptone bile X-glucuronide (TBX) agar (Vergine, Salerno, Barca, Berardi, 
& Pollice, 2017). The use of common culturing methods could safely be employed without bias to 
obtain a wide range of strains of the organisms, as was shown in studies by Mellmann et al., (2011), 
and Van Veen, Claas, & Kuijper (2010). 
According to Jozefczuk et al. (2010) stressed cells need energy in repairing damaged organelles at the 
appropriate temperature. Bennett & Lenski, (1993) reported a 40-50% improvement in E. coli cell 
fitness at 42⁰C but not the multiplication of the cells. Thus a careful manipulation of the incubation 
media and the temperature of incubation may be employed in culturing a wide variety of strains of a 
bacteria species from an environment such as the dairy farm soil. The use of standard microbiological 
culturing techniques was proposed for the isolation of a variety of E. coli strains from the dairy farm 
soils for this study. 
This study aims to isolate a wide variety of E. coli strains that are not biased toward the possession of 
AMR genes from the farm soil environment.  
2.2 Method development 
A triplicate experiment was conducted to compare EC broth (Oxoid, CM0853 Thermo Scientific™, 
Auckland, NZ) an enrichment selective medium and phosphate-buffered saline (PBS) solution which 
serves to dislodge bacteria from the soil material as a wash medium (Fatima, Pathak, & Rastogi 
Verma, 2014; Ghosh & LaPara, 2007; Toljander, Artursson, Paul, Jansson, & Finlay, 2006), at three 
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different temperatures of 37°C, 42°C, and 44.5°C. This was to determine the appropriate incubation 
medium and temperature that would result in the optimal isolation of potential E. coli from farm 
soils. Templeton loam soils collected from the Lincoln University conventional dairy farm and the 
Lincoln University Biological Husbandry Unit (BHU) were used for these experiments. Statistical 
analysis was done by SigmaPlot 14.0 Kruskal-Wallis ANOVA on ranks. 
A hand-held auger of 40 mm diameter and 300 mm of depth and a garden trowel was used to collect 
soil samples including foliage and roots. These were then stored in labelled sterile 1 000 mL screw-
capped Shott bottles. Samples were collected from 10 different paddocks at each location. Five 
random samplings of ⁓200 g were made per paddock into ⁓1 000 g of soil/bottle/paddock. Five 
sampling points with equal distances between them were measured by foot-steps from the paddock 
gate to the nearest watering trough. 
An aseptic technique was used to prevent contamination of samples between different farms. 
Equipment was washed with tap water, disinfected with 1% VirkonTM solution dried, and sprayed 
with 70% ethanol. On all farms, during all sampling times, paddocks, where soil samples were taken, 
had been grazed within the last 24-48 h.  
All samples were processed within 24 h of their collection. Twenty-five g of a paddock’s composited 
soil was mixed with 225 mL of EC broth (Oxoid™ CM0853 Thermo Scientific™, Auckland, NZ) in a  
2 000 mL sterile stomacher bag. The stomacher bag with the soil was then shaken using a stomacher 
(Interscience BagMixer®, France) for one min at three stroke/s, to form a soil slurry. The soil slurry 
was then put into a sterile cotton-plugged 500 mL conical flask and incubated in a shaker-incubator 
(Thermo Scientific™ MaxQ 4 000, Auckland. NZ) at 37°C, 42°C or 44.5°C at 1 g for 8-12 h (Hakalehto 
et al., 2010; Patel et al., 2014). A triplicate experiment was conducted at each of the selected 
temperatures for each ⁓1 000 g soil sample. One mL of solution was pipetted from the supernatant 
into 9 mL of sterile PBS solution in 15 mL Eppendorf® tubes and gently vortexed to represent a 10-1 
dilution. A serial dilution was then prepared from 10-1 to the 10-6 diluent. From the diluents, 100 µL 
 32 
of the solution was plated onto MacConkey agar (Oxoid, CM0945 Thermo Scientific™, Auckland, NZ), 
spread, and incubated at the E. coli physiological optimum temperature of 37°C for 24 h in duplicate 
(Kobayashi, Suehiro, Cach Tuyen, & Suzuki, 2007). A 0.5 nm OD600 (SmartSpec® Bio-Rad Laboratories 
Pty. Ltd, Auckland, NZ) cell suspension of E. coli ATCC25922 was prepared and plated on MacConkey 
agar for comparison, as a positive control. Five colonies, each from a separate agar plate showing a 
reddish-pink colony with precipitate typical of E. coli on the MacConkey agar plates were selected 
and streak plated onto EMB agar (Oxoid, CM0069 Thermo Scientific™, Auckland, NZ). This was then 
incubated at 37°C for 24 h. A single typical greenish metallic-sheen-coloured colony similar to the E. 
coli ATCC25922 positive control organism was selected from each plate and streak-plated onto 
NMUG agar (Oxoid, CM0945 Thermo Scientific™, Auckland, NZ). A colony from the NMUG agar plate 
was then Gram-stained for the typical E. coli morphology and colouration of single pink rod-shaped 
cells. A colony from the NMUG agar plate showing a bluish fluorescence at 366 nm wavelength of UV 
was later streaked onto a TBX agar (Oxoid, CM0945 Thermo Scientific™, Auckland, NZ) and incubated 
at 37°C for 24 h (Figure 2.1). The use of TBX agar further substantiated E. coli specificity as well as the 
ability to sight contaminating colonies without the need of UV lamp as with NMUG agar when -80°C 
stored samples were cultured.  At this stage, cultured colonies that gave a greenish colouration on 
TBX agar had their identity confirmed by PCR according to Bej, Dicesare, Haff, and Atlas (1991) 
protocol.  
Future isolation procedure may be by spread plating diluents of soil slurry onto TBX agar without the 
previously mentioned E. coli selective agars. This would reduce labour and use of materials. Further 
the soil slurry may also be divided into different Eppendorf tubes. Number of Eppendort tubes 
required would be as many as many are required of E. coli isolates per composited soil sample. For 
example in this study, 10 isolates where desired from a composited 1 kg farm soil samples. Thus the 
soil slurry from the sample could be divided into 10X 15 ml Eppendorf tubes before incubation at 
44.5°C in EC broth. This would eliminate of isolating E. coli from a single clonal ancestry as an isolate 
would be selected per tube.
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Figure 2.1 Sequential use of selective/indicative agar media for the isolation of potential dairy farm soil E. coli isolates. 
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The tip of a sterile 200 mL pipette tip was used to pick E. coli cells from a separated single colony and 
put into 20 mL ultrapure DNA/RNA-free water (GIBCO™, Thermo Scientific™, Auckland, NZ) in a 1.5 
mL Eppendorf® tube to make a bacterial cell suspension. The cell suspension was then heat-lysed 
(Brian et al., 1992) at 95°C for 5 min in a heat block (AcuBlock™ Labnet International INC. NJ, USA) 
and centrifugated (Eppendorf® Minispin® plus, Sigma-Aldrich, Auckland, NZ) at 4 000 g for 5 min, a 
2 µL aliquot of the heat lysate bacteria suspension was then used as the DNA template for the E. coli 
specific PCR (Bej, Dicesare, et al., 1991). All DfSEC isolates used for the study were species identity 
confirmed by PCR. Primers used were: Forward; 5'-AAAACGGCAAGAAAAAGCAG-3' and Reverse; 5'-
AC GCGTGGTTACAGTCTTGCG-3' located within the uidA structural gene of E. coli as outlined by Bej et 
al. (1991) and also cited by numerous authors (Brasher, DePaola, Jones, & Bej, 1998; Chigor, Ibangha, 
Chigor, & Titilawo, 2020; Iqbal et al., 1997; Khan et al., 2007; Kibbee, Linklater, & Örmeci, 2013; 
Maheux et al., 2009; Molina IV & Lowe, 2012; Ntuli, Njage, & Buys, 2017). A 20 µL master mix of 0.2 
µL of Taq polymerase, 2 µL of 10X PCR buffer, 2 µL of Q (Bio-Rad Laboratories Pty. Ltd, Auckland, NZ), 
2 µL of MgCL2, 0.8 µL each of forward and reverse primers (10 mM), 0.8 µL of dNTPs (10 mM) with 
DNA template and made up to 20 mL with ultra-pure DNA/RNA-free water. The mixture was placed 
into a thermocycler (Labnet MultiGene TC 9600G. Sigma-Aldrich, Auckland NZ) for 30 cycles at 94°C 
denaturing for 1 min and primer annealing at 55°C for 1 min and extension at 72°C for 3 min. The PCR 
product was visualised following a 2% agarose gel electrophoresis 1X TBE buffer, with 0.07 µL 
Sybrsafe (Invitrogen®, Auckland, NZ)/mL of gel, run at 90 V for 60 min and visualised with a 
molecular imager (Gel Doc™ XR+ Bio-Rad Laboratories Pty. Ltd, Auckland, NZ). The farm soil E. coli 
isolates were compared to E. coli ATCC25922 for the E. coli specific molecular band size of 
approximately 147 bp (Brasher et al., 1998) referenced to the 1 kb+ molecular marker (Fisher 
BioReagents™, Thermo Scientific™ Auckland, NZ) (Figure 2.3). 
A 50 µL -80°C glycerol stock of 75% brain heart infusion broth (Oxoid, CM1135 Thermo Scientific™, 
Auckland, NZ): 25% glycerol (Fisher Scientific, Leicester, UK) was prepared from a single greenish 
colony from the TBX agar plate in a 1.8 mL cryovial (Tarsons CRYOCHILL™ VIAL External threaded 
Starfoot base-sterile 1.8 mL Kolkata, India) for storage and used for all future analysis.   
 35 
2.3 Results  
Soil samples from the biological husbandry unit and the conventional dairy farm did not show 
notable differences in the number of potential E. coli colonies across the various plates. Incubation 
with EC broth at 44.5°C resulted in 90% of the colonies that showed the typical E. coli colony 
morphology after tandem culturing on the selected E. coli specific agars being confirmed by the E. 
coli specific PCR across all dilution plates from both farming systems (Table 2.1). Incubation in EC 
broth at 42°C also gave a ratio of an E. coli: non-E. coli colony and cellular morphology of 9:1 (90%). 
Incubation of the dairy farm soil in PBS at 37°C resulted in a low number of potential E. coli isolates 
compared to non-E. coli isolates (> 0.1) ratio. The ratio of potential E. coli isolates to that of non-E. 
coli isolates on MacConkey agar after 12 h of incubation, either with PBS solution at 37°C, 42°C or 
44.5°C and EC broth at 37°C, 42°C or 44.5°C varied significantly (P < 0.001), using the Kruskal-Wallis 
ANOVA on ranks (SigmaPlot 14.0) (Table 2.1). Incubation in EC broth at 42°C and but not 44.5°C 
resulted in potential E. coli isolates with comparatively larger colonies compared to incubation in PBS 
at the same temperatures (Figure 2.2). This improved the ease of selecting an isolated colony for 
further analysis without contaminants. Agar plates that were at lower dilutions than 10-6 diluents 














Figure 2.2 Comparison of incubation media  
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Table 2.1 The mean ratio of potential E. coli to non-E. coli isolates 
  Temperature (°C)  
Incubation medium 37 42 44.5 
PBS 0.01± 0.09 0.50± 0.04 0.25± 0.05 
EC broth 0.25± 0.09 0.90± 0.09 0.90±0.01 
 
A triplicate isolation experiment from dairy farm soil slurry after 12 h incubation at 37°C, 42°C, and 
44.5°C was conducted to determine the most effective media and incubation temperature for best 
isolation results. At a ratio of 49:1, the colonies that showed typical E. coli characteristics on 
MacConkey agar showed positive characteristics of green-metallic-sheen colonies on EMB and 
further gave a bluish fluorescence on NMUG under 322 nm UV lamp. All isolates (100%) with 
greenish colonies on TBX agar, were identified as E. coli specific using the uidA-based PCR assay (Bej, 
McCarty, et al., 1991). 
In all, 200 E. coli isolates with bluish fluorescence at 322 nm UV showed greenish colonies on TBX 
agar and molecular band ⁓147 bp on agarose gel electrophoresis using 1xTBE buffer of PCR for the 






MM=Molecular marker  
Ref.= E. coli ATCC25922 
BHU1, BHU2 = Biological Husbandry Unit isolates 1&2 
CDF1, CDF2 = Conventional Dairy Farm isolates 1&2 
Figure 2.3. Confirmation of the species identity of presumptive E. coli isolates from dairy farm soil 






MM Ref. BHU1 BHU2 CDF1 CDF2
Fisher BioReagents™ 1kb+ MM
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2.4 Discussion  
As an incubation medium, the EC broth had the potential to cause multiplication of the E. coli 
population in the soil samples which would result in isolates with a common ancestry (Maloy, 1990; 
Somova, 2020). However, the culturing temperature of 44.5°C, which is outside of the physiological 
optimum temperature of 37°C for E. coli (Ron & Davis, 1971) may have limited such a phenomenon 
as demonstrated by Lenski & Bennett (1993), Hunke & Betton (2003) and Jozefczuk et al. (2010) in E. 
coli heat-stressed experiments. Ron & Davis (1971) explained that the limited multiplication of E. coli 
cells at temperatures between 40-45°C was due to the heat-sensitive nature of the enzyme 
homoserine trans-succinylase (in comparison with other essential enzymes) which decreases 
methionine and thus protein synthesis and slows multiplication.  
E. coli in the soil are stressed (Evans & Wallenstein, 2012; Manzoni et al., 2012; Moll & Engelberg-
Kulka, 2012; Rangel, 2011) and need energy for repairs (Kamarthapu et al., 2016). PBS does not 
contain any energy source and did not improve culturing of potentially stressed soil E. coli isolates by 
repair of cell structures or organelles. This would explain the comparatively smaller colonies obtained 
from PBS incubated soil supernatants.  
The results in this study were similar to other studies where culturing methods were used in the 
isolation of E. coli and other microbial species from environmental samples without the use of 
antimicrobials in the isolation procedure (Ahmed & Shimamoto, 2014; Amoafo, Gooneratne, & On, 
2020; Chaudhary et al., 2013; Ishii, Ksoll, Hicks, & Sadowsky, 2006; Zhao et al., 2016). In a method 
development study Amoafo, Gooneratne, & On (2020) cost-effectively isolated > 200 strains of 
Staphylococcus aureus whose identity were PCR confirmed from conventional and organic dairy farm 
soils by modification of existing culturing techniques. Apostolakos et al. (2020) used no 
antimicrobials in the isolation process of E. coli from cloacal and carcass samples of broiler chickens 
from Northern Italy and reported no bias in the isolated E. coli profile to antimicrobials and the 
subsequent genetic study. However, when the authors included cefotaxime antimicrobials in the 
isolation process of an earlier study (Apostolakos, Mughini-Gras, Fasolato, & Piccirillo, 2019) there 
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was a bias towards ESBL/AmpC resistant E. coli isolates. In another study, Habteselassie et al. (2008) 
used selected antimicrobials in tandem on soil samples to bias the selection of E. coli strains collected 
in an experiment on the factors affecting the survival and growth of E. coli in the soil environment. 
In conclusion, this protocol for the isolation of dairy farm soil E. coli was sensitive (100% of soil 
samples examined yielded E. coli isolates), appropriate (selective conventional antimicrobial agent 
not used) and cost-effective approach of obtaining a diverse (belong to different phylogenetic 
groups, varied antimicrobial susceptibility and growth rate) range of > 200 E. coli strains with identity 





Dairy farm soil sampling  
 
3.1 Sampling sites 
The Geraldine and Pleasant Point regions are a farming community involved in crops (grains and 
vegetables), forestry, and animal (dairy cattle, sheep, and deer) farming. The region comprises the 
counties of Geraldine, Levels, Mackenzie, and Waimate. It is bounded in the north by the Rangitata 
River, Forest Creek, and part of the Two Thumb mountain range, in the west by the crest of the 
Southern Alps, in the south by the Waitaki River, and in the east by the Pacific Ocean. Of the total 
area of 137 600 km2, 86% is farmed. The soils of this Canterbury region are silty sandy loams, formed 
mainly from greywacke alluvium. The soils have variation in-depth as they are underlined with gravel 
and boulders. The soil may be stony throughout its profile or maybe 20 to 100 mm of silt or sandy 
loams above the shingle (Landcare Research, Soil Map online https://smap.landcareresearch.co.nz/). 
The vegetation type on most dairy farm fields (paddocks in NZ) is ryegrass (Lolium sp.) with white and 
red clover (Trifolium repens and Trifolium pratense) swards.  
Within the Geraldine and Pleasant Point catchment of the South Island of NZ, are two organic dairy 
farms, each of which has a conventional dairy farm within 5-10 km distance. The Clearwaters (CW) 
organic dairy farm (GPS: 44°15'53.8"S 171°10'11.2"E) and Peel Forest (PF) conventional dairy farm 
(GPS: 44°00'50.4"S 171°16'26.4"E) are slightly closer together, about ⁓5 km apart. While the Totara 
Valley (TL) organic dairy farm (GPS: 44°14'17.5"S 171°04'02.1"E) and Mill Road (MRD) conventional 
dairy farm (GPS: 44°16'23.9"S 171°10'12.7"E) are also about 5 km apart. All four farms are located 
within a ⁓20-25 km radius. 
This presented a unique opportunity to study the effect that dairy farming husbandry systems with 
the use of antimicrobials, agrochemicals, and chemical fertilizers have on the AMR profile of E. coli 
isolated from their soils. These farms are similar in size, having 600-800 milking cows, stock 
concentration (cows/ha), with each husbandry stocking breeds of over 90% Holstein Friesian, 
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vegetation, and soil type. All four farms practice similar husbandry of twice a day milking, dates and 
methods of drying off, calving schedules, and breeding regimes. All farms have been in operation for 
over a decade, enough time for the type of husbandry system to have long-term effects on the soils 
and the microbes in the soils. 
Based on the results of the method development conducted in the preliminary study (Chapter 2), the 
same sampling and isolation methods were used in this main study. 
3.2 Sampling times 
The sampling of soils from the four dairy farms was conducted at four time-points with the 
probability of variation in E. coli characteristics being shaped by seasonal variations of soil moisture 
and temperature (Coneyworth et al., 2020; Mattiello, 2016). This is more so in New Zealand where 
dairy farming is mainly pasture-based (Cuttance et al., 2017; Li, Snow, & Holzworth, 2011) and 
geographically exposed to relatively high UV index (Bornman et al., 2015; Moran et al., 2004). To this 
effect, efforts were made to sample at different times of the year when different husbandry 
practices were undertaken in the New Zealand dairy industry and for consecutive years. 
Unfortunately, due to logistical problems, sampling during the summer months was missed (Table 
3.1).  
Table 3.1 Dairy farm soil sampling calendar  
Sampling order Season Month dairy farm practice year 
first soil sampling spring October start of calving to start of mating 2017 
second soil sampling spring October start of calving to start of mating 2018 
third soil sampling autumn March milking/grass pasture management 2018 




For each sampling time, > 200 dairy farm soil E. coli (DfSEC) isolates of at least 50 isolates per farm 
whose identity was confirmed by PCR (Bej, Dicesare, et al., 1991) were isolated from the four farms 
and stored in a 25% glycerol stock in BHI (Chapter 2) at a temperature of -80°C for future analysis. 
Such that in total, for this study, 814 DfSEC were isolated over the four-time sampling periods (Table 
A1.1). 
3.4 Discussion 
In this study, the choice of the experimental site enabled the elimination of bias that may have 
resulted from differences in climatic/weather conditions, soil, and vegetation types. Further, the 
location of Geraldine at the foothills of the snow-capped Southern Alps meant the farms sourced 
water from a location that was comparatively uncontaminated by human activity. This would 
arguably mean the E. coli isolates in the soil would only be affected by the practices on the farm, 
giving more meaning to the results of the experiment. The selected conventional dairy farms had an 
organic dairy farm located within a 5-10 km radius and this set up a scenario for comparison of the 
effect of the husbandry practices on the farms, limiting other confounding factors. However, cross-
contamination of the farms by wildlife (Nugent et al., 2011), shared contractors (Kerr & Layton, 1983; 
Rijswijk & Brazendale, 2017), and possibly waterways (Dymond, Serezat, Ausseil, & Muirhead, 2016; 
Monaghan, De Klein, & Muirhead, 2008) could not be ruled out. The soil sampling adopted in this 
study, from the paddock gate to the nearest water trough would have promoted the chances of 




Antimicrobial susceptibility testing of dairy farm soil E. coli isolates 
4.1 Introduction 
In an antimicrobial resistance study, antimicrobial susceptibility testing (AST) is used as an indicator 
of phenotype expression of resistance/susceptibility of a bacterium to a particular antimicrobial or 
class of antimicrobials (European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2019; 
Peng et al., 2017; Threlfall, Fisher, Ward, Tschape, & Gerner-Smidt, 1999). In medicine, AST helps to 
improve the precision in antimicrobial therapy to help reduce the burden that bacterial diseases 
cause, both to humans and in agriculture by reducing the unsubstantiated use of antimicrobials 
(Dietvorst, Vilaplana, Uria, Marco, & Muñoz-Berbel, 2020; Mohan et al., 2013). AST provides specific 
information for therapeutics and other antimicrobial usages (Dietvorst et al., 2020; Vineetha, 
Vignesh, & Sridhar, 2015). 
Frequently, AST is based on a modified version of the protocol formulated and standardised by W. M. 
Kirby and his colleague, A. W. Bauer in 1960, working at the University of Washington, School of 
Medicine (Bauer, Kirby, Sherris, & Turck, 1966). This was adopted by The WHO as the standard 
guideline for AST globally in the 1960s (Hudzicki, 2009). Antimicrobial susceptibility testing (AST) may 
be done in a liquid or solid medium (Choi et al., 2013; Clinical Laboratory Standards Institute (CSLI), 
2019; EUCAST, 2019; Humphries et al., 2018). With the solid agar medium (Kirby-Bauer method), a 
known concentration of an antimicrobial disc (~6 mm in diameter) is put on a known concentration 
of bacteria evenly spread over an agar medium (Hudzicki, 2009). After the incubation at optimal 
conditions, the area of inhibition of bacteria growth around the disc indicates the 
susceptibility/resistance of the bacteria to the antimicrobial used (CLSI, 2019; EUCAST, 2019; 
Humphries et al., 2018).  
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4.2 Materials and methods 
Mueller-Hinton (MH) agar plates (Oxoid CM0337 Thermo Scientific™, Auckland, NZ) were prepared 
according to the manufacturer’s instructions. Briefly, a solution of the agar base was sterilized by 
autoclaving at 121°C for 15 min and poured into a sterile Petri dish to a depth of 4 mm, dried, and 
stored in plastic bags at 4°C until use (Cockerill, 2011). Plates of MH agar used at all times were 
freshly prepared and not more than five days old.  
A single colony of the dairy farm soil isolated E. coli growing on a TBX agar plate at 24 h was used to 
inoculate 5 mL of 0.1 M PBS solution using a sterile microbiological loop and gently vortexed for 10 s. 
The turbidity of the bacteria suspension was compared to the turbidity of 0.5 McFarland standard 
solution (0.5 mL of 0.048 M BaCl2 to 99.5 mL of 0.18 M H2SO4) and measured by a photo 
spectrometer (SmartSpec3000™ Bio-Rad Laboratories Pty. Ltd, Auckland, NZ) to be between 0.08-0.1 
nm OD600 (EUCAST, 2013). 
Table 4.1 List of antimicrobials and their concentrations used for the study 
Antimicrobial Concentration µg Symbol 
cefoxitin 30 FOX30 
cefpodoxime 10 CPD10 
chloramphenicol 30 C30 
ciprofloxacin 30 CIP30 
gentamicin 10 CN10 
meropenem 10 Mem10 
nalidixic acid 30 Na30 
tetracycline 30 Te30 
 
A fresh sterile cotton bud was immersed in the bacteria suspension and pressed against the bottle 
container to remove the excess bacterial suspension and then used to make an initial mat spread 
onto the MH agar plate. This was repeated after turning the plate at 90° to obtain a uniform spread 
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of bacteria on the agar surface. Antimicrobial discs (Oxoid™ Thermo Scientific™, Auckland, NZ) for 
selected antimicrobials (Table 4.1) stored in a desiccant at 4°C were placed on the agar and firmly 
pressed using forceps sterilised by dipping in 95% ethanol and flamed. 
 
The agar plates were first held with the right-side-up (lid-side-up) for about 5 min and later inverted 
(within 15 min of plating) and incubated at 37°C for 24 h (Andrews & Testing, 2001). The inhibition 
zone diameters (mm) at the point of inhibition were measured using a ruler and interpreted into 
resistant (R), intermediate (I) and susceptible (S) reactions according to the European Committee on 
Antimicrobial Susceptibility Testing EUCAST (2015) breakpoints for the disc diffusion method of 
antimicrobial susceptibility testing (Table A1.1). However, for nalidixic acid, the breakpoint of 
inhibition zone used was as indicated by the British Society for Antimicrobial Chemotherapy (BSAC) 
methods for AST (Wootton, 2014) as the EUCAST (2015) document had ‘not applicatble’(N/A) for 
nalidixic acid on E. coli. Inhibition zones of the dairy farm soil isolated E. coli were compared to 
reference E. coli NCTC12241 and E. coli ATCC25922 in all cases as recommended by the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST) (2015). Records of the antimicrobial 
profile of at least 50 PCR confirmed E. coli (Bej, Dicesare, et al., 1991) from each farm for each of the 
four sampling times (spring 2017, spring, autumn, and winter of 2018) were recorded on a Microsoft 
Excel spreadsheet and data was analysed using the fit binary regression model in Minitab19 
statistical software at 95% confidence interval (CI). 
The criteria for the selection of the group of antimicrobials (Table 4.1) for this study was based on 
the following rationale. 
a) cefpodoxime as a third-generation cephalosporin and ESBL (Shankar & 
Balasubramanium, 2014) 
b) chloramphenicol, ciprofloxacin, gentamicin, meropenem, and tetracycline as listed by 
the World Health Organisation (WHO) essential medicine (Organization, 2019); 
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c) cefoxitin and meropenem as the yardstick for a potential ESBL resistant organism, as 
recommended by EUCAST for antimicrobial susceptibility testing (EUCAST, 2019); 
and 
d) nalidixic acid as a synthetic antimicrobial, resistance to which may be as the result of 
human activity only (Kyzioł, Khan, Sebastian, & Kyzioł, 2020; Michael, Dominey-
Howes, & Labbate, 2014).  
 
4.3 Results  
The AST for the four farms, over four sampling times against eight different antimicrobials with a 
total of 7 224 tests (Table A1.1) showed that 3.7% of the isolates tested were resistant to at least one 
of the eight selected antimicrobials. A summary of DfSEC isolates showing intermediate-
resistant/resistant to the selected antimicrobials is provided in Table 4.2 
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Table 4.2 Summary of DfSEC showing intermediate-resistance/resistance to selected antimicrobials 
  Antimicrobial 
 farm/season/year Te30 Na30 CPD10 CN10 MEM10 CIP30 FOX30 C30 Total 
Organic CWS17 11 0 15 0 4 0 12 0 42 
 CWS18 0 1 2 1 0 0 2 0 6 
 CWA18 2 0 2 0 0 0 2 0 6 
 CWW18 0 0 0 0 2 0 1 0 3 
 TLS17 1 0 10 0 0 0 18 0 29 
 TLS18 0 0 6 0 1 0 1 0 8 
 TLA18 0 0 3 4 1 0 11 0 19 
 TLW18 0 0 0 0 0 0 3 1 4 
Conventional MRDS17 1 6 4 0 8 0 5 0 24 
 MRDS18 1 1 3 0 1 0 2 4 12 
 MRDA18 0 0 2 0 0 0 8 0 10 
 MRDW18 0 0 5 1 0 0 11 0 17 
 PFS17 9 4 5 10 3 0 2 2 35 
 PFS18 6 0 2 0 0 0 2 0 10 
 PFA18 5 0 4 0 0 0 10 0 19 
 PFW18 2 0 3 0 0 0 9 2 16 




Statistical analysis showed a significant difference (P < 0.0001) between the eight different 
antimicrobials used and the sampling time point of the DfSEC isolates. When the different farming 
systems were compared but similar locations, the Peel Forest conventional dairy farm was 0. 65 
(odds ratio) times more likely to be resistant compared to the closely located Clearwaters organic 
dairy farm, but the DfSEC isolates from the Mill Road conventional dairy farm were 0.58 (odds ratio) 
less likely to be resistant compared to the closely located Totara Valley organic dairy farm. When 
similar farming systems but different locations were compared, the Peel Forest conventional dairy 
farm showed less chance of isolates being resistant compared to the Mill Road conventional farm 
with an odds ratio of 1.22. The Totara Valley organic farm had a higher chance of the DfSEC isolates 
being resistant compared to the Clearwaters organic farm with an odds ratio of 0.78 (Table 4.3). 
Table 4.3 Comparison between the antimicrobial profile of resistant dairy farm soil E. coli isolates  
by farming systems and geographical location over four seasons of sampling. At 95% CI 
Conventional farm 
 
Organic farm Odds ratio: CI 
Mill Road 
 
Totara Valley 0.58: 1.06, 2.09 
Mill Road 
vs 
Clearwaters 0.58: 0.36, 0.78 
Peel Forest Clearwaters 0.65: 0.43, 0.95 
Peel Forest 
 








Totara Valley vs Clearwaters 0.78:  0.53, 1.16 
 
Combined data from the two organic farms were compared to combined data from the two 
conventional farms (Table 4.4) and the spring of 2017 data showed a significant difference (P < 0.01), 
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with a higher prevalence of resistance in the organic farms compared to the conventional farms 
(odds ratio 1.72). However, in the spring and winter of 2018, the prevalence of resistance was 
significantly higher (P < 0.0001) in the conventional farms compared to the organic farms (odds ratio 
of 0.20, 0.08) respectively. In the autumn of 2018, there was no significant difference between the 
two farming systems regarding the prevalence of resistance (P = 0.29) but the organic farms showed 
0.74 less chance of showing resistance compared to their conventional counterparts (0.74 odds ratio 
of resistance). In this study, a comparison of the percentage resistance of the 814 DfSEC to the eight 
selected antimicrobials was compared between the organic farm soil isolates and their conventional 
farm counterparts at each sampling-time point. The P-value and odds ratio of the comparison was 
assessed at 95% CI. Overall, DfSEC isolates from the organic dairy farms showed a lower prevalence 
of resistance to the antimicrobials tested, compared to their counterparts from the conventional 
farms. (Table 4.4). 
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Table 4.4 Summary of resistance against select antimicrobials demonstrated by isolated dairy farm soil E. coli  
Season/year. Organic (n=2) vs Conventional (n=2) dairy farms. Confidence interval (CI) of 95% 
  % of DfSEC resistant to selected antimicrobials between conventional 





system FOX30 CPD10 CIP10 C30 CN10 Mem10 Na30 Te30 P-value Odds ratio: CI 
Spring 2017 organic 36.9 9.6 0.0 0.0 0.0 12.3 0.0 11.4 < 0.01 1.72: 1.14, 2.60 
conventional 21.0 5.4 0.0 0.0 2.0 26.9 2.9 6.7 
Spring 2018 organic 7.7 0.0 0.0 0.0 0.9 0.0 0.9 0.0 < 0.0001 0.28: 0.15, 0.52 
conventional 12.9 0.9 0.0 3.9 0.0 12.0 0.9 7.2   
Autumn 2018 organic 15.4 4.8 0.0 2.9 3.8 2.0 0.0 1.9 0.29 0.74: 0.42, 1.30 
conventional 13.1 0.0 0.0 0.0 0.0 3.0 0.0 4.3 
< 0.0001 
 
Winter 2018 organic 5.1 0.0 0.0 1.0 0.0 2.0 0.0 0.0 0.09:  0.03, 0.25 
conventional 20.5 5.9 0.0 7.0 3.0 0.9 1.0 1.0 
FOX30=cefoxitin 30 μg/disc: CPD10=cefpodoxime 10 μg/disc: CIP10=ciprofloxacin 10 μg/disc: C30=chloramphenicol 30 μg/disc 
CN10=gentamicin 10 μg/disc: Mem10= meropenem 10 μg/disc: Na30=nalidixic acid 30 μg/disc: Te30= tetracycline 30 μg/disc 
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4.4 Discussion  
In this study, the use of the Kirby-Bauer disc diffusion method for AST enabled the differentiation of 
DfSEC into resistant and susceptible isolates to a range of eight different antimicrobials. Since its 
adaptation by the WHO as a standard method for AST the Kirby-Bauer disc diffusion method has 
been widely used and has been compared positively to other phenotypic testing methods (Bhatt, 
Tandel, Shete, & Rathi, 2015; Bukhari, Ahmed, & Zia, 2011; Joseph et al., 2011; Murray, Niles, & 
Heeren, 1987; Vyas, Sharma, Kumar, Kumar, & Mehra, 2015). The choice of method for AST depends 
on the study organism (wild-type versus non-wild-type) and the antimicrobial of choice with regards 
to the availability of breakpoint data (CLSI, 2019; EUCAST, 2019). In this study, there was available 
data from the two frequently used guidelines on the antimicrobials used as well as the study 
organism of DfSEC. Although for nalidixic acid, the reference breakpoint used was for E. coli obtained 
from urinary tract infection studies EUCAST (2015). The disc diffusion method is easy to use (Bukhari 
et al., 2011) and available to the standard microbiological laboratory (Vyas et al., 2015). Besides, 
further testing using the phenotype screening kit MAST™ of combined double-disc synergy test 
(CDDST) (Chapter 5) was done to confirm the disc diffusion method used earlier in the study (Stuart 
& Leverstein-Van Hall, 2010). 
The antimicrobial profile of the DfSEC isolates from the conventional dairy farms where a significant 
amount of antimicrobials, herbicides, pesticides, and inorganic nitrogen-based fertilizers are 
frequently used indicated a higher percentage of resistant DfSEC isolates compared to isolates from 
the organic dairy farms during three of the four sampling-time points. However, the organic dairy 
farms were not devoid of antimicrobial-resistant strains as the spring 2017 sampling indicated a 
significantly higher prevalence of resistant isolates from the organic system compared to the 
conventional. In NZ, conventional dairy farming used about 11% (10 230 kg of antimicrobials) of the 
national antimicrobial usage in 2017 (Ministry for Primary Industries, 2019) and this trend has been 
increasing (Ministry for Primary Industries, 2019). Since about 30-80% of antimicrobial used is 
excreted whole or as metabolites (Manzetti & Ghisi, 2014; Schallenberg & Armstrong, 2004; 
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Srinivasan, Sarmah, & Manley-Harris, 2014), a significant amount of antimicrobials is excreted into 
the conventional dairy farm soils and impact the soils microbiome’s AMR status (Schallenberg & 
Armstrong, 2004), as opposed to organic dairy farming. For instance, a 2014-15 study in five different 
regions in New Zealand including North Canterbury indicated ~4.8 mg of active ingredient/population 
correction unit (PCU, defined as the mass of active ingredient divided by total biomass) to ~684 000 
cows. This is considered low compared to international standards (Bryan & Hea, 2017).  
It has been argued and confirmed by some authors that the use of antimicrobials and other 
agrochemicals in conventional dairy and other agricultural husbandry systems increases the amount 
of AMR bacteria and ARGs in the bacteria compared to the limited/non-usage of these chemicals on 
organic farms (Awad et al., 2014; Österberg et al., 2016; Schwaiger, Schmied, & Bauer, 2010). 
However, a study in four different European countries comparing the AMR from pig faecal samples 
from organic and conventional farms found no difference between the AMR of isolated microbes 
from the farming systems (Gerzova et al., 2015). Similarly, in this study, overall, the antimicrobial and 
other agrochemical usages by the conventional dairy farms in the Geraldine area of South Canterbury 
may not have affected the antimicrobial status of E. coli isolates in the farms’ soil significantly, 
compared to the limited/non-usage of antimicrobials and other agrochemicals by the organic dairy 
farms. This may also be attributed to the pastoral type of farming by both systems where the cows 
are held on a vast area of land all year (Hancock, 1950) round and not in the small defined area as in 
intensive dairy farming systems in other organisations for economic co-operation and development 
(OECD) countries (Hancock, 1950; Hillerton, Irvine, Bryan, Scott, & Merchant, 2017; Lewthwaite, 
1964). Secondly, the Geraldine area is a rural community of 2 301 in 2013 
(http://infoshare.stats.govt.nz/Census/2013) and 138 km from the nearest industrialised city of 
Christchurch. This would limit industrial and domestic waste and chemicals that may seep into the 
agricultural lands during rainwater run-offs and flooding times. Further, being located at the foothills 
of the snow-capped Southern Alps means the farms' source of water from rivers, streams, creeks, 
and wells are comparatively uncontaminated with chemicals that would impact the microbial 
population in their soils in comparison to that in other parts of the country.  
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The definition of AMR varies depending on whether the term is used clinically, epidemiologically, or 
gene-centrically with the comparison between wild-type and non-wild-type strains (Martínez, Coque, 
& Baquero, 2015). The definition of antimicrobials (Chapter 1) indicates that antimicrobials in the 
dairy farms soil could be from the soil’s natural microbiome as soil bacteria release antimicrobials 
into their environment to protect themselves from other bacteria (Martinez, 2009; Martínez, 2008; 
Martínez, 2012; Nesme & Simonet, 2015; Raaijmakers & Mazzola, 2012; Wellington et al., 2013). 
Thus in the organic or conventional dairy farms soil, the existence of antimicrobial agents and their 
metabolites irrespective of the impact of human activities cannot be ruled out (Berendonk et al., 
2015; Martínez et al., 2015). For instance analysis of soil collected from 12 organic farms in Nebraska, 
the USA between May and June of 2013 found 93% of the soil samples contained sulphonamides and 
tetracycline resistance genes (Cadena et al., 2018). 
However, the effect of an antimicrobial on the metabolism of a bacteria depends on the adequate 
concentration of the antimicrobial reaching the site of its action on the target microbe (Lietman, 
1986; Lobritz et al., 2015; Maier et al., 2018). As such, from the conventional dairy farm as opposed 
to the organic dairy farm, it would be expected that adequate concentrations of antimicrobials and 
their metabolites, as well as those of other agrochemicals, affect the soil’s microbiome to a greater 
extent.  
In this study, the soil samples from which E. coli isolates were isolated for their antimicrobial profiling 
were not screened for the presence of antimicrobials or their metabolites which, as previously 
argued, may affect the resistance/susceptibility status of the E. coli isolated from them (Li, 2014; 
Thiele‐Bruhn, 2003). However, since antimicrobials in the environment, especially the farm soil 
environment are ubiquitous (Martínez et al., 2015), it would be impossible to determine how much 
of it is due to human activities or otherwise unless time and quantity of antimicrobials from human 
activity deposited in that environment over a period were determined (Berendonk et al., 2015).  
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Chapter 5 
Confirmatory phenotypic screening for dairy farm soil E. coli 
showing resistance to selected antimicrobials 
5.1 Introduction 
Confirmatory phenotype screening of an organism for its potential to produce a resistant enzyme is 
indicated when reduced susceptibility to a group of antimicrobials is detected in a routine AST 
(Thomson, 2010). For the broad-spectrum β-lactam groups of carbapenems, monobactams, and 
cephalosporins the chosen antimicrobials are cefoxitin, cefpodoxime, and imipenem, respectively (Al-
Sarawi, Jha, Baker-Austin, Al-Sarawi, & Lyons, 2018; Earnshaw et al., 2013; EUCAST, 2013). The 
underpinning logic for this procedure, according to the Public Health England (2016) and Stuart & 
Leverstein-Van Hall (2010), is the need to effectively identify bacterial strains that produce the 
various classes of β-lactamases while differentiating them from strains whose resistance are 
conferred, either solely or in combination with other resistance mechanisms such as hyper-
expression of the efflux pump mechanism. This is because, clinically, antimicrobial resistance by the 
release of an antimicrobial degrading enzyme (agent) may be solved by the use of inhibitors like 
avibactam, vaborbactam, relebactam (Wong & van Duin, 2017), sulbactam, tazobactam, or clavulanic 
acid (Papp-Wallace & Bonomo, 2016) against the degrading enzyme, but not when the 
microorganism hyper-expresses the efflux pump or reduced permeability mechanism for 
antimicrobial resistance. For instance, some Enterobacteriaceae including E. coli and Pseudomonas 
auroginosa produce β-lactam hydrolysing enzymes, may hyper-express the efflux pump mechanism 
(Livermore, 2001), or change the cell permeability of an antimicrobial by modifications of their outer 
membrane porin proteins (Doumith, Ellington, Livermore, & Woodford, 2009).  
A confirmatory phenotype screening procedure tests an antimicrobial, and a known inhibitor(s) of 
the class of β-lactamase (Public Health England, 2016). Both double-disc synergy test (DDST) consists 
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of an antimicrobial disc only and the disc with only the inhibitor (Giske et al., 2011; Giske et al., 2013; 
Khosravi, Hoveizavi, & Mehdinejad, 2013; Pailhoriès et al., 2014) and the combined double-disc 
synergy test (CDDST), antimicrobial disc only and a disc with antimicrobial combined with enzyme 
inhibitor are widely used (Kumar, Arora, Mishra, & Dogra, 2018; Numanović et al., 2013; Pandya, 
Prajapati, Mehta, Kikani, & Joshi, 2011). The inhibition zone shown by the test organism to the 
antimicrobial is compared to the inhibition zone against the β-lactamase inhibitor. All the tests are 
based on the use of enzyme inhibitors such as boronic acid, cloxacillin, clavulanic acid, or 
ethylenediaminetetraacetic acid (EDTA) against positive and negative control organisms. When the 
difference in the distance as indicated by the manufacture of the kit being used is greater than the 
specified distance (mm) a judgment is made as to whether the test organism produces the β-
lactamase enzyme against the antimicrobial being tested for, or not.  
Presently, screening test kits available for confirmatory phenotypic screening are Oxoid (Dardilly, 
France) (Garrec, Drieux-Rouzet, Golmard, Jarlier, & Robert, 2011), Mast CO. (Liverpool, UK) 
(Nourrisson et al., 2015; Safari, Mozaffari Nejad, Bahador, Jafari, & Alikhani, 2015), direct-on-target 
microdroplet growth assay (DOT-MGA) (Correa-Martínez, Idelevich, Sparbier, Kostrzewa, & Becker, 
2019) and the βLACTAM method (El-Jade et al., 2018; Poirel, Fernández, & Nordmann, 2016). 
However, the βLACTAM method is based on a colour change of the hydrolysed β-lactam 
antimicrobial from yellow to red, of a carboxy-propyloxyimino-containing compound HMRZ-86 
(Hanaki et al., 2007; Hanaki, Kubo, Nakano, Kurihara, & Sunagawa, 2004; Morrison & Siu, 2000). The 
level of sensitivity and specificity of such chromogenic tests depend on the type of resistance 
mechanism, the species of bacteria, and the level and type of resistant expression as shown in a 
study by Renvoisé et al. (2013). 
5.2 Materials and methods 
A total of 200 isolates that showed resistance to FOX30 and Mem10 of the carbapenem antimicrobial 
group and/or CPD10 of the cephalosporin group of antimicrobials, zero inhibition zone (6 mm, disc 
diameter) to Te30, and > 15 mm diameter against C30 were selected as potential carbapenemase, 
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AmpC, and ESβL(s) producers and phenotypically screened. For the detection of AmpC and/or ESBL 
enzyme-producing E. coli isolates, MASTDISCS® Combi AmpC and ESBL Detection Discs D68C 
commercial kit (MAST™ Group Ltd, Liverpool, UK) were used. The test kit was made up of four 
different discs (Table 5.1). For the detection of carbapenemases class A [Klebsiella pneumoniae 
carbapenemase (KPC)] type, class B Metallo-β-lactamases (MBLs), and class D, oxacillinases-48-like 
(OXA-48) enzyme production (Doyle et al., 2012), the combined double-disc synergy test (CDDST) 
with MASTDISCS® combi Carba plus D73C (MAST™ Group Ltd, Liverpool, UK) kits were used (Table 
5.2). 
Table 5.1. MASTDISCS®kit (D68C) for phenotype screening for potential AmpC and extended-
spectrum β-lactamase-producing dairy farm soil E. coli isolates 
Disc label Disc content 
A cefpodoxime 10 µg 
B cefpodoxime 10 µg+ESβL inhibitor 
C cefpodoxime 10 µg+AmpC inhibitor 
D cefpodoxime 10 µg+ESβL+AmpC inhibitor 
 
All discs were stored at 4°C and used according to the manufacturer’s instructions and no expired 
discs were used. E. coli NCTC13351 was used as ESβL positive and E. coli ATCC25922 as ESBL, KPC, 




Table 5.2. MASTDISCS® (D73C) combi Carba plus for phenotype screening of potential 
carbapenemase-producing dairy farm soil E. coli isolates 
Disc label Disc content 
A* penem 
B* penem+MBL inhibitor 
C* penem+KPC inhibitor 
D* penem+AmpC inhibitor 
E* temocillin+MBL inhibitor 
 
Briefly, a single E. coli colony from a TBX agar plate not more than 24 h old was used. The cell 
concentration, method of spread, and disc placement were carried out similarly to the disc diffusion 
method of antimicrobial susceptibility testing procedure described previously (Chapter 4). All four 
discs (A, B, C, and D) were placed on an agar plate with sufficient spacing between them so as not to 
fuse inhibition zones. Weekly quality control of disc performance was conducted using a negative 
control E. coli ATCC25922 during the phenotype screening periods. The interpretation of the test 
results was made according to the manufacturer’s instructions as follows: 
For AmpC and ESBL detection discs D68C (MAST™ Group Ltd, Liverpool, UK) (Figure 5.1). 
All inhibition zones differ by ≤ 2 mm No ESBL or AmpC activity. 
Inhibition zone of ≥ 5 mm between antimicrobial-only disc and any of the antimicrobials combined 
with inhibitor, the organism is positive for the release of a β-lactamase enzyme (ESBL or AmpC activity). 
When differences between discs are ≤ 2 mm the organism is negative for the release of a β-lactamase. 
D–B ≥ 5 mm, C – A ≥ 5 mm, B – A, and D – C ≤ 4 mm → AmpC activity only 
B–A ≥ 5 mm, D – C ≥ 5 mm, B – D, and C – A ≤ 4 mm → ESBL activity only. 
D–C ≥ 5 mm, B – A ≤ 4 mm → ESBL, and AmpC combined activity. 
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Figure 5.1. Phenotype screening for AmpC and ESBL producing dairy farm soil E. coli isolates 
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For the detection of AmpC with porin loss KPC and MBL activity, the D73C (MAST™ Group Ltd, 
Liverpool, UK) the interpretations were as follows:  
B*–A* ≥ 5 mm; C*-A* and D*-A* < 5 mm → MBL activity. 
C*–A*, ≥ 5 mm; B*-A, D*-A*< 5 mm → KPC activity.  
Distances between discs A*, B* C*, and D* ≤ 2 mm and E < 10 mm → OXA-48 positive 
Distances between discs A*, B*, C*, and D* ≤ 2 mm and E > 10 mm → AmpC, KPC, OXA-48 negative 
(Figure 5.2). 
 




The use of the CDDST D68C and the D73C (MAST™ Group Ltd, Liverpool, UK) kits enabled the 
confirmation of potential ESBL and AmpC β-lactamase producing DfSEC in this study. In this study, 31 
isolates were phenotypically positive for the potential to excrete ESBL or AmpC β-lactamase or a 
combination of the two (Table 5.3). Out of the 31 isolates, 20 could additionally produce AmpC 
enzymes. Indicating the organism’s ability to produce both AmpC and ESBL enzymes, similar to 
finding by Poulou et al. (2014) in a comparative study. The isolate TL56W18 was the only isolate that 
showed the potential to produce ESBL, KPC and AmpC hydrolysing enzymes, while PF55W18 was the 
only isolate to show the potential to produce ESBL, AmpC, and MBL (Table 5.3). It is worthy to note 
that, KPC, OXA, and MBL are all carbapenem hydrolysing β-lactamases (Naas, Nordmann, Vedel, & 
Poyart, 2005). 
 
Statistical analysis by binary logistic regression in Minitab19 indicated that there were no significant 
differences (P > 0.05) between the two farming systems with regards to the number of isolates 
positive for the excretion of β-lactam hydrolysing enzymes only. However, an odds ratio of 1.5 
indicated more isolates from the conventional dairy farms released β-lactamase compared to isolates 
from the organic dairy farms. 
The only isolate out of 31 that was positive for the release of the OXA-48 hydrolysing enzyme, 
PF55W18 was from the Peel Forest conventional dairy farm with the zone diameter of > 10 mm to 
temocillin+MBL inhibitor. The OXA type β-lactamases are poorly inhibited by clavulanic acid (Naas & 
Nordmann, 1999) unlike ESBLs that are sensitive to clavulanic acid as an inhibitor (Poulou et al., 
2014). Comparison between similar farming systems but different locations showed that the western 
located organic dairy farm of Totara Valley organic farm had eight isolates releasing ESBL, AmpC, or 
MBL hydrolysing enzymes with one isolate releasing resistant enzymes to multiple classes of 
antimicrobials while three isolates from the eastern located Clearwaters organic farm excreted only 
ESBL hydrolysing enzymes. In this study all isolates that showed phenotype characteristics of 
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resistance to the third generation cephamycin, FOX30 (Table 5.3) had their genome sequenced for 
molecular analysis (Chapter 7). According to Onishi, Daoust, Zimmerman, Hendlin, and Stapley (1974) 
cephamycins such as cephamycins B and C are 50 to 170 times respectively, more rapidly hydrolysed 
by β-lactamase produced by certain members of the Enterobacteriaceae family such as Enterobacter. 
cloacae compared to the cephamycin cefoxitin due to cefoxitin being a poor substrate for the β-
lactamase these organisms produce.  
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Table 5.3. Phenotype screening for DfSEC and their resistance to cefoxitin 30 μg/disc (FOX30). 
Using D68C and D73C* (MAST™ Group Ltd, Liverpool, UK) 
  
Differences in inhibition zones to D68C 
mm 
Differences in inhibition zones to D73C* 
mm 
FOX (30 mg) 
resistant 
Resistant type 
Farm Isolate B-A D-C D-B C-A D-C B*-A* C*-A* D*-A* E ≤ 10 mm blaESBL 
Clearwaters (CW) 28-A18 7 0 1 8 0 2 6 6 21 + ESBL+AmpC# 
 33-S18 5 2 2 5 2 0 4 5 20 + ESBL+AmpC# 
 49-A18 3 5 6 4 5 0 6 5 22 + ESBL+AmpC# 
Mill Road (MRD) 21-A18 14 4 4 14 4 4 15 17 22 + ESBL+AmpC# 
 22-W18 6 0 0 6 0 2 2 2 17 + ESBL+AmpC# 
 24-S17 4 5 7 4 5 1 1 3 21 + ESBL+AmpC# 
 30-S17 6 0 1 7 0 3 2 2 21 - ESBL 
 33-S17 5 0 1 6 0 0 0 1 19 - ESBL 
 37-S17 5 0 0 5 0 0 1 1 25 - ESBL 
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Table 5.3 continued 
  
Differences in inhibition zones to D68C 
mm 
Differences in inhibition zones to D73C* 
mm 
FOX (30 mg) 
resistant 
Resistant type 
Farm Isolate B-A D-C D-B C-A D-C B*-A* C*-A* D*-A* E ≤ 10 mm blaESBL 
Peel Forest (PF) 17-S17 5 0 0 5 0 2 2 1 21 - ESBL 
 22-A18 5 2 3 6 2 0 0 0 25 - ESBL 
 24-A18 3 6 6 3 6 2 1 2 25 - ESBL 
 25-S18 6 5 4 5 5 1 4 2 20 + ESBL+AmpC# 
 32-A18 5 6 5 4 6 3 2 1 21 + ESBL+AmpC# 
 40-S17 5 0 1 6 0 0 1 0 22 - ESBL 
 45-S17 6 0 1 7 0 1 2 4 22 - ESBL 
 45-W18 3 1 1 3 1 4 6 4 24 + ESBL+AmpC# 
 52-W18 6 0 1 7 0 5 4 4 25 + ESBL+AmpC# 
 55-W18 7 0 1 8 0 2 2 2 8 + ESBL+AmpC# +OXA-48 
 30-A18 3 2 5 6 2 0 2 2 21 + ESBL 
 14-A18 7 0 1 8 0 4 11 4 22 + ESBL+AmpC# 
 15-A18 3 5 5 3 5 1 1 5 16 + ESBL+AmpC# 
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Table 5.3 continued 
  Differences in inhibition zones to D68C 
mm 
Differences in inhibition zones to 
D73C* mm 
FOX (30 mg) 
resistant 
Resistant type 
Farm Isolate B-A D-C D-B C-A D-C B*-A* C*-A* D*-A* E ≤ 10 mm blaESBL 
Totara Valley (TL) 12-A18 1 6 6 1 6 1 1 0 22 + ESBL+AmpC# 
 1-S18 4 6 6 6 6 3 10 10 21 + ESBL+AmpC# 
 23-A18 4 1 5 6 1 2 2 1 21 - AmpC 
 2-A18 4 5 5 1 5 0 2 2 24 + ESBL+AmpC# 
 33-S18 5 0 1 6 0 4 2 4 20 - ESBL 
 54-S18 7 0 0 7 0 0 0 1 18 + ESBL+AmpC# 
 56-A18 6 2 0 4 2 12 3 4 19 + ESBL+KPC+AmpC# 
 87-A18 14 4 4 15 4 4 15 18 22 + ESBL+AmpC# 
 11-A18 7 1 1 7 1 1 1 1 20 - ESBL 
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5.4 Discussion  
In this study, a comparison between the inhibition zones around the disc with antimicrobial only and 
the synergistic disc with antimicrobial and the antimicrobial inhibitor helped to identify bacteria that 
release β-lactam hydrolysing chemicals as a mechanism of resistance. This procedure, however, does 
not indicate resistance due to the efflux pump, cell membrane impermeability, or change in the 
molecular structure of the β-lactam antimicrobial (Willems, Verhaegen, Magerman, Nys, & 
Cartuyvels, 2013). In this study, 20 DfSEC were resistant against FOX30 with inhibition zones ≤ 10 
mm. Earlier studies used the inhibition zone of 18 mm (Onishi et al., 1974) and 4 μg/mL minimum 
inhibitory concentration (MIC) (Lepeule et al., 2012) as criteria for selection of resistance against 
antimicrobials of the cephalosporin group and cefoxitin of the cephamycins. In a comparative study 
of assays for the determination of AmpC β-lactamase producing E. coli, FOX(30) was found to be the 
discriminative parameter as 20 out of 21 (Peter-Getzlaff et al., 2011) and 55 out of 59 E. coli (Ghosh 
& Mukherjee, 2016) strains which were AmpC β-lactamase producers were resistant against 
cefoxitin. In another study on E. coli isolates from humans, cattle, and swine the production of AmpC 
β-lactamase was based on the resistance of the isolates to cefoxitin ≥8 μg/mL by the microdilution 
method (Johnson, Kuskowski, Owens, Gajewski, & Winokur, 2003). 
E. coli may release hydrolysing enzymes including extended-spectrum β-lactamases such as KPC-
lactamases, MB-lactamases, and OXA-48-lactamases to nullify the effects of not only β-lactam class 
of antimicrobials but other classes as well (Nordmann et al., 2012a; Nordmann, Dortet, & Poirel, 
2012b; Nordmann, Naas, & Poirel, 2011), as was noted in this study. Otherwise, E. coli have the 
intrinsic ability to remove noxious substances by the efflux pump mechanism (Cox & Wright, 2013; 
Miller & Sulavik, 1996), reduce antimicrobial permeability into the cell (Knopp & Andersson, 2015; 
Lou et al., 2011) or modify antimicrobial target sites (Santajit & Indrawattana, 2016). 
The phenotype screening results in this study compared to the original AST results may be explained 
based on;  
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a) AST does not involve the use of an anti-β-lactamase substance such as clavulanic acid, EDTA, or a 
boronic acid (Lalitha, 2004).  
b) The various DfSEC may have possessed alternate resistant mechanisms, or under-expressed the 
antimicrobial-hydrolysing compound (Coyne, Guigon, Courvalin, & Périchon, 2010; Stuart & 
Leverstein-Van Hall, 2010; Yelin & Kishony, 2018).  
c) Bacteria antimicrobial mechanisms may be over-expressed or under-expressed (Iredell, Brown, & 
Tagg, 2016; Yelin & Kishony, 2018) under different circumstances and conditions.  
Besides, changes in environmental conditions such as growth rate, increased respiration, the 
formation of oxygen radicals, biofilm formation, and indirect resistance may affect the detection of a 
phenotype expression of resistance to an antimicrobial (Hughes & Andersson, 2017). Sánchez-
Romero and Casadesús (2014) reported a heterogeneous expression of efflux pump activity among 
Salmonella enterica cells and colonies to nalidixic acid and suggested that adaptive 
resistance/susceptibility may explain differences in the phenotypic expression of 
resistance/susceptibility of certain bacteria to a particular antimicrobial at different times.  
The CDDST or the DDST indicates the presence of the hydrolysing enzyme, but the release of these 
enzymes by the bacteria may be intermittently, or under-expressed in some cases (Pitout, 2012a; 
Sundin, 2009). This is similar to the sporadic expression of plasmid-mediated AmpC and other ESBL 
expressions in E. coli (Naseer, Haldorsen, Simonsen, & Sundsfjord, 2010). Further, the demonstration 
of AmpC resistance may be by outer membrane porin loss (Ananthan & Subha, 2005) and confer 
resistance to amino-penicillins, oxyamino-cephalosporins, cephamycins, and monobactams (Bush & 
Bradford, 2016; Maleki et al., 2015; Peter-Getzlaff et al., 2011). However, in a human UTI study, all 
AmpC producing E. coli were found to be ESBL producers (Gupta, Rani, Singla, Kaistha, & Chander, 
2013). ESBLs cause resistance to all penicillins, third-generation cephalosporins such as ceftazidime, 
cefotaxime, and ceftriaxone, and aztreonam, but not to the closely related cephamycins such as 
cefoxitin (Shaikh, Fatima, Shakil, Rizvi, & Kamal, 2015). In this study, all DFSEC with ≥ 10 mm 
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inhibition zone diameter to FOX (30) were subjected to whole-genome sequencing (WGS) for 
molecular analysis to tease out the possibility of genotype-phenotype resistance(s) (Chapter 7).  
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Chapter 6 
Evaluation of interrelatedness of dairy farm E. coli isolates using 
phylogenetic grouping 
6.1 Introduction 
Escherichia coli strains from various niches and sources have wide importance in both human and 
veterinary medicine, environmental sciences, genetics, and molecular biology application in research 
The characteristics and properties of E. coli whether as commensals or pathogens may be shared 
(Tóth et al., 2012) and transmitted along clonal lineages which can be identified as phylogenetic 
groups based on PCR methods (Agarwal et al., 2012; Alegría et al., 2020; Gordon, 2010; Tenaillon et 
al., 2010; Zhu Ge et al., 2014). For instance, the phylogenetic groups of E. coli (A, B1, B2, and D) 
(Gordon, Clermont, Tolley, & Denamur, 2008) and E and F (Clermont et al., 2013) are known to 
exhibit different phenotypic characteristics such as the difference in temperature/growth rate 
relationships, sugar metabolism, and AMR profiles (Gordon et al., 2008; Walk et al., 2007). 
Escherichia coli strains may be grouped according to their serotype (Laing et al., 2012; Russo & 
Johnson, 2000), metabolic profile (Liao, Kim, & Tomb, 2002; Sousa, Hordijk, Steel, & Martin, 2015), 
and DNA hybridisation (Boileau, d'Hauteville, & Sansonetti, 1984; Guo et al., 2016; Moseley et al., 
1980). Apart from these profiling methods, E. coli phylogenetic profiling has also brought more 
understanding to their evolutionary relatedness, especially, the pathogenic ones like the Shigella 
genus (Chaudhuri & Henderson, 2012) and enteroinvasive E. coli (EIEC) (Van den Beld & Reubsaet, 
2012) using the molecular tool of wgMLST (Bai et al., 2019; van Hoek et al., 2019). The pulsed-field 
gel electrophoresis method is also widely used (Akindolire & Ateba, 2018; Ha et al., 2020). However, 
for organisms that tend to have multiple characteristics within a limited spread of strain variation, 
wgMLST is deemed more informative and the preferred technique (Harbottle, White, McDermott, 
Walker, & Zhao, 2006; Neoh, Tan, Sapri, & Tan, 2019) for interrelatedness and classification studies. 
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Apart from the immune status and other health aspects of an organism, the pathogenesis of an E. 
coli infection is based on the virulence of the strain (Phillips-Houlbracq et al., 2018; Riley, 2014). The 
association between a phylogenetic group and the severity and/or persistence of a disease like 
bovine mastitis cannot be ignored (Tomazi, Coura, Gonçalves, Heinemann, & Santos, 2018). For 
instance, bovine mastitis studies have found the E. coli phylogenetic groups of A and B1 to be most 
commonly associated with the disease (NandaKafle et al., 2017; Sheldon et al., 2010b; Suojala et al., 
2011; Valat et al., 2012). Similarly, according to Liu et al. (2014), E. coli strains of the phylogenetic 
group A tend to harbour the highest number of virulence genes and cause the majority of acute 
bovine mastitis compared to the other groups. The association between E. coli phylogenetic groups 
and pathogenicity can be found in other organisms as well. For instance, in humans, and poultry the 
phylogenetic groups B2 and A, respectively are more pathogenic compared to the other groups 
(Jakobsen et al., 2010; Micenková et al., 2016).  
Clermont, Bonacorsi, & Bingen (2000) proposed the use of the chuA, yjaA genes, and TSPE4.C2 DNA 
fragment in a triplex PCR process in assigning 230 E. coli strains which had previously been grouped 
into their various phylogenetic groups, in a validation experiment. These E. coli strains were put into 
these phylogenetic groups based on the presence/or absence of the chuA, yjaA, and TSPE4.C2 genes. 
Various authors have used this method of E. coli phylogenetic determination to align pathogenomic 
determinants of E. coli in their studies: Valat et al. (2012) used this triplex PCR protocol to assign 204 
ESBL producing E. coli strains from cows with diarrhoea to their phylogenetic groups of A, B1, B2, D, 
and the virulent factor (VF) encoding genes. The authors were able to determine the percentages of 
the 204 strains that carried the blaCTX-M-15 IncI1-type plasmid. Australian researchers, Obeng, 
Rickard, Ndi, Sexton, & Barton (2012) used this method to place 251 E. coli strains from a poultry 
source into phylogenetic groups while assessing the virulence factors and antimicrobial-resistant 
profile of the E. coli strains to some selected antimicrobials including ciprofloxacin, florfenicol, 
gentamicin, streptomycin, and tetracycline. The link between ExPEC (extra-intestinal pathogenic E. 
coli) from humans with animal origin was commented on by analysing the similarity of ExPEC strains 
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by molecular method. The Clermont et al. (2000) triplex PCR phylogenetic analysis was used by 
Bélanger et al. (2011) in their study. 
Gordon et al. (2008), evaluated the accuracy of the Clermont et al. (2000), triplex PCR method by 
comparison of the E. coli multilocus sequence typing (The French MLST http://www.pasteur.fr/mlst 
and The German http://web.mpiib‐berlin.mpg.de/mlst/dbs/Ecoli schemes) with the triplex PCR 
phylogenetic typing of 662 E. coli strains from varying sources. Their results indicated a 95% 
consistency between the two methods (Gordon et al., 2008). It was also found that 9% of the strains 
that were assigned phylogenetic group A were incorrectly grouped. Secondly, some strains that were 
originally assigned to phylogenetic group A based on the null presence of the three genes (chuA-, 
yjaA- and TSPE4.C2) should, in reality, have been classified as ‘non-assignable’. Also, some strains 
that were triplex PCR assigned to phylogenetic group D were unassigned or put into a new 
phylogenetic group, E (Gordon et al., 2008), citing (Escobar-Páramo, Clermont, & Blanc-Potard, 2004) 
and (Selander, Caugant, & Whittam, 1987) 
Despite its extensive use, a search through the GenBank databases by Doumith, Day, Hope, Wain, & 
Woodford (2012) revealed some nucleotide polymorphism within the annealing regions of the PCR 
primers for the three genes used for the Clermont et al. (2000) triplex PCR. This, according to 
Doumith et al. (2012), causes some E. coli strains to be erroneously assigned to phylogenetic groups. 
The use of an internal control primer of the E. coli glutamate decarboxylase (gad) gene as well as 
using newly designed primers was proposed (Doumith et al., 2012). Improvement in the accuracy of 
assigning strains to their correct phylogenetic groups was noted when the Clermont et al. (2000) 
method was compared to the new quadruplex PCR method and compared by GenBank BLAST 
(Doumith et al., 2012). Overdevest et al. (2015) used the Doumith et al (2012) quadruplex PCR 
protocol to accurately find the association between the phylogenetic grouping of 108 wild-type E. 
coli and 134 ESBL producing E. coli strains in a study. Similarly, Freitag, Michael, Kadlec, Hassel, & 
Schwarz (2017) used the same quadruplex PCR method in a study on 878 E. coli isolates from cows 
with mastitis to accurately assign the isolates to their phylogenetic groups. 
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Following the discovery of the shortfalls in the Clermont et al. (2000) triplex PCR method a review 
was carried out by Clermont et al (2011). The original chuA, yjaA, and TspE4.C2 genes were 
maintained and changes were made to the primer sequences to avoid polymorphism during the 
annealing stage of the PCR. The phylogeny groups of clade I, III, IV, and V were also classified 
(Clermont et al., 2013). Apart from these changes, a new arpA gene was included with the previous 
three genes to develop a new quadruplex PCR (Clermont et al., 2013). The inclusion of the arpA gene 
was used as an internal control and as a tool to distinguish between strains which would otherwise 
be classified as phylogenetic group D or B2 into a new phylogenetic group, F. Further, when an 
absence of the arpA gene in the new quadruplex PCR product was noted, it helped to put strains into 
cladesII, III, IV, and V, otherwise, the organisms were identified as either Escherichia albertii or 
Escherichia fergusonii.  
After validating the quadruplex PCR method, Clermont et al. (2013) proposed a new E. coli 
phylogenetic grouping of A, B1, B2, C, D, E, F, and clade I-V. This method and proposal have since 
been widely accepted and used by various researchers around the world (Beattie et al., 2020; da 
Silva, de Mello Santos, & Silva, 2017; Hassen et al., 2020; Iranpour et al., 2015; Kumar, Nahid, & 
Zahra, 2017; Kuznetsova et al., 2018; Massot et al., 2016; Müştak et al., 2015; Rana et al., 2017; 
Tomazi et al., 2018) and improved upon with a web-based computerised approach (Beghain, Bridier-
Nahmias, Le Nagard, Denamur, & Clermont, 2018).  
In this chapter, the phylogenetic relationship among E. coli strains recovered and characterised from 
each of the four farms examined (as described in Chapters 2-5) were examined, to evaluate any 
possible interrelationship between them (given the proximity of the sites), resistance traits and/or 
human cases, using the validated Clermont et al. (2013) method and subsequently wgMLST, for their 
interrelatedness (Chapter 7).   
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6.2 Materials and methods 
6.2.1 Isolates 
In this study 814 dairy farm E. coli (DfSEC) isolates were grouped into groups A, B1, B2, C, D, E, or 
clade I, II, III, IV, or V phylogenetic of E. coli using primers and the protocol described by Clermont et 
al. (2013).  
6.2.2 PCR phylogenetic typing 
Escherichia coli cells from a 24 h old single colony from a TBX agar plate were suspended in PBS at a 
concentration equivalent to 0.5 McFarland standard. The cell suspension was heat-lysed (Brian et al., 
1992) at 95°C for 5 min in a heat block (AcuBlock™ Labnet International INC NJ, USA) and centrifuged 
(Eppendorf® Minispin® plus, Sigma-Aldrich, Auckland, NZ) at 12 000 g for 5 min. The supernatant 
was used as the source of DNA for the PCR reaction. A 20 µL PCR reaction was set up using 2 µL of 
10X PCR buffer, 0.4 µL of 2 µM each of dNTP, 0.4 µL of Taq polymerase, 2 µL each of primer’s forward 
(f) and reverse (r) for chuA1 (f), chu2 (r), yjA, Trp at 20 pmol each. For Acek (f) and Arp(r) at 20 pmol 
each, however, 4 µL of primers were used per reaction. The reaction mixture was completed with 1.2 
µL of 25 mM MgCL2, 2 µL of molecular grade distilled water, and 1 µL of the DNA template (Clermont 
et al., 2013; Lescat et al., 2013).  
The reactions were set in a thermocycler (Labnet MultiGene TC 9600G Sigma-Aldrich, Auckland, NZ) 
for 30 cycles of denaturing 94°C for 5 min followed by annealing at either 57°C for 2 s (for group D+E) 
or 59°C for 2 s for quadruplex and A+C differentiation and extension at 72°C for 5 min. The final 
product was stored at 4°C until the PCR product was run on 2% agarose gel (2 g molecular grade 
agarose to 100 mL of 1M tris EDTA buffer) electrophoresis using 1X TBE buffer and 0.07 µL Sybrsafe 
(Invitrogen, Auckland, NZ)/mL of gel, run at 90 V for 60 min, visualised and photographed with a 
molecular imager (Gel Doc™ XR+ Bio-Rad Laboratories Pty. Ltd, Auckland, NZ). Statistical analysis was 
done using t-tests or ANOVA, as appropriate, in SigmaPlot14.0 statistical software. 
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6.2.3 Phylogenetic group assignation 
In this study, the phylogenetic group assignation was done according to the guidelines of Clermont et 
al. (2013). Briefly, the presence (+) or absence (-) of a quadruplex PCR product band in a lane 
corresponding to an isolate was marked according to the molecular mass of the band. The 
phylogenetic group was assigned according to the final analyses of the band’s absence/presence (-/+) 
as outlined by Clermont et al. (2013) (Figure 6.1 and Appendix C1), using the hyperladder™ V (HVL) 
(Bioline, Meridian® Biosciences, Total Lab Systems Ltd, Auckland, New Zealand). In cases where an 
isolate was initially typed by the quadruplex PCR as either the A+C phylogenetic group or the D+E 
phylogenetic group, a second PCR was run using the primers trpAgpC.f, trpAgpC.f and ArpAgpE.f, 
ArpAgp.r, respectively. The primers trpBA.f and trpBA.r were included as an internal control which 
also helped to differentiate between phylogenetic group E and clade I+II (Clermont et al., 2013). 
An isolate, when assigned a preliminary group of D+E, E+Clade I+II, or A+C was re-assigned its final 
phylogenetic group after confirmation or denial of the presence of a band when a secondary PCR 
with the trpAgpC or tryAgpE primer in a duplex PCR reaction corresponding to a group C or E, 
respectively instead of a group A or D accordingly. Based on the reviewed E. coli phylogenetic group 
method, Clermont et al. (2013) constructed a minimum spanning tree to show the phylogenetic 
groups of a subset of E. coli strains originally misclassified by the triplex PCR method (Figure 6.2). 
Statistical analysis of the phylogenetically typed 814 E. coli isolates collected from the four farms 
over the four-time points was done using the Mann-Whitney Rank Sum t-test or by Kurskal-Wallis 




arp + + + + +  - + - - -  
chuA - - - + -  - - + - -  
yjaA - - + - +  - + + - -  
tspE4.C2 + + - + -  - - + - -  
Group B1 B1 A+C D+E A+C HVL U A+C B2 nil nil HVL 
 U=unknown 
HVL=hyperladder™V 
Figure 6.1 E. coli quadruplex phylogenetic group assignation 










Figure 6.2 Phylogenetic group tree of E. coli isolates after modification of modified Clermont et al. 
(2000) 
Isolates in red were originally, erroneously assigned to group D using the Clermont et al. (2000) 





















Material removed for copyright compliance 
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6.3 Results  
The phylogenetic grouping, using the Clermont et al. (2013) protocol for 814 DfSEC isolates isolated 
from the dairy farm soil in 2017-2018 (Chapter 2) is shown in Table 6.1. The B1 phylogenetic group 
predominated at 73.7% of the 814 dairy farm soil isolates. The E phylogenetic group at 9.6% was the 
next most common, followed by group phylogenetic A at 5.8% and group C at 5.3%. The clade I+II 
and cladeIII+IV+V groups were 0.7% and 0.9% of the total, respectively. The B2 and D groups each 
represented 0.5% of the 814 isolates. None of the DfSEC were of the F group and 3.1% of the isolates 
could not be placed in any of the presently recognised E. coli phylogenetic groups using the Clermont 
et al. (2013) protocol. 
Statistical analysis showed no significant difference between the phylogenetic groups of the two 
farming systems of conventional and organic dairy farming. Also, there were no significant 
differences in the phylogenetic groupings between the farms. Similarly, there were also no significant 
differences between the phylogenetic groups according to the four sampling times by the Kurskal-
Wallis ANOVA on ranks SigmaPlot 14.0 statistical analysis. 
In this study, the aim of the phylogenetic grouping of the DfSEC isolates was to evaluate the 
phylogenetic relationships among the 814 DfSEC isolates obtained to ascertain any possible linkages 
between isolates from differing dairy farming of the AMR E coli isolates. Also, the phylogenetic 
grouping could help elucidate possible links between the DfSEC and other mammals including 
humans and their companion animals that may have interaction with the cows in their environment 
on a typical dairy farm in the Geraldine district and New Zealand in general. Thirdly, to assess the 
possibilities of phylogenetic grouping with causative agents of common dairy farming diseases such 
as mastitis and metritis.  
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Table 6.1 The phylogenetic groupings of 814 confirmed dairy farm soil E. coli isolates collected over 
4-seasons. 
Phylogenetic group 
Farm-season-year (n) A B1 B2 C D E F Clade I,II Clade III-V Unknown 
CW-S-17 50 2 45 0 1 0 2 0 0 0 0 
CW-A-18 50 1 40 0 6 0 2 0 0 0 1 
CW-S-18 47 0 28 0 5 1 13 0 0 0 0 
CW-W-18 47 4 26 0 2 1 13 0 0 1 0 
TL-S-17 51 0 34 0 5 0 4 0 0 0 8 
TL-A-18 47 3 36 0 0 0 0 0 1 0 7 
TL-S-18 50 1 46 0 0 0 24 0 0 1 0 
TL-W-18 47 7 35 0 0 0 5 0 1 1 3 
MRD-S-17 68 4 54 2 3 0 4 0 0 0 1 
MRD-A-18 55 4 42 1 0 1 6 0 1 1 0 
MRD-S-18 50 2 38 1 3 0 6 0 0 0 2 
MRD-W-18 50 9 32 0 0 0 9 0 0 0 3 
PF-S-17 50 1 29 0 13 0 6 0 1 0 0 
PF-A-18 55 0 38 0 3 1 9 0 2 2 0 
PF-S-18 49 3 38 0 1 0 6 0 0 1 0 
PF-W-18 48 6 39 0 1 0 2 0 0 0 0 
Total 814 47 600 4 43 4 78 0 6 7 25 
%  5.8 73.7 0.5 5.3 0.5 9.6 0.0 0.7 0.9 3.1 
CW=Clearwaters organic dairy farm: TL=Totara valley organic dairy farm: MRD=Mill road conventional 
dairy farm: PF=Peel Forest conventional dairy farm: S-17=spring of 2017: S-18=spring of 2018: A-
18=autumn 2018: W-18=winter of 2018 
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6.4 Discussion  
In this study, the E. coli phylogeny group B1 was the predominant group in the 814 DfSE isolates 
collected from the dairy farms. This was similar to other studies that have looked at the phylogenetic 
grouping of E. coli isolates of bovine origin (Blum & Leitner, 2013; Milanov, Prunic, Velhner, 
Todorovic, & Polacek, 2015; Suojala et al., 2011). The phenomenon of different members of the 
various E. coli phylogenetic groups dominating in prevalence among a particular species of animals 
and humans as well as niches has been demonstrated in numerous studies (Ewers, Antão, Diehl, 
Philipp, & Wieler, 2009; Ewers, Bethe, Semmler, Guenther, & Wieler, 2012). Even for a particular 
animal species, the distribution of the various phylogenetic groups as commensals or pathogens may 
belong to different phylogenetic groups (Jang et al., 2017; Keane, 2016; Mercat et al., 2016; Suojala 
et al., 2011). This is true for the E. coli associated with cattle. Studies that dealt with the E. coli from 
the bovine environment such as soils and manure have indicated the phylogeny group B1 to be most 
predominant (Blum & Leitner, 2013; van Overbeek et al., 2020). This is similar to results in this study 
with the B1 group dominating at 73% of the DfSEC isolates. 
Mastitis is the most concerning pathology on a dairy farm (Ruegg, 2017; Ruegg & Petersson-Wolfe, 
2018; Ruegg & Reinemann, 2002). In New Zealand, about 14/100 cows/annum of the milking herd on 
a bovine dairy farm would be affected by mastitis (McDougall & Compton, 2002). The best treatment 
of mastitis is the use of antimicrobials because the main causative agents are bacteria including E. 
coli (McDougall, 2002). In most OECD countries including New Zealand, milk from cows with mastitis 
being treated with antimicrobials must be disposed-off, until the withholding period of the drug is 
over (Anika et al., 2019). The milk is either fed to calves on the farm or disposed of in the sewage 
(Lago, Godden, Bey, Ruegg, & Leslie, 2011; Ruegg, 2017; Ruegg & Reinemann, 2002). The mastitis-
causing bacteria from such milk may thus end up in the soils of the fields, through the digestive 
system of the calves and the sewage used for irrigation (Houlbrooke, Horne, Hedley, Hanly, & Snow, 
2004). Polacek (2015) explained that pathogenic E. coli strains possess special features like curli 
fimbriae for adhesion, invasion of host cells and to protect themselves with biofilm formation to 
enable them to persist in the mammalian system to avoid destruction by antimicrobials. Such soil E. 
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coli isolates may easily penetrate mammalian cells with such features to cause infection and be able 
to avoid destruction by antimicrobials (Milanov et al., 2015). 
In this study, the second most common of the E. coli phylogeny groups was type E at 5.9% using the 
Clermont et al. (2013) method. This method can tease out E. coli isolates that were previously 
grouped into group D+E into either D, E, or clade II+III+IV and A+C into either A or C groups as 
opposed to a previous phylogeny typing method that other authors have used (Gordon, 2010). 
Authors who have used the less sensitive Clermont et al. (2000) method have indicated the 
phylogeny group D to be next in common following groups B1 and A in pathological cases of mastitis 
(Suojala et al., 2011; Zhang et al., 2018) and metritis (Gonzalez Moreno, Torres Luque, Oliszewski, 
Rosa, & Otero, 2020; Silva et al., 2009). Similarly, while the phylogenetic group A had featured in 
most studies, group C had had little mention but, in this study, 5.3% of the DfSEC belonged to the C 
group. This may be because, in this study, DfSEC isolates that would have been typed as A or A+C 
were re-typed with the trpAgpC primers to differentiate A+C into As and Cs. Other studies had used 
the earlier version, Clermont et al. (2000), typing protocol and had not been able to differentiate 
some E. coli isolates into their phylogenetic groups as robustly as provided by Clermont et al. (2013). 
This was shown by Logue et al. (2017) in a study. 
According to Blum and Leitner (2013) and Kempf, Slugocki, Blum, Leitner, and Germon (2016) the E. 
coli phylogenetic group A is most commonly associated with mastitis and metritis (inflammation of 
the endometrium), respectively. In this study, it may be argued that the members of the phylogeny 
group A, may have originated from the mammary glands of the cows with mastitis or from secretions 
and/or aborted foeti from cows with metritis because of the pathogenic traits they displayed, and 
the virulent determinant carried. Also, in this study, the phylogenetic group B2 was 0.5% of the 814 
DfSEC isolates and may have originated from humans, cats, and/or dogs (Bogema et al., 2020; Collis 
et al., 2019; Kidsley et al., 2020; Toombs-Ruane et al., 2017). This is because, the phylogenetic group 
B2 is hardly associated with bovine (Liu et al., 2014; Madec et al., 2012) but it is the predominant 
group associated with humans and their companion animals of cats (Zogg, Zurfluh, Schmitt, Nüesch-
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Inderbinen, & Stephan, 2018) and dogs (Harada et al., 2012; Mateus et al., 2013), common on New 
Zealand dairy farms.  
In New Zealand, some E. coli and Shiga toxin-producing E. coli (STEC) O157:H7 and other bacterial 
infections in humans have been attributed to contact with farm animal subjects and/or their 
products with cattle as the principal source of these infections (Gilpin, Scholes, Robson, & Savill, 
2008; Gilpin et al., 2020; Jaros et al., 2013). This study highlights such a possibility and also the 
possibility of humanly sourced infectious E. coli getting into the cattle environment of a dairy farm 
soil. This is explained by E. coli of phylogenetic A and B2 being most commonly associated with 




Whole-genome sequencing of dairy farm soil E. coli isolates 
producing Extended Spectrum β-lactamases. 
Whole-genome sequencing (WGS) offers the most sensitive and specific approach in determining the 
resistant gene(s) encoded by bacteria (Ellington et al., 2017). Pulsed-field gel electrophoresis (PFGE) 
has been used by many researchers over the years. It continues to be used to identify clones that 
may frequently be antibiotic-resistant, it lacks the sensitivity and specificity offered by WGS, 
especially if the organisms share ancestry (Ruppitsch et al., 2015; Salipante et al., 2015).  
In research cases, where diversity, origin, and epidemiological data are of relevance, WGS offers the 
best approach even when compared to multi-locus sequence typing (Chen, Karanth, & Pradhan, 
2020; Egan et al., 2020; Liu et al., 2020; Lytsy, Engstrand, Gustafsson, & Kaden, 2017; Walker et al., 
2013). It is well noted, however, that obtaining, analysing, and implementing the information from a 
WGS is not trivial (Carriço, Rossi, Moran-Gilad, Van Domselaar, & Ramirez, 2018) despite computer 
software and interpretation guides (Kozyreva et al., 2017; Lindsey, Pouseele, Chen, Strockbine, & 
Carleton, 2016; Rouard et al., 2019; Wyres et al., 2014).  
From 2001 to the present, there has been a huge reduction in the cost, decrease in turn-around time 
and the increase in quality of WGS outputs, as well as an increase in the number of WGS service 
providers and the availability of equipment and reagents both for the preparation of samples for 
WGS and the running of it (Gullapalli, Desai, Santana-Santos, Kant, & Becich, 2012; Koboldt, 
Steinberg, Larson, Wilson, & Mardis, 2013; Shang et al.). There are also commercially available kits 
for the extraction and preparation of high-quality genomic DNA samples for WGS at reasonable 
costs, easy-to-follow instructions, and have a long shelf life.  
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The human-genome project, which was completed in 2001 after 20 years of work and over 3 billion 
USD spent, elevated WGS into a new sphere of molecular science. One of the key by-products of the 
project was the reduction in the cost of WGS (Lander, 2011; Lander et al., 2001).  
In this study, 20 DfSEC isolates that showed the potential to release ESBLs enzymes and had an 
inhibition zone to FOX30 of ≥ 10 mm after phenotype screening (Chapter 5) were subjected to WGS 
and whole genome multi-locus sequence typing (wgMLST) analysis to confirm the resistance 
genotype and investigate the presence of other genetic AMR traits. 
 
7.1 Materials and methods 
The genomic DNA template for WGS was extracted using the column-based genomic DNA extraction 
kit, GenElute™ Bacterial Genomic DNA kit Sigma-Aldrich, Auckland, NZ. Briefly, a single colony of 24 h 
old DfSEC (previously species identified by PCR and stored at -80°C, Chapter 2) from a TBX agar plate 
was streak-plated onto nutrient agar and incubated at 37°C for 24 h. A single colony from the 
nutrient agar plate was put into 1 mL of molecular grade pure water and washed by centrifugation of 
cell suspension at 12 000 g for 2 min. The use of TBX agar plate gave instant recognition of possible 
contaminants without the need for UV lamp as in NMUG usage, while the final use of nutrient agar 
prevented the blue colouration from TBX agar, possibly interfering with DNA concentration 
determination by a spectrophotometer (Sánchez-Fito & Oltra, 2015) such as a Nanodrop (DeNovix 
DS-11+ Spectrophotometer, dNature Diagnostics& Research Ltd, Gisborne, NZ). 
The resulting pellet of the washed E. coli cells was re-suspended in 180 µL of the GenElute™ lysis 
solution. Then, 20 µL of RNase solution was added to the lysed cell solution to help remove RNA 
contaminants and incubated at room temperature for 2 min. A 20 µL aliquot of proteinase K solution 
was added to the sample, vortexed gently for 30 s and incubated at 55°C for 30 min. 200 µL of a 
second GenElute™ lysis solution was then added to the sample after the initial 30 min incubation at 
55°C and incubated further at 55°C for 10 min. A homogenous mixture was obtained. Subsequently, 
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200 µL of absolute ethanol was added to the lysate, and the mixture vortexed for 8 s, a homogenous 
mixture resulted.  
A GenElute™ column was prepared for DNA binding by adding 500 µL of GenElute™ column-
preparation solution to the column and centrifuged at 12 000 g for 1 min. The flow-through was then 
discarded. The prepared binding column was mounted into a 2 mL Eppendorf tube as the collection 
tube and the cell lysate was put into the column. Using a 1 000 µL pipette tip with a wide enough tip 
to avoid shredding of the DNA product, the contents of the sample mixture were gently pipetted 
onto the prepared column in a 2 mL Eppendorf tube and centrifuged at > 6 500 g for 1 min. The flow-
through was again discarded but the column was maintained. A 500 µL of GenElute™ solution1 and a 
wash solution were added onto the column and span at > 6 500 g for 1 min and the flow-through was 
discarded. Finally, 200 mL of a GenElute™ elution buffer was added to the column and span at 6 500 
g for 1 min.  
The resulting solution of genomic DNA was tested for quality, and purity-checked using a Nanodrop 
(DeNovix DS-11+ Spectrophotometer, dNature Diagnostics & Research Ltd, Gisborne, NZ). Then, 5 µL 
of the extracted genomic DNA was again checked for quality and purity on a 0.8% agarose gel using 
SybrSafe to aid visualisation and photography by an imager (Gel Doc™ XR+ Bio-Rad Laboratories Pty. 
Ltd, Auckland, NZ). 
For the WGS, DNA libraries were prepared using Nextera® XT v2 Library Preparation Kit (Illumina, 
San Diego, USA) and pooled libraries were sequenced on a NextSeq 550 sequencer (Illumina). 
Sequences were quality checked and evaluated using Nullarbor. The genomes were assembled using 
SPAdes within BioNumerics 7.6 (Applied Maths, Sint-Martens-Latem, Belgium). A range of 
phenotypes was predicted both within BioNumerics and through Nullarbor (Nullarbor Github: 
https://github.com/tseemann/nullarbor). Whole-genome Multi-Locus Sequence Typing (wgMLST) 
was performed in BioNumerics. The BioNumerics of E. coli wgMLST scheme indexes sequence 
differences for up to 17 380 genes. A wg-MLST minimum spanning tree was generated for 20 DfSEC 
isolates. In this study, these isolates were chosen based on their zone of inhibition to cefoxitin 30 mg 
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(FOX30) being as low as ≤ 10 mm after disc diffusion antimicrobial susceptibility testing according to 
the protocol outlined by EUCAST (2019). The genomes were exported from BioNumerics in Fasta 
format and submitted to the PubMLST rMLST species identification website 
(https://pubmlst.org/bigsdb?db=pubmlst_rmlst_seqdef_kiosk) as another form of identification.  
This aspect of the study was contracted out to ESR, Christchurch, NZ for processing. 
The concatenated contiguous sequences of the 20 DfSEC isolates were loaded into Geneious™ Pro. 
The nucleotide sequence of the open reading frame (ORF) of ESBL genes evaluated by Dallenne, Da 
Costa, Decré, Favier, and Arlet (2010) (Table 7.1) were obtained from the NCBI website in Fasta 
format. The nucleotide sequence of each gene’s ORF was queried against the sequenced assembly of 
each of the 20 DfSEC isolates for translated amino acid matches using the Geneious™ Pro 
bioinformatics software. This was similar to the ResFinder for determination of ARGs, with coverage 
identity set at 98% (but possible at 80%-100%) to help remove noises such as the fragment of genes 
(Zankari et al., 2012). In this study, significant hits defined as > 80% query coverage with > 70% 
pairwise identity (Kluytmans-van den Bergh et al., 2016) were then used as queries for the Basic 
Local Alignment Search Tool (BLAST) searches of NCBI protein conserved domain for protein (Lu et 
al., 2020) database(s) (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) to identify the 
protein (enzyme) they encoded. To confirm that the enzyme that resulted from the BLAST NCBI 
search query was of relevance as a genotype-phenotype determinant (Hendriksen et al., 2019), the 
nucleotide sequence of a particular gene’s ORF was first BLAST queried. The resulting enzyme’s 
accession number, name, and description were compared to the enzyme resulting from each DfSEC 
isolate’s BLAST NCBI query. 
Briefly 
• The “Fasta” format of the nucleotide sequence of the ORF of a gene variant was queried for 
the protein (enzyme) that is encoded in the NCBI conserved domain site. 
• The protein name, code, and accession number, as well as the E-value, were recorded 
• The nucleotide sequence of the ORF of a gene variant was queried against the concatenated 
sequence of a DfSEC’s nucleotide sequence (assembly). 
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• The contig number, coordinates, coverage, and pairwise percentages were noted. 
• The amino acid of matching pair of > 80% coverage and > 70% pairwise identity of a gene 
variant’s ORF versus concatenated nucleotide sequence of DfSEC query was copied from 
Geneious™ Pro result output (Zankari et al., 2012). 
• The copied amino acid sequence in Fasta format was queried in the NCBI conserved domain 
similar to the procedure for the Fasta format of the ORF of the gene variant in question (Table 
7.2-7.8). 
The phylogenetic tree was created in Geneious™ Pro using the matching nucleotide sequence of the 
DfSEC isolates and that of the various AMR genes that had significant coverage and pairwise identity 
of > 83% and > 70% respectively. In Geneious™ Pro, the cost matrix of 65% (5.0/-0.4) with a gap penalty 
of 12 or 6, gap extension penalty of 3, the global alignment with free end gaps, using the Tamura-Nei 
genetic distance model to build a neighbor-joining tree with no out-groups. These parameters were 
similar to parameters set by Wylie, Luo, Li, and Jones (2012) in a study and Harris, Balcerzak, Johnston, 




Table 7.1. Beta-lactamase genes used for Geneious™ Pro 5.6.7 analysis 
bla gene variant accession number 
TEM 1 EF125012 
 
29 DQ269440 
SHV 1 AF148850 
 
2 AY570959 
OXA 1 JO2967 
 
48 AY236073 






























Table 7.1 continued 
bla gene variant accession number 
FOX 1 X77455 
 2 Y10282 





MOX 1 D13304 
 
2 AJ276453 















DHA 1 EF406115 
 
2 AF259520 
BIL 1 X74512 
ACT 1 U58495 
MIR 1 M37839 
VEB 1 AF324833 
PER 1 Z21957 
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Table 7.1 continued 
bla gene variant accession number 
GES 1 AF156486 
 2 AF326355 
















7.2 Results  
7.2.1 DNA extraction 
A clear band with no smearing was obtained for all 20 samples (Figure 7.1) when the GenElute™ 
Bacterial Genomic DNA kit (Sigma-Aldrich, Auckland, NZ) was used to extract the genomic DNA from 
the 20 selected samples for WGS. The concentration and ratio of all samples submitted for WGS was 
> 10 µg/mL and the ratio of 260/280 nm by a Nanodrop (DeNovix DS-11+ Spectrophotometer, 
dNature Diagnostics& Research Ltd, Gisborne, NZ) was between 1.80 and 2.00. 
 
Figure 7.1 Gel electrophoresis showing DNA extracted from selected dairy farm soil E. coli isolates. 
.
1     2    3    4    5    6    7   8     9   10  11  12 13  14  15  16   17  18   19   20Samples for 
WGS
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7.2.2 Resistant genes analysis of DfSEC isolates 
The 20 DfSEC isolates submitted for wgMLST encoded at least one of 12 different ARGs (Table 7.2) 
according to the Nullarbor bioinformatics software analysis. From the two organic dairy farms, all 
nine (100%) of the isolates studied encoded two or more resistance genes. The isolates CW33S18, 
TL1S18, and TL2A18 encoded three ARGs. Similarly, all DfSEC isolates encoded two or more ARGs 
according to the Nullarbor analysis. The isolates PF14A18 and PF15A18 encoded the most number of 
ARGs at 7/12 while the isolate PF55W18 encoded 6/17 resistant genes and PF32A18 encoded 4/12 
ARGs. Out of the 20 DfSEC isolates 18 encoded the mdfA membrane protein gene according to the 
Nullarbor bioinformatics software analysis at > 90% coverage for the tetracycline-resistant gene 
tet(34)1. Two isolates negative for the tet(34)1 gene were from the Peel Forest conventional farm. 
However, according to the Geneious™ Pro, all 20 isolates carried a similar nucleotide sequence to 
tet(34)1 gene ORF at > 67.0% coverage and > 76.0% pairwise identity (Table 7.9). All three isolates 
that possessed the fosfomycin resistant gene variant, fosA7, were from the organic dairy farms while 
all isolates that showed the resistant gene variants apart from tet(34)1, aph(3), and sul2.2 to 
tetracycline, aminoglycosides, and sulphonamides respectively, were from the Peel Forest 
conventional dairy farm. 
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Table 7.2. Summary of resistant gene variants encoded by dairy farm soil E. coli isolates.  
Based on the Nullarbor analysis  
































































CW28A18 - - - - - - + - ± - - - 2 
CW33S18 - - - - - + + - ± - - - 3 
CW49A18 - - - - - - + - ± - - - 2 
MRD21A18 - - - - - - + - ± - - - 2 
MRD22W18 - - - - - - + - ± - - - 2 
MRD24S17 - - - - - - + - ± - - - 2 
PF14A18 + - + + - - + + ± - + - 7 
PF15A18 + - + + - - + + ± - + - 7 
± = < 90% coverage 
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Table 7.2 continued 


































































No of resistant 
gene variants 
PF25S18 - - - - - - + - ± - - - 2 
PF30A18 - - - - - - + - - - - - 1 
PF32A18 - - - - + - + - ± + - - 4 
PF45W18 - - - - - - + - ± - - - 2 
PF52W18 - - - - - - + - - - - - 1 
PF55W18 - + - + + - + - ± - - + 6 
TL12A18 - - - - - - + - ± - - - 2 
TL1S18 - - - - - + + - ± - - - 3 
TL2A18 - - - - - + + - ± - - - 3 
± = < 90% coverage  
 94 
Table 7.2 continued 

































































TL54S18 - - - - - - + - ± - - - 2 
TL56S18 - - - - - - + - ± - - - 2 
TL87A18 - - - - - - + - ± - - - 2 





In addition to the results obtained using the Nullarbor bioinformatics software analysis, a Geneious™ 
Pro query of the nucleotide sequences of ESBL genes that were investigated by Dallenne et al. (2010) 
(Table 7.1) were also considered in this study. 
For the blaACT-1 gene variant, the nucleotide sequence match between the ORF of the gene variant 
and the nucleotide assembly of each of the DfSEC that showed coverage > 86% with > 70% pairwise 
identity was queried in the NCBI protein BLAST. The results of the blaACT-1 gene variant ORF 
nucleotide sequence protein BLAST search and that of each of the 20 DfSEC isolates were similar in 
encoding for the AmpC protein with the same accession number, E-value, and protein description. 
(Table 7.3). Relatedness of the DfSEC isolates regarding the nucleotide sequence of the ORF of the 
blaACT-1 gene (Figure 7.2) indicates the closer relation of isolates CW28A18, MRD22W18, PF30A18, 
PF52W18, and TL2A18 that had matching nucleotide sequence with the ORF of the blaACT-1 gene at 
the contig 10 but with different coordinates than the rest of the DfSEC isolates. 
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Table 7.3. Result of Geneious™ Pro 5.6.7 query and NCBI BLAST for blaACT-1 gene variant ORF.  
Gene name   Interval  %Pairwise identity % Query coverage  E value Protein name Accession number 
blaACT-1  3-995 - - - AmpC PRK11289 
DfSEC isolate Contig. Isolate coordinates %Pairwise identity % Query coverage  E value Protein name Accession number 
CW28A18 10 159075-159997 71.5 84.7 3.17e-135 AmpC PRK11289 
CW33S18 49 13058-14028 71.5 84.7 3.17e-135 AmpC PRK11289 
CW49A18 38 29021-29943 70.9 84.7 5.84e-132 AmpC PRK11289 
MRD21A18 47 4752-5674 71.3 84.7 1.67e-132 AmpC PRK11289 
MRD22W18 10 13724-14646 71.5 84.7 3.12e-135 AmpC PRK11289 
MRD24S17 19 74213-75135 71.5 84.7 3.07e-135 AmpC PRK11289 
PF14A18 44 23919-24841 71.5 84.7 3.25e-135 AmpC PRK11289 
PF15A18 52 15336-16258 71.5 84.7 3.25e-135 AmpC PRK11289 
PF25S18 60 4754-5676 71.5 84.7 3.19e-135 AmpC PRK11289 
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Table 7.3 continued 
DfSEC isolate Contig. Isolate coordinates %Pairwise identity % Query coverage  E value Protein name Accession number 
PF30A18 10 174201-175123 71.5 84.7 3.20e-131 AmpC PRK11289 
PF32A18 47 13058-13980 71.5 84.7 3.77e-134 AmpC PRK11289 
PF45W18 21 13613-14535 71.2 84.7 2.51e-135 AmpC PRK11289 
PF52W18 10 166671-166017 71.3 84.7 3.21e-135 AmpC PRK11289 
PF55W18 3 40899-41821 71.6 84.7 6.97e-135 AmpC PRK11289 
TL12A18 8 159275-160197 71.5 84.7 3.15e-135 AmpC PRK11289 
TL1S18 45 4753-5675 71.5 84.7 3.17e-135 AmpC PRK11289 
TL2A18 10 159185-160155 71.5 84.7 3.12e-135 AmpC PRK11289 
TL54S18 51 13058-13980 71.5 84.7 3.10e-135 AmpC PRK11289 
TL56S18 51 4754-5676 71.5 84.7 3.05e-135 AmpC PRK11289 







Figure 7.2 Phylogenetic tree of DfSEC isolates nucleotide match to blaACT-1 gene ORF 
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Similar to the results obtained for the blaACT-1 variant, the blaBIL-1 gene variant also had all the 20 
DfSEC isolates carrying nucleotide sequences encoded for the production of AmpC protein of 
accession number PRK11289 described as beta-lactamase/D-alanine carboxypeptidase (provisional). 
The nucleotide sequence for both the blaACT-1 and blaBIL-1 gene variants was located at the same 
contig for each isolate with similar coordinates. However, for the blaBIL-1 gene variant, the coverage 
cover was wider at > 88% coverage and > 70% pairwise identity (Table7.4). The phylogenetic tree 
(Figure 7.3) of the matching nucleotide sequence of the DfSEC isolates to the ORF of the blaBIL-1 
gene, bears a close similarity to that of the blaACT-1 phylogenetic tree and indicates the 
comparatively close relatedness of the two gene variants’ (Jeong et al., 2011) nucleotide sequences 




Table 7.4. Result of Geneious™ Pro 5.6.7 query and NCBI BLAST for blaBIL-1 gene variant ORF. 
Gene name   Interval  %Pairwise identity % Query coverage  E value Protein name Accession number 
blaBIL-1   82-1227 - - - AmpC PRK11289 
DfSEC isolate Contig. Isolate coordinates %Pairwise identity % Query coverage E value Protein name Accession number 
CW28A18 10 159000-160084 70.9 88.9 7.02e-144 AmpC PRK11289 
CW33S18 49 12971-14055 70.9 88.9 7.02e-144 AmpC PRK11289 
CW49A18 38 28946-30030 71.2 88.9 1.38e-146 AmpC PRK11289 
MRD21A18 47 4677-5761 70.8 88.9 8.68e-143 AmpC PRK11289 
MRD22W18 10 13637-14721 70.9 88.9 6.91e-144 AmpC PRK11289 
MRD24S17 19 74138-75222 70.9 88.9 6.81e-144 AmpC PRK11289 
PF14A18 44 23844-24928 70.9 88.9 7.20e-144 AmpC PRK11289 
PF15A18 52 15261-16345 70.9 88.9 7019e-144 AmpC PRK11289 
PF25S18 60 4679-5763 70.9 88.9 7.06e-144 AmpC PRK11289 
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Table 7.4 continued 
DfSEC isolate Contig. Isolate coordinates %Pairwise identity % Query coverage E value Protein name Accession number 
PF30A18 10 174126-175210 71.3 88.9 1.15e-147 AmpC PRK11289 
PF32A18 47 12971-14055 70.9 88.9 6.86e-144 AmpC PRK11289 
PF45W18 21 13526-14611 71.4 89.0 1.70e-151 AmpC PRK11289 
PF52W18 10 165758-166842 70.9 88.9 7.11e-145 AmpC PRK11289 
PF55W18 3 40824-41908 71.0 88.9 1.54e-145 AmpC PRK11289 
TL12A18 8 159200-160284 70.9 88.9 6.98e-144 AmpC PRK11289 
TL1S18 45 4678-5762 70.9 88.9 7.02e-144 AmpC PRK11289 
TL2A18 10 159158-160242 70.9 88.9 6.91e-144 AmpC PRK11289 
TL54S18 51 12971-14055 70.9 88.9 6.88e-144 AmpC PRK11289 
TL56S18 51 4679-5763 7.09 88.9 6.75e-144 AmpC PRK11289 





Figure 7.3 Phylogenetic tree of DfSEC isolates nucleotide match to blaBIL-1 gene ORF 
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A query of the blaCMY-2 gene variant’s ORFs nucleotide sequence in the NCBI conserve domain 
resulted in an AmpC protein with the accession number PRK11289, described as a provisional version 
of a beta-lactamase/D-alanine carboxypeptidase enzyme. All the 20 DfSEC matching nucleotide 
sequences with the blaCMY-2 gene variant ORF encoded a protein with the same name and 
accession number as the blaCMY-2 gene variant’s ORF. The blaCMY-2 gene variant was also located 
at the same contig as those of the blaACT-1 and blaBIL-1 gene variants with similar coordinates, for 
each of the DfSEC isolates (Table 7.5). The phylogenetic tree of the matching nucleotide sequence of 
the DfSEC isolates with the blaCMY-2 ORF (Figure 7.4) also bears a close resemblance to the 
phylogenetic tree of the blaACT-1 and the blaBIL-1 genes as the coordinates and the contigs at which 
matches are indicated for the various DfSEC isolates are closely matched. 
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Table 7.5. Result of Geneious™ Pro 5.6.7 query and NCBI BLAST for blaCMY-2 gene variant ORF. 
Gene name  Interval %Pairwise identity %Query cover E value Protein name Accession number 
CMY-2  
 
 1-1143 - - - AmpC PRK11289 
DfSEC isolate Contig. Isolate coordinates %Pairwise identity % Query coverage  E value Protein name Accession number 
CW28A18 10 159000-160084 71.3 95.5 5.72e-151 AmpC PRK11289 
CW33S18 49 12971-14055 71.3 95.5 5.72e-151 AmpC PRK11289 
CW49A18 38 28946-30030 71.6 95.5 3.93e-153 AmpC PRK11289 
MRD21A18 47 4677-5761 71.2 95.5 2.47e-149 AmpC PRK11289 
MRD22W18 10 13637-14721 71.3 95.5 5.63e-151 AmpC PRK11289 
MRD24S17 19 74138-75222 71.3 95.5 5.55e-151 AmpC PRK11289 
PF14A18 44 23844-24928 71.3 95.5 5.87e-151 AmpC PRK11289 
PF15A18 52 15261-16345 71.3 95.5 5.86e-151 AmpC PRK11289 
PF25S18 60 4679-5763 71.3 95.5 5.75e-151 AmpC PRK11289 
PF30A18 10 174126-175210 71.7 95.5 9.35e-155 AmpC PRK11289 
PF32A18 47 12971-14055 71.3 95.5 5.60e-151 AmpC PRK11289 
PF45W18 21 13526-1411 71.8 95.5 4.63e-158 AmpC PRK11289 
PF52W18 10 165758-166842 71.3 95.5 5.80e-151 AmpC PRK11289 




Table 7.5 continued 
DfSEC isolate Contig. Isolate coordinates %Pairwise identity % Query coverage  E value Protein name Accession number 
TL12A18 8 159200-160284 71.3 95.5 5.69e-151 AmpC PRK11289 
TL1S18 45 4678-5762 71.3 95.5 5.72e-151 AmpC PRK11289 
TL2A18 10 159158-160242 71.3 95.5 5.64e-151 AmpC PRK11289 
TL54S18 51 12971-14055 71.3 95.5 5.61e-151 AmpC PRK11289 
TL56S18 51 4679-5763 71.3 95.5 5.51e-151 AmpC PRK11289 
TL87A18 15 100645-101729 71.3 95.5 5.56e-151 AmpC PRK11289 
 




Figure 7.4 Phylogenetic tree of DfSEC isolates nucleotide match to blaCMY-2 gene ORF 
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Table 7.6. Result of Geneious™ Pro 5.6.7 query and NCBI BLAST for blaDHA-1 gene variant ORF. 
Gene name  Interval %Pairwise identity %Query coverage E value Protein name Accession number 
blaDHA-1  113-1109 - - - AmpC PRK11289 





%Pairwise identity % Query coverage  E value Protein name Accession number 
CW49A18 38 28966-29975 63.1 88.3 1.79e-24 AmpC PRK11289 
PF30A18 10 174145-175155 62.9 88.4 2.68e-22 AmpC PRK11289 
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Of the 20 DfSEC isolates only CW49A18 and PF30A18 had nucleotide sequences with enough 
coverage (88.33% and 88.42%) and pairwise identity (63.1% and 62.9%) respectively, to encode for 
proteins from their queries. The protein encoded for by the blaDHA-1 gene variant ORF was an AmpC 




Table 7.7. Result of Geneious™ Pro 5.6.7 query and NCBI BLAST for blaMIR-1 gene variant ORF. 
Gene name 
 
Interval %Pairwise identity %Query coverage E value Protein  Accession number 
blaMIR-1 ORF 1-1143 1-1143 - - - AmpC PRK11289 
DfSEC isolate Contig. Gene coordinates %Pairwise identity %Query coverage E value Protein  Accession number 
CW28A18 10 159997-158984 70.5 88.5 3.62e-128 AmpC PRK11289 
CW33S18 49 13058-14071 70.5 88.5 3.61e-128 AmpC PRK11289 
CW49A18 38 29943-28930 70.1 88.5 1.21e-121 AmpC PRK11289 
MRD21A18 47 5674-4661 70.1 88.5 9.85e-123 AmpC PRK11289 
MRD22W18 10 13724-14737 70.5 88.5 3.56e-128 AmpC PRK11289 
MRD24S17 19 75135-74122 70.5 88.5 3.51e-128 AmpC PRK11289 
PF14A18 44 24841-23823 70.5 88.5 3.71e-128 AmpC PRK11289 
PF15A18 52 16258-15245 70.5 88.5 3.70e-128 AmpC PRK11289 
PF25S18 60 5676-4663 70.5 88.5 3.63e-128 AmpC PRK11289 
PF30A18 10 175123-174110 70.2 88.5 1.22e-121 AmpC PRK11289 
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Table 7.7 continued4.31 
DfSEC isolate Contig. Gene coordinates %Pairwise identity %Query coverage E value Protein  Accession number 
PF32A18 47 13058-14071 70.2 88.5 4.31e-127 AmpC PRK11289 
PF45W18 21 13613-14626 70.5 88.5 3.48e-128 AmpC PRK11289 
PF52W18 10 166755-165742 70.5 88.5 3.66e-128 AmpC PRK11289 
PF55W18 3 41821-40808 70.5 88.5 3.38e-128 AmpC PRK11289 
TL12A18 8 160197-159184 70.5 88.5 3.59e-128 AmpC PRK11289 
TL1S18 45 5675-4662 70.5 88.5 3.61e-128 AmpC PRK11289 
TL2S18 10 160155-159142 70.5 88.5 3.56e-128 AmpC PRK11289 
TL54S18 51 13058-14071 70.5 88.5 3.54e-128 AmpC PRK11289 
TL56S18 51 5676-4663 70.5 88.5 3.48e-128 AmpC PRK11289 




Figure 7.5 Phylogenetic tree of DfSEC isolates nucleotide match to blaMIR-1 gene ORF 
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In this study, the blaACT-1, blaBIL-1, blaCMY-2 and the blaMIR-1 gene variants ORF had similar 
nucleotide matches with the 20 DfSEC isolates. The nucleotide matches were at the same contig and 
location (Tables 7.3, 7.4, 7.5, and 7.6) inferring the possibility that an isolate may encode for either 
blaACT-1, blaBIL-1, blaCMY-2 or the blaMIR-1 gene variant only and not all four of them according to 
the parameters used for the Geneious™ Pro phylogenetic trees with a gap penalty of 12 (Figures 7.2, 
7.3, 7.4 and 7.5). 
Table 7.8 Location of the matched nucleotide sequence for blaACT-1, blaBIL-1, blaCMY-2, and 
blaMIR-1 gene ORF with DfSEC isolates. 
According to Geneious™ Pro analysis. 
 
bla gene ORF nucleotide sequence match coordinates 
DfSEC blaACT-1  blaBIL-1 blaCMY-2  blaMIR-1  
CW28A18 159075-159997 159000-160084  159000-160084 159997-158984 
CW33S18 13058-14028 12971-14055 12971-14055 13058-14071 
CW49A18 29021-29943 28946-30030 28946-30030 29943-28930 
MRD21A18 4752-5674 4677-5761 4677-5761 5674-4661 
MRD22W18 13724-14646 13637-14721 13637-14721 13724-14737 
MRD24S17 74213-75135 74138-75222 74138-75222 75135-74122 
PF14A18 23919-24841 23844-24928 23844-24928 24841-23823 
PF15A18 15336-16258 15261-16345 15261-16345 16258-15245 
PF25S18 4754-5676 4679-5763 4679-5763 5676-4663 
PF30A18 174201-175123 174126-175210 174126-175210 175123-174110 
PF32A18 13058-13980 12971-14055 12971-14055 13058-14071 
PF45W18 13613-14535 13526-14611 13526-1411 13613-14626 
PF52W18 166671-166017 165758-166842 165758-166842 166755-165742 





Table 7.7 continued 
 
bla gene ORF nucleotide sequence match coordinates 
DfSEC blaACT-1  blaBIL-1 blaCMY-2  blaMIR-1  
TL12A18 159275-160197 159200-160284 159200-160284 160197-159184 
TL1S18 4753-5675 4678-5762 4678-5762 5675-4662 
TL2A18 159185-160155 159158-160242 159158-160242 160155-159142 
TL54S18 13058-13980 12971-14055 12971-14055 13058-14071 
TL56S18 4754-5676 4679-5763 4679-5763 5676-4663 






Table 7.9. Result of Geneious™ Pro 5.6.7 query and NCBI BLAST for blaTEM-1 gene variant ORF.  
Gene name  Interval %Pairwise 
identity 
%Query coverage E value Protein name Accession number 
blaTEM-1  7-858 - - - PRK15442 PRK15442 
DfSEC isolate Contig. Gene coordinates %Pairwise 
identity 
%Query cover E value Protein  Accession number 
PF32A18 22 57411-58271 99.9 100 0e+00 PRK15442 PRK15442 
PF55W18 68 3663-4523 99.9 100 0e+00 PRK15442 PRK15442 
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The blaMIR-1 gene variant had 20 DfSEC’s with an 88.5% query cover and > 70% pairwise identity 
wide coverage percentage compared to the blaACT-1, blaBIL-1, and blaCMY-2 but at the same contig 
and similar coordinates and the nucleotide sequence encoding for the same proteins with the same 
accession number and description of β-lactamase/D-alanine carboxypeptidase (Table 7.8). 
The DfSEC isolates PF32A18 and PF55W18 had coverage of 100% and 99.9% pairwise identity with 
the blaTEM-1 gene variant and the nucleotide sequence query indicated the production of the 
blaTEM-1 β-lactamase hydrolysing enzyme from the Peel Forest conventional dairy farm, isolated in 
autumn of 2018 encode for the production of blaTEM-1 ESBL enzyme (Table7.8) described as beta-
lactamase at the NCBI protein domain site (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). 
For the tet(34)1 tetracycline resistance genes, the query cover threshold of > 67% coverage cover 
and > 75% pairwise identity was used during the Geneious™ Pro 5.6.7 analysis. The gene’s accession 
number of AB061440.1 was sourced from a peer-reviewed journal article by Roberts (2005). The 
tet(34)1 ORF nucleotide sequence was queried in the NCBI conserved domain protein BLAST and the 
result corresponded to a protein with the same name as the accession number of PRK09177 which 
was described as a validated xanthine-guanine phosphoribosyltransferase. Subsequently, the 
nucleotide sequence at the matching coordinates at the designated contig on the genome assembly 
of the DfSEC was queried in the NCBI protein BLAST for the possible proteins that the isolates may 
encode. All 20 DfSEC isolates carried nucleotide sequences that encoded for similar protein to the 
protein encoded by the nucleotide sequence of the tet(34)1 gene ORF (Table 7.9).  
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Table 7.10. Result of Geneious™ Pro 5.6.7 query and NCBI BLAST for tet(34)1 gene variant. 
Gene name 
 
Interval %Pairwise identity %Query cover E value Protein  Accession number 
tet(34)1 ORF  7-465 - - - PRK09177 PRK09177 
DfSEC isolate Contig. Gene coordinates %Pairwise identity %Query cover E value Protein name  Accession number 
CW28A18 26 39910-40265 75.6 67.3 5.34e-65 PRK09177 PRK09177 
CW33S18 16 102168-102523 75.0 67.3 2.76e-62 PRK09177 PRK09177 
CW49A18 50 9363-9722 75.1 67.3 6.63e-64 PRK09177 PRK09177 
MRD21A18 28 16951-17306 75.1 67.3 2.81e-62 PRK09177 PRK09177 
MRD22W18 36 7614-7969 75.1 67.3 2.72e-62 PRK09177 PRK09177 
MRD24S17 1 16888-17243 75.6 67.3 5.18e-65 PRK09177 PRK09177 
PF14A18 7 127893-128248 75.4 67.3 6.67e-64 PRK09177 PRK09177 
PF15A18 7 127893-128248 75.4 67.3 6.66e-64 PRK09177 PRK09177 
PF25S18 9 122050-122405 75.1 67.3 2.78e-62 PRK09177 PRK09177 
PF30A18 14 114059-114414 74.5 67.3 4.80e-59 PRK09177 PRK09177 
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Table 7.9 continued 
DfSEC isolate Contig. Gene coordinates %Pairwise identity %Query cover E value Protein name Accession number 
PF32A18 20 16882-17237 75.1 67.3 2.70e-62 PRK09177 PRK09177 
PF45W18 49 17000-17355 75.4 67.3 6.27e-64 PRK09177 PRK09177 
PF52W18 46 16882-17237 74.8 67.3 3.41e-61 PRK09177 PRK09177 
PF55W18 9 90304-90659 75.1 67.3 2.59e-52 PRK09177 PRK09177 
TL12A18 30 51909-52264 75.4 67.3 6.46e-64 PRK09177 PRK09177 
TL1S18 17 16882-17237 75.1 67.3 2.70e-62 PRK09177 PRK09177 
TL2S18 46 8589-8944 75.4 67.3 6.40e-64 PRK09177 PRK09177 
TL54S18 30 19512-19867 75.1 67.3 2.71e-62 PRK09177 PRK09177 
TL56S18 2 241997-242352 75.1 67.3 2.66e-62 PRK09177 PRK09177 







Figure 7.6 Phylogenetic tree of DfSEC isolates nucleotide match to tet(34)1 gene ORF 
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All the above nucleotide sequences encoded for the validated protein xanthine-guanine 
phosphoribosyltransferase with similar accession numbers and intervals from 2-355 as the previous 
nucleotide sequence. The protein PRK09177 is a member of the protein superfamily cl00306. This 
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family encompasses 41 other proteins that are involved in metabolic activities of E. coli amino acid 
transformations (https://www.ncbi.nlm.nih.gov/Structure/cdd/cl00309). 
The combination of the resistance genes encoded by the 20 DfSEC that were sequenced for genomic 
analysis by the Nullarbor and Geneious™Pro5.6.7 bioinformatics software are shown in Table 7.10. A 
phylogenetic of the nucleotide match of the tet(34)1 gene ORF with the DfSEC isolates (Figure 7.6) 
indicated close relatedness of isolates from different farms. Similarly, the close relatedness of the 
blaACT-1, blaBIL-1, blaCMY-2, and the blaMIR-1 gene variants compared to the tet(34)1 gene is 
indicated by the cluster of the blaACT-1, blaBIL-1, blaCMY-2, and the blaMIR-1 gene variants genes 
ORF nucleotide matches as opposed to the tet(34)1 gene match as shown in the phylogeny tree with 




Figure 7.7 Phylogenetic tree of blaACT-1, blaBIL-1, blaCMY-2, bla MIR-1, and tet(34)1 gene ORF with two exemplar DfSEC isolates. 




































































































  Geneious™ Pro Analysis    Nullarbor analysis  
CW28A18 + + + - + - +  - - - - - - - - + - - ± 
CW33S18 + + + - + - +  - - - - - - - + + - - ± 
CW49A18 + + + + + - +  - - - - - - - - + - - ± 
MRS21A18 + + + - + - +  - - - - - - - - + - - ± 
MRD22W18 + + + - + - +  - - - - - - - - + - - ± 
MRD24S17 + + + - + - +  - - - - - - - - + - - ± 
PF14A18 + + + - + - +  + - + + - + - - + + - ± 
PF15A18 + + + - + - +  + - + + - + - - + + - ± 
aph=aminoglycoside; blaACT, blaBIL, blaCMY, blaDHA, blaTEM, tet=tetracyclines; fos=fosfomycin: mdf=multidrug transporter: sul=sulphonamide 
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  Geneious™ Pro analysis   Nullarbor analysis     
PF25S18 + + + - + - +  - - - - - - - - + - - ± 
PF30A18 + + + + + - +  - - - - - - - - + - - ± 
PF32A18 + + + - + + +  - - - - + - - - + - + ± 
PF45W18 + + + - + - +  - - - - - - - - + - - ± 
PF52W18 + + + - + - +  - - - - - - - - + - - ± 
PF55W18 + + + - + + +  - + - + - - + - + - + ± 
TL12A18 + + + - + - +  - - - - - - - - + - - ± 
TL1S18 + + + - + - +  - - - - - - - + + - - ± 
aph=aminoglycoside; blaACT, blaBIL, blaCMY, blaDHA, blaTEM, tet=tetracyclines; fos=fosfomycin: mdf=multidrug transporter: sul=sulphonamide 
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 Geneious™ pro analysis   Nullarbor analysis      
TL2A18 + + + - + - +  - - - - - - - + + - - ± 
TL54S18 + + + - + - +  - - - - - - - - + - - ± 
TL56S18 + + + - + - +  - - - - - - - - + - - ± 
TL87A18 + + + - + - +  - - - - - - - - + - - ± 





Differences in parameter tuning and algorithm mechanisms may cause different clustering software 
tools to produce different results based mainly on the way the software program was programmed 
to identify and remove redundant data (Zou, Lin, Jiang, Liu, & Zeng, 2018). The volume of short reads, 
unique versus non-unique mapping, and base quality, during sequence alignment of experimental 
sample and reference sample genome, are some steps that may carry errors and cause different 
outputs (Dolled-Filhart, Lee, Ou-yang, Haraksingh, & Lin, 2013). These are all tied up in the type of 
assembler (EULER-SR, Velvet, IDBA-UD, or SPAdes) and the Phred-Phrad consensus package adopted 
by the assembler (Cameron et al., 2017), and these may affect the output the software provides 
(Zhang et al., 2011). The differences between how Geneious™ Pro 5.6.7 and Nullarbor dealt with 
gaps and anomalies in the nucleotide sequence of the isolates as well as the coverage and pairwise 
percentages adopted may have resulted in the differences in their outputs (Pedersen & Quinlan, 
2017). The ResFinder for determination of resistance genes encoded by bacteria species used for the 
Nullarbor analysis set the coverage range at 2/5 of the length of the resistant gene with 98% pairwise 
identity (Zankari et al., 2012). For the Geneious™ Pro 5.6.7 analysis, the coverage was set at > 80% 
and pairwise identity at > 70% similarities between DfSEC sequence assembly and nucleotide 
sequence of resistant gene ORF. For the tet(34)1 gene, however, the threshold for the Geneious™ 
Pro 5.6.7 in this study was reduced to > 67% coverage cover and > 75% pairwise identity. The set 
parameters, although within acceptable limits as indicated by (Devos & Valencia, 2000) were lower 
than that set for the Nullarbor analysis (Chapter 7.1) and may explain the discrepancies between the 
two outputs. 
In this study, the resulting outputs of both the Nullarbor and Geneious™ Pro 5.6.7 bioinformatics 
software analysis (Table 7.10) indicated that the combined isolates from the conventional dairy farm 
encoded nucleotide sequence with > 84% coverage and > 74% pairwise identity to the ORF of more 
resistant gene variants than the combined isolates from the organic dairy farms. The isolates 
PF14A18 and PF15A18 carried the most resistant gene variants, of 7/12 apiece according to the 
Nullarbor analysis. These were followed by PF55W18 that bore 6/12 gene variants. The CW49A18, 
CW33S18, and PF30A18 with 3/12 resistant gene variants were the third highest. Similarly, the DFSEC 
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isolates from the Peel Forest conventional dairy farm had three of its isolates PF55W18, PF30A18, 
and PF32A18 having 4/7 nucleotide matches to the ORFs of the genes analysed by the Geneious™ 
Pro software. DfSEC isolates that encoded nucleotide sequence matches for the blaACT-1, blaBIL-1, 
blaCMY-2, or the blaMIR-1 gene counted at a single gene variant match. Only CW49A18 from the 
Clearwaters organic dairy farm had 4/7 matched nucleotide sequences to the ORFs of these gene 
variants. The rest of the isolates each had 3/7 gene ORF nucleotide sequence matches (Table 7.10). 
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By the use of whole-genome multi-locus sequence typing (wgMLST) of E. coli BioNumerics 
(http://www.applied-maths.com/sites/default/files/extra/Release-Note-Eschericha-coli-Shigella-
schema.pdf., a minimum spanning tree was created showing the loci differences between all 20 
DfSEC isolates from the four farms that showed multi-resistance to antimicrobials (Figure 7.8).  
 
Figure 7.8. Minimum spanning tree of DfSEC isolates with multiple antimicrobial resistance 
CW=Clearwaters organic farm: PF=Peel Forest conventional farm: MRD=Mill Road conventional 
dairy farm TL=Totara Valley organic dairy farm 
S17=spring 2017: S18=spring 2018: A18=autumn 2018: W18=winter 2018 
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DfSEC isolates CW33S18 and TL1S18 were the closest related isolates of the B1 phylogenetic group 
with no loci differences by wgMLST (Figure 7.8); potentially, an indication of a common source of 
origin. The B1 phylogenetic group members of PF14A18 and PF15A18 were the next close relatives 
with a 1 locus difference. These two organisms were isolated from the same paddock at the same 
sampling time and may explain their close relations.  
Two of the isolates from the Peel Forest conventional dairy farm were of the phylogenetic group A 
and were comparatively distant from the isolates of the B1 group discussed above which may 
indicate differences in origin at 2349 loci differences apart. The two DfSEC isolates of the 
phylogenetic group E, one each from the geographically closely located Clearwaters and Peel Forest 
farms (Chapter 3), were also comparatively distantly related by loci difference of 3287 and 3274 
signifying the possibility of differences in origin. 
From a summary of the BioNumerics bioinformatics software analysis (https://www.applied-
maths.com/news/e-coli-genotyping-plugin-version-12-available) (Table 7.11), both isolates of the 
phylogenetic group E (CW49A18 and PF30A18) indicated the same virulence determinants of iss, air, 
gad, and eiLA, and the phylogenetic group A (PF45W18 and PF55W18) isolates carried a single 
virulence factor, iss with all four closer in relation compared to the rest of the isolates (Figure 7.8). 
No virulence determinants were detected in TL87A18, only one virulence determinant was detected 
in PF45W18, and multiple virulence determinants in the remaining 18. The type 1 fimbriae, fimH 
gene alleles, were found in all 20 isolates but differed in the variant they each carried. The fimH2 
allele, however, was found in CW33A18, TL1S18, and TL54S18. The fimH8 allele was detected in 
MRD24S17 and TL12A18. The two isolates of the phylogenetic group A PF55W18 and PF45W18 
carried the multi-resistant fimH30 allele. The rest of the DfSEC isolates (n=13) carried other less 
common variants of the fimH gene variants as per work carried out by Roer et al. (2017). 
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Table 7.12 Phylogenetic grouping of DfSEC isolates based on Clermont et al. (2013) protocol with multiple resistance genes; serotype and virulence 
determinants according to BioNumerics bioinformatics software analysis. 
Farm Isolate Resistant type Phylogenetic group Serotype Virulence determinant 
Clearwaters (CW) 28-A18 ESBL+AmpC# B1 O10 :H42 iss, IpFA 
 33-S18 ESBL+AmpC# B1 - :H2 iss, IpFA 
 49-A18 ESBL+AmpC# E O11 :H15 iss, air, gad, eiLA 
Mill Road (MRD) 21-A18 ESBL+AmpC# B1 O45 :H51 iss, IpFA 
 22-W18 ESBL+AmpC# B1 O166 :H49 iss, IpFA 
 24-S17 ESBL+AmpC# B1 O150 :H8, H40 IpFA 
Peel Forest (PF) 14-A18 ESBL+AmpC# B1 O9 :H21 iss, IpFA, iha 
 15-A18 ESBL+AmpC# B1 O9 :H21 iss, IpFA, iha 
 25-S18 ESBL+AmpC# B1 - :H16 iss, 
 30-A18 ESBL+AmpC# E O138 :H48 iss, air, gad, eiLA 
air=enteroaggregative immunoglobulin protein: astA=heat stable enterotoxin 1: cdtb=cytolethal distending toxin B 




Table 7.10 continued 
Farm Isolate Resistant type Phylogenetic group Serotype Virulence determinant 
Peel Forest 32-A18 ESBL+AmpC# B1 O138 :H19 iss, IpFA, mchF, iroN 
 45-W18 ESBL+AmpC# A 09 :H30,H32 iss 
 52-W18 ESBL+AmpC# B1 0142 :H38 iss, IpFA 
 55-W18 ESBL+AmpC# A O9 :H30 iss 
Totara Valley (TL) 1-S18 ESBL+AmpC# B1 - :H2 iss, IpFA 
 2-A18 ESBL+AmpC# B1 O133 :H7 iss, IpFA, cdtB 
 12-A18 ESBL+AmpC# B1 O82 :H8,H40 iss, IpFA, cdtB 
 54-S18 ESBL+AmpC# B1 O152 :H2 IpFA, astA 
 56-A18 ESBL+AmpC# B1 - :H39 iss 
 87-A18 ESBL+AmpC# B1 - :H10 - 
air=enteroaggregative immunoglobulin protein: astA=heat stable enterotoxin 1: cdtb=cytolethal distending toxin B 
eiLA=Salmonella HilA homolog: gad=glutamate decarboxylase: iha=adherence protein: iss=increased serum survival: IpFA=long 
polar fimbriae  
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Metadata of all 20 DSfSEC isolates were submitted to the NCBI Data benk and accorded accession 
numbers listed in Table 7.13  
Table 7.13. NCBI accession number of DfSEC isolates 
Isolate Organism NCBI accession number 
CW28A18 E. coli SAMN21857572 
CW33S18 E. coli SAMN21873234 
CW49A18 E. coli SAMN21873284 
MRD21A18 E. coli SAMN21873318 
MRD22W18 E. coli SAMN21873423 
MRD24S17 E. coli SAMN22130149 
PF14A18 E. coli SAMN22130150 
PF15A18 E. coli SAMN21894888 
PF25S18 E. coli SAMN22014245 
PF30A18 E. coli SAMN21904186 
PF32A18 E. coli SAMN21905091 
PF45W18 E. coli SAMN22251002 
PF52W18 E. coli SAMN22231228 
PF55W18 E. coli SAMN21923850 
TL12A18 E. coli SAMN21926700 
TL1S18 E. coli SAMN22216216 
TL2A18 E. coli SAMN21926618 
TL54S18 E. coli SAMN21976240 
TL56S18 E. coli SAMN22130148 







According to the classification by Bush (2013), β-lactamase enzymes may be classified into A, B, C, 
and D groups. In this study, all 20 selected DfSEC were found to contain nucleotide sequences similar 
to the nucleotide sequence of either blaACT-1, blaBIL-1, blaCMY-2, or blaMIR-1 gene variants that 
encoded for AmpC (group C) enzyme. The AmpC enzyme confers resistance to cephalothin, cefazolin, 
cefoxitin, most penicillins, and β-lactamase inhibitor-β-lactam combinations (Jacoby, 2009). The 
isolates PF32A18 and PF55W18, further carried the ESBL blaTEM-1 gene variant as confirmed by their 
genomic analysis using the Nullarbor and Geneious™Pro5.6.7 bioinformatics software. This genetic 
character had been confirmed by their phenotype disc diffusion antimicrobial susceptibility test 
against FOX30 and the MASTDISCS® (MAST™ Group Ltd, Liverpool, UK) phenotype screening assay 
(Chapter 6). This was in line with other studies that have undergone similar tests and assays to verify 
the existence of bla genes in E. coli strains from various niches (Durmaz, Bal, Gunaydin, Yula, & 
Percin, 2015; Ghaderi, Yaghoubi, Amirfakhrian, Hashemy, & Ghazvini, 2020; Shahcheraghi, Nasiri, & 
Noveiri, 2010; van den Bunt et al., 2019).  
The chromosomally stemmed blaCMY-2, blaACT-1, and blaMIR-1 genes (Reisbig & Hanson, 2004), 
originated from Enterobacter cloacae (Bradford, 2001) may be found on a transposon and 
transmitted to and from chromosomes and plasmids (Ku, Lee, Chuang, & Yu, 2018). All three genes 
may be located on a single transposon and transmitted together and are derived from older broad-
spectrum β-lactamases such as blaTEM1&2 and blaSHV1 (Ku et al., 2018; Thomson, 2001). The 
blaACT-1 gene of 381 amino acid length shared 94% homology with the 150 bp sequence of the 
blaMIR-1 gene with 86, 73, and 71% pairwise identities with AmpC β-lactamase genes from E. 
cloacae P99, Citrobacter freundii OS60, and E. coli K19, respectively (Barnaud et al., 1998). This was 
similar in this study where all 20 DfSEC isolates had nucleotide sequences similar to the nucleotide 
sequence of the ORF of either the blaACT-1, blaBIL-1, blaCMY-2 or the blaMIR-1 gene variants and 
located at the same contig with similar coordinates and encoded for the production of the AmpC 
enzyme. The closeness in the relationship between the matched nucleotide sequences of the DfSEC 
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isolates and that of the nucleotide sequences of the ORF of the blaACT-1, blaBIL-1, blaCMY-2, and the 
blaMIR-1 gene variants is also indicated by the phylogenetic tree created (Figure 7.7). This figure is an 
example for the rest of the DfSEC by using the isolates CW49A18 and CW28A18 with a gap penalty of 
6 in the Geneious Pro bioinformatics software. Previous authors have used gap penalties between 
1.5 (Das, Fearnside, Sarker, Forwood, & Raidal, 2017) and 12 (Pyo et al., 2014) in their studies. 
The DfSEC isolates nucleotide sequence match with the ORF of the gene variants’ similarity in the 
nucleotide sequence of these genes also indicated by the close resemblance of the phylogenetic tree 
created for the various DfSEC isolates using the ORFs of the blaACT-1, blaBIL-1, blaCMY-2, and the 
blaMIR-1 gene variant ORF, compared to the comparatively different tet(34)1 gene variant with a gap 
penalty of 12 (Figures 7.2-7.6). The Geneious Pro bioinformatics software may treat nucleotide 
sequences that are not matched as null (Hwang, Han, Hong, & Han, 2017) instead of an A 
(adenosine), C (cytosine) G (guanine), or a T (thymine) because of the gap penalty (Zou et al., 2018). 
This may infer that the DfSEC isolates encode nucleotide sequence match for one of these gene 
variants only and not of multiple gene variants. Since the blaCMY-2 gene variant is the is abundant 
AMR gene in New Zealand (Jean, Hsueh, & Group, 2016; Karkaba, Hill, Benschop, Pleydell, & 
Grinberg, 2019) compared to the prevalence of the other three (blaACT-1, blaBIL-1 and blaMIR-1), it 
may be speculated that in this study, the DFSEC isolates encode for the blaCMY-2 nucleotide 
sequence rather than any of the other three. In this study, the Geneious Pro bioinformatics software 
may not have identified mutations, deletions (INDELs), single nucleotide polymorphisms (SNPs), and 
variable number tandem repeats (VNTRs).  
According to Poirel et al.(2018), the prevalence of various bla genes and other ARGs depends on the 
geographical location, the species from which the E. coli were isolated, and the pathological 
condition in question. This may explain the findings in this study as the E. coli isolates were sourced 
from bovine dairy farm soils. Other studies that have sourced E. coli from particular niches have 
shown that E. coli of a particular phylogenetic group, serovar, or a virulence determinant dominate 
that particular niche. Studies from France on 1427 Klebsiella pneumoniae isolates from bovine 
mastitis (Dahmen, Métayer, Gay, Madec, & Haenni, 2013), Spain on environmental, human and meat 
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sourced E. coli (Ojer-Usoz, González, & Vitas, 2017), Canada on E. coli from humans (Mulvey et al., 
2005), South Korea on E. coli from beef cattle and the Czech Republic on E. coli from manure and 
milk (Kyselková, Jirout, Vrchotová, Schmitt, & Elhottová, 2015; Kyselková, Kotrbová, et al., 2015) have 
confirmed this phenomenon.  
The blaDHA-1 may have originated from Morganella morganii as the AmpR and AmpC regions of the 
gene has a 98% intracistronic match with the genomic DNA of the organism and spread to other 
bacteria including members of the Enterobacteriaceae family as plasmid borne inducible gene 
(Barnaud et al., 1998; Verdet, Arlet, Barnaud, Lagrange, & Philippon, 2000). The blaDHA-1 has close 
similarities to the nucleotide sequences of the blaACT-1, blaCMY-2, and blaBIL-1 gene variants at 
98% and protein sequence similarity of between 53-58% according to a study by (Barnaud et al., 
1998). In this study, the genomic nucleotide sequence of the DfSEC isolates had a sequence query 
coverage of > 88% and a pairwise identity of > 62% on the same contig as those of blaACT-1, blaCMY-
2, and blaBIL-1 gene variants and encoded for the production of AmpC protein (enzyme) and may 
also explain their phenotype resistances especially, to FOX30 for the two isolates CW49A19 and 
PF30A18 (Table7.6). The hydrolytic activity of the AmpC enzyme is similar irrespective of their origin 
(Reis et al., 2020) and this may explain the reduced resistance to the cephalosporin antimicrobial 
FOX30 (Jacoby, 2009; Pitout, 2012b) (Table A1.1).  
Generally, the bla genes in Enterobacteriaceae are not always found in all parts of the globe at the 
time of their initial discovery (Khoshbakht, Shahed, & Aski, 2020; Lübbert et al., 2015). Presently the 
closely related large family of β-lactam hydrolysing enzymes of blaCTX-M, blaSHV, and blaTEM gene 
variants are found worldwide (Ojdana et al., 2014; Toombs-Ruane et al., 2017). These phenomena 
may indicate a gradual spread from a common source to other parts of the world as was the case for 
the New Delhi-Metallo-β-lactamase gene variant (blaNDM-1) transmission from Indian to New 
Zealand by human migration (López-Cerero & Almirante, 2014; Shahid et al., 2014; Williamson et al., 
2012). The blaTEM gene variants together with its closely associated genes of blaCTX-M and blaSHV 
variants were the first of the β-lactamases to be described (Poirel et al., 2018; Toombs-Ruane et al., 
2017). These resistance genes have numerous variants, with newer ones continuously being 
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discovered in different geographical locations and niches and have the highest prevalence of 
resistance to ESBLs in Enterobacteriaceae, especially E. coli (Liakopoulos, Mevius, & Ceccarelli, 2016; 
Michael et al., 2015). In New Zealand, the most prevalent blaESBL, mostly from human sources, is the 
CTX-M type (Freeman et al., 2012; Heffernan, Dyet, Woodhouse, & Williamson, 2014). Similarly, 
among domestic cats and dogs, the blaCTX-M type is the next most common, followed by a blaCMY-2 
variant (Karkaba et al., 2019). This is comparable to data from other parts of the world. A study of the 
prevalence of ESBL producing E. coli on a Bavarian dairy and beef cattle farm (Schmid et al., 2013) 
found the most prevalent gene variant to be the blaCTX-M-1 gene variants at 96%, 23% for the 
blaCMY-2 gene, and only 2.5% for AmpC type. A Chinese study of ESBL resistant E. coli isolates from 
bovine mastitis found 78%, 56%, and 16% of the isolates either in singlet or combination to be 
blaCTX-M, blaTEM, and blaSHV genes variants respectively (Yang et al., 2018).  
In this study, the mdfA gene was common to all the DfSEC isolates investigated, which is in line with 
the suggestion that the mdfA gene is intrinsic to E. coli strains (Heng et al., 2015; Sigal et al., 2005) 
and common to most bacteria (Lewinson et al., 2003). According to Levy (2002), the mdfA gene is 
activated by environmental signals or by mutation of a regular gene for expression. The E. coli mdfA 
gene is of 410 amino acid residues arranged in 12 transmembrane helices with their N and C 
terminals embedded in the cytoplasm (Adler & Bibi, 2002). This amino acid sequence encodes for a 
member of the major facilitator superfamily of proteins which confers resistance to a wide variety of 
compounds toxic to bacteria, including antimicrobials of different structures and mechanisms of 
action (Edgar & Bibi, 1997; Heng et al., 2015; Nagarathinam et al., 2017). This was biologically 
demonstrated in a study by exposing mutant and wild-type strains of E. coli to high concentrations of 
biologically toxic ethidium bromide and chloramphenicol (Sigal, Molshanski-Mor, & Bibi, 2006). The 
role of the mdfA gene in reducing the minimum inhibition concentration of fluoroquinolones by the 
efflux pump was also demonstrated in clinical E. coli isolates by Swick, Morgan-Linnell, Carlson, and 
Zechiedrich (2011). This may explain the reduced susceptibility of these 20 DfSEC isolates in this 
study to cefoxitin, together with tetracycline resistance in four others.  
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In this study, all 20 DfSEC encoded similar nucleotide sequences to the ORF of the tet(34)1 resistant 
gene to tetracycline(67% coverage and 74% pairwise identity), but only four of the isolates were 
phenotypically resistant to it. In a South Korean study of 146 E. coli isolates from beef cattle that 
were resistant to tetracycline, none of the isolates carried the tet(34)1 gene variant but rather tet(A), 
tet(B), and tet(C) at 46%, 45%, and 7%, respectively (Shin, Shin, Jung, Belaynehe, & Yoo, 2015). Also, 
in a Czech Republic study that looked at the occurrence of tet genes in the faeces, manure, and milk 
of cows of various ages from conventional dairy farms, after the farm's routine use of intrauterine 
tetracycline suppository, the authors found all the various tet genes variants to be the age of cow 
and manure dependant. The authors also found that tet (W), tet(O), and tet(Q) predominated in all 
samples, and tet(A), tet(M), tet(Y), and tet(X) were less so. No tet(34)1 was found in this study apart 
from samples taken from aged manure at 2 m deep (Kyselková, Jirout, et al., 2015). These findings 
were similar to the USA study (Yang et al., 2020). In this study, the soil samples from which the E. coli 
strains were isolated, were taken from the surface to 30 cm of soil depth with conditions which may 
be equated to that depth of the aged manure and may explain the findings of tet(34)1 gene variant in 
18 of the 20 DfSEC isolates investigated by the Nullarbor bioinformatics software (Table 7.2). 
In this study, the nucleotide match between the DfSEC isolates and the ORF of the tet(34)1 gene 
variant encoded for the production of the metabolic protein xanthine-guanine 
phosphoribosyltransferase, an intrinsic E. coli enzyme (Krenitsky, Neil, & Miller, 1970). This enzyme is 
involved in the metabolism of purine, xanthine, and guanine amino acids in the purine salvage 
pathway of E. coli (Vos, Parry, Burns, de Jersey, & Martin, 1998) for the synthesis of DNA, RNA, and 
the generation of ATP during biogenesis (de Souza Dantas, Ramos dos Santos, Guimarães Pereira, & 
Medrano, 2008). This is constituent with the findings in this study as, although all 20 DfSEC isolates 
carried similar nucleotide sequence that matched the nucleotide sequence of the ORF of the tet(34)1 
gene at 67.3% coverage and 75.1% pairwise identity, only 4/20 (PF15A18, PF25S18, MRD21A18, and 
MRD22A18) of the isolates were phenotypically resistant to Te(30) (Table A1.1). Organisms may 
genetically encode a resistant gene but not express the resistance phenotypically (Mbelle et al., 
2019). The resistance showed by these four isolates may be due to their ability to hyper-express the 
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efflux pump mechanism to extrude tetracycline from the cytoplasm by active transport, (Blair, 
Richmond, & Piddock, 2014; Roberts, 2005) or by the use of ribosomal protection proteins, and 
modification of the drug (Roberts, 2005; Thaker et al., 2010).  
In this study, apart from all the 20 DfSEC submitted for WGS demonstrating the potential to harbour 
multiple resistance genes to different antimicrobial groups, and phenotypically being resistant to the 
cefoxitin (FOX30), 3.7% of the 814 DfSEC isolates from both dairy farming systems showed varying 
susceptibility/resistance to other groups of antimicrobials. Such a result was confirmed by other 
studies on E. coli from different niches (Sunde & Norström, 2006; Wu et al., 2012).  
In this study, there were differences in the output of the Nullarbor and Geneious™ Pro 5.6.7 
bioinformatics software. These differences could be attributed to the parameters set to detect the 
resistant determinants used in the two analyses. For the genotype-phenotype determinant in the 
Geneious™ Pro 5.6.7, the homologous nucleotide sequence between the ORF of the gene variant 
under consideration and the genome assembly of the DfSEC at > 80% and pairwise identity at > 70% 
was used. The matching nucleotide sequence was NCBI BLAST queried for the encoding protein 
(enzyme) as the genotype-phenotype AMR determinant. For the Nullarbor analysis, however, the 
genome sequences of the DfSEC isolates were put through the ResFinder4.0 software (Bortolaia et 
al., 2020). The ResFinder4.0 software was set up using four different databases including translations 
of genotype into phenotype by a panel of experts who reviewed AMR determinants from applicable 
literature (Bortolaia et al., 2020) with the query cover at 2/5 length of the resistant gene and 
pairwise identity at 98%. This explains the matching outputs of the Geneious™ Pro 5.6.7 and 
Nullarbor analysis regarding the blaTEM-1 resistant gene (Geneious™ Pro 5.6.7 pairwise identity was 
at 99.9%) but not with blaACT-1, blaBIL-1, blaCMY-2 and blaDHA and blaMIR-1 resistant gene 
variants whose pairwise identity were set at > 70%.  
In Enterobacteriaceae such as E. coli, resistance to an extended-spectrum β-lactam antimicrobial is 
achieved in three major ways: excretion of the corresponding hydrolysing enzymes to the particular 
β-lactam antimicrobial (Noval, Banoub, Claeys, & Heil, 2020; Pfeifer & Eller, 2012), the use of cell wall 
transpeptidases that antimicrobials do not bind to, or by active removal of the particular 
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antimicrobial from the cell (Wilke, Lovering, & Strynadka, 2005). The biochemical structure of 
enzymes involved in the process of crosslinking the peptidoglycan molecule to an antimicrobial 
structure and the change in the structure of a target site of membrane-bound serine transpeptidases 
play a crucial role in the bacteria’s ability to resist the effects of an antimicrobial (Lobanovska & Pilla, 
2017). Similarly, modification of the chemical structure of most antimicrobials, such as the side-
chains of the β-lactam ring, results in new activities of the drug and mostly an expansion of the 
spectrum of the group of antimicrobials (Cooper, Hatfield, & Spry, 1973; Page, 2012; Yamamoto et 
al., 1982). Thus, the chemical structure of the proteins or family of proteins involved in the three-
step/three-site biogenesis of the bacteria cell wall would play vital roles in the 
susceptibility/resistance of a bacteria to an antimicrobial (Kong, Schneper, & Mathee, 2010). In this 
study, the DfSEC isolates that showed resistance to antimicrobials all carried nucleotide sequences 
that encoded for proteins or family of proteins which would help the cell avoid destruction by one or 
the other mechanism described above.  
Globally, ESBL-producing E. coli, as well as E. coli resistant to third and fourth cephalosporins like 
cefoxitin, are widespread (Padmini, Ajilda, Sivakumar, & Selvakumar, 2017). A 2009-2012 data from a 
study initiated in 2002 in the Asia-Pacific region to study the trend of AMR in 1762 
Enterobacteriaceae isolates of which 56.3% were E. coli collected from 38 different hospitals from 10 
countries in the region, including three hospitals in New Zealand, indicated that 28%, 50.3% and 74% 
of the total number of Enterobacteriaceae isolates were susceptible to extended-spectrum beta-
lactam antimicrobials, third and fourth generation cephalosporins, respectively (Lu et al., 2012). A 
similar study of 903 E. coli isolates from women aged between 18-65 in five European countries 
(Austria, Greece, Portugal, Sweden, and the UK) with uncomplicated lower urinary tract infection 
(UTI) also found 120 (13.3%) to be resistant against four or more (multi-resistant) of the antimicrobial 
agents used in the study (Kahlmeter & Poulsen, 2012). The commonest resistant genes in the 
European study (Kahlmeter & Poulsen, 2012) were of the CTX-M and AmpC variants. Similarly, an 
Asia-Pacific region study (Jean, Hsueh, et al., 2016) found the blaCTX-M and blaCMY-2 resistant 
genes to be most common. In this study, of the total 814 DfSEC studied, 2.45% (20/814) were found 
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to harbour multi-resistant genes of seven gene variants, and close similarity to the nucleotide 
sequence of the ORF of the blaACT-1, blCMY-2, blaMIR-1 genes were common to all 20 multi-
resistant isolates according to nucleotide sequences analysis by the Geneious™ Pro at 95% coverage 
and 73% pairwise identity. A Southern Pennsylvania, USA study on the widespread nature of 
antimicrobial resistance genes from lactating cows’ faeces and soil around the cattle barns was 
examined. It was found that the most abundant genes were the multidrug-resistant genes (44.7%), 
vancomycin-resistant genes (12.5%), tetracycline at 10.5%, bacitracin (10.4%) and β-lactam 
resistance genes were at 7.1%, MLS efflux pump (6.9%)  (Pitta et al., 2016). The major ESBL resistant 
genes include blaTEM, blaSHV, and blaCTX-M and are found all over the world (Bora et al., 2014; 
Coque, Baquero, & Cantón, 2008), while others such as blaOXA (Evans & Amyes, 2014) may be 
relative, and with plasmids, play a crucial role in their transmission and spread (Benz et al., 2021).  
A New Zealand study that looked at the relatedness of Streptococcus uberis from the mammary 
glands of cows with clinical and subclinical mastitis from different dairy herds from different districts 
using the genomic tool of pulsed-field gel electrophoresis indicated dissimilarities between isolates 
from different herds but similarities between isolates from different quarters of the same cow 
(Douglas, Fenwick, Pfeiffer, Williamson, & Holmes, 2000). A similar study on Shiga toxin-producing E. 
coli (STEC) from 102 farms in different regions of New Zealand using PCR/MALDI-TOF genomic tools 
indicated the possibility of E. coli spread within a farm but not between farms (Browne et al., 2018). 
In this study, the minimum spanning tree generated from the Nullarbor analysis of the 20 DfSEC 
isolates indicated some level of relatedness between two isolates from different farms (TL1S18 and 
CW33S18) (Figure 7.8). The use of wgMLST as a genomic tool for the relatedness study of bacteria 
species is more sensitive than the use of pulsed-field gel electrophoresis (David et al., 2013; Schouls 
et al., 2009). In the New Zealand dairy farming industry, it is common and traditional for farms to 
share contractors such as milk buying companies, feed, and fertiliser suppliers and to tread common 
walk-ways (Hidano, Gates, & Enticott, 2019; Kerr & Layton, 1983), especially on moving days 
(https://www.dairynz.co.nz/business/moving-day/managing-contractors/). This phenomenon, as 
well as running waterways (McWilliam & Balzarova, 2017) and wild animals including birds, may 
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cause the spread of microbes between farms located in the same catchment or area. This may 
explain findings in this study where some E. coli isolates from a particular farm showed close 
relatedness to another isolate from a different farm. 
In New Zealand, 2016 data indicated 8.9 cases per 10 000 people of STEC with living near cattle or 
contact with cattle and their manure/faeces as the principal sources of infection, but not from food 
(Browne et al., 2018; Jaros et al., 2016). The STEC O157:H7 is most commonly known globally, for the 
severe morbidity and mortality it causes (Akindolire, 2019). According to Coombes et al. (2008), 
there are over 200 highly virulent non-O157 STEC serotypes that can be found worldwide. A 2008 
study (Leotta et al., 2008) of STEC-types found in Argentina, New Zealand and Australia indicated 
that in Argentina and New Zealand most haemolytic uraemia syndromes were caused by the STEC 
O157:H7 types but less so in Australia. In that study, the 76 E. coli strains could be divided into 10 
different clusters, 46 different patterns with 36/76 strains showing unique patterns, indicating the 
wide variability and close relatedness that these organisms share, similar to findings in this study. In 
New Zealand (Jaros et al., 2013) as well other parts of the world (Jaros et al., 2014; Leotta et al., 
2008) cattle are considered to be the main reservoirs of STEC and is a frequent source of infection in 
human outbreaks. A New Zealand study of 91 STEC strains from rectal swabs of cattle and 48 strains 
from sheep showed the majority of them to be of H8 or H10 flagellum subtype (Cookson et al., 2010). 
Similarly, in this study, 2/20 DfSEC isolates had the H8 flagellum and 1/20 was of the H10 type. In 
another Australia/New Zealand study involving data from 182 human patients and isolated 179 
cephalosporin-resistant E. coli strains had 39% of isolates were of the H30 subtype (Rogers et al., 
2015), while in this study 2/20 (10%) of isolates were of the H30 subtype.  
The data from this study did not include any of the more prevalent pathogenic subtypes of O157, 
O26, O111, or O145 (Cookson et al., 2010) subtypes, the presence of H8 and H30 subtypes may be of 
concern to human health and caution in dealing with E. coli isolates from the soil of dairy farms may 
need to be advocated for. This is because, in the present study, toxins and the toxicity level of the 
DfSEC isolates were not looked at. Such a test could be done in the future to shed more light on the 
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variability of E. coli isolates and the potential danger that commensal to cattle but virulent to humans 
(Jaros et al., 2013) E. coli may pose to public health risks. 
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Chapter 8 
Conclusions of the study  
Until the onset of the Covid-19 pandemic, the topmost priority of not only the WHO, but the FAO, 
and centres for disease controls around the world, was antimicrobial resistance (AMR) development, 
prevalence, and spread (Silva et al., 2021; World Health Organization, 2020). AMR is expected to 
overwhelm health facilities, derail a century’s worth of medical progress, and cause more deaths 
than cancer by the year 2050 (Bhatia, 2018). Scientists around the globe have questioned how best 
to control AMR development, prevalence and have put efforts into discovering new potent 
pharmaceuticals (Tacconelli et al., 2018). Arguably, the cost in financial terms, quality of life, and 
other societal losses caused by AMR can never be accurately or near accurately assessed (World 
Health Organization, 2014). The surveillance which governments are encouraged to carry on the 
development, prevalence, and spread of AMR to help address the situation, would be enhanced by a 
baseline study of the current situation. This could be followed by the frequent comparison of 
industries that use chemicals including agrochemicals and antimicrobials with industries that use 
these chemicals sparingly or not at all.  
The design of this study was aimed at providing valuable information on the current AMR situation in 
the Geraldine area of South Canterbury, New Zealand. The phenotype and genotype AMR status of 
the widely accepted indicator organism of AMR, E. coli, in the soils of the fast-growing dairy industry 
was looked at by comparing isolates from two organic dairy farms to their counterparts from two 
conventional farms in the district.  
In New Zealand, as well as most developed countries the use of antimicrobials is the key component 
in the control of the most economically important disease of mastitis and other infectious diseases in 
the dairy industry (McDougall, 2001, 2002; McDougall & Compton, 2002; McDougall et al., 2017). 
Antimicrobials are used annually in New Zealand conventional dairy farms as opposed to non-usage 
in organic dairy farms for the prevention and control of mastitis and end up in the soils of the fields 
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(Tasho & Cho, 2016). Secondly, dairy farming in New Zealand is pastoral based and the need to 
control weeds on the pastures and in fodder feed is critical and herbicides including salts of 
glyphosate and 2, 4-D Ethylhexyl ester is commonly used (Ghanizadeh & Harrington, 2019; 
Manktelow et al., 2005) on conventional dairy farms but not on organic dairy farms. These 
agrochemicals in combination with antimicrobial usage contribute to the development of 
antimicrobial resistance in the soils (Kurenbach, Hill, Godsoe, van Hamelsveld, & Heinemann, 2018; 
Van Bruggen et al., 2018). The phenotype and genotype AMR status of dairy farm soil E. coli (DfSEC) 
isolates from conventional dairy farms with regular use of antimicrobials and other agrochemicals 
were compared to that of their counterparts from the organic dairy farms with limited/non-usage of 
antimicrobials and other agrochemicals. The soil harbours the widest range of strains and the highest 
amount of any particular bacteria species (Lauber, Hamady, Knight, & Fierer, 2009; Yergeau, 
Newsham, Pearce, & Kowalchuk, 2007). Since microorganisms are the source of most antibiotics, it 
follows that antibiotics can be found in all soils containing bacteria on the planet irrespective of 
human intervention (Wellington et al., 2013). The soil acts as a depot for industrial, agricultural, and 
wastes of all kinds (Alloway, 1996; Gorovtsov et al., 2019). It may be expected that any soil with a 
history of human industrial, domestic, and/or agricultural wastes would contain antimicrobials and 
other chemicals that may not only accelerate the development of AMR in the soil's bacteria 
population (Baquero & Blázquez, 1997; Davies & Davies, 2010; Michael et al., 2014) but would also 
contain a larger variety of antimicrobial-resistant genes (ARGs) and their variants compared to areas 
without human intervention (Qi et al., 2019). 
It is possible to deduce from the findings in this study that, presently, the conventional dairy farming 
system in the Geraldine area may not have impacted the development of AMR in DfSEC isolates to 
any significant extent compared to their organic counterparts but there is a tendency for the E. coli 
found in the conventional dairy farm soils to possess more ARGs. Similarly, in a Swiss study, the 
antimicrobial resistance status of different species of bacteria to a selected group of antimicrobials 
did not find any significant differences between the two farming systems regarding their influence on 
the antimicrobial resistance of the majority of bacteria species studied (Roesch et al., 2006). 
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However, a study in the USA of Staphylococcus aureus from the milk of conventional dairy farm cows 
compared to their counterparts from organic dairy farms to selected antimicrobials (Tikofsky, Barlow, 
Santisteban, & Schukken, 2003) found the conventional dairy farming system to significantly 
influence the antimicrobial resistance status of Staphylococcus aureus in their milk. 
 
In this study, among the 20 isolates selected for genomic analysis, those with the highest number of 
ARGs were from the conventional Peel Forest dairy farm soil, with two of them having up to six ARGs. 
This would imply that at any one time, there would be more resistant gene variants in circulation in 
the soils of the conventional dairy farms compared to their organic counterparts, in the Geraldine 
district. The second finding from this study was that some of the highly prevalent antimicrobial 
resistant genes recorded from other parts of the world and New Zealand, blaCTX-M and blaSHV were 
not found in the Geraldine catchment of South Canterbury dairy farm soils. The presence of blaCMY-
2 variant, second in abundance in New Zealand (Jean, Hsueh, et al., 2016; Karkaba et al., 2019) may 
be concluded in a future study. The non-prevalence of the most commonly found ARGs of blaCTX-M 
and blaSHV and the low prevalence of AMR DfSEC in the dairy farming systems of the Geraldine 
district may be related to a) its comparatively remote location. Geraldine is a rural community, 
distant away from the nearest industrial and heavily populated cities. The nearest industrialised city 
to the Geraldine district of South Canterbury is Christchurch, 140 km away. b) The waterways 
including rivers, streams, and creeks in the Geraldine district are sourced from melted snow from 
atop the mountain ranges of the Southern Alps located to the west of the district. This implies there 
are very little if any contaminants of heavy metals and other chemicals from industries and human 
settlements to compound AMR development. c) The pastoral (paddock-based) dairy farming and the 
mild climatic conditions in the Geraldine area means the stock is held on a wide area of land all year 
round compared to other OECD countries (Barry, 1974; Flysjö, Henriksson, Cederberg, Ledgard, & 
Englund, 2011) and antimicrobials (Jechalke, Heuer, Siemens, Amelung, & Smalla, 2014) and other 
agrochemicals (Groot & van’t Hooft, 2016; Sparks & Lorsbach, 2017) are not deposited in a defined 
area to enhance AMR development. A review of the role that intense deposition and accumulation of 
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agrochemicals especially glyphosate plays in the development of AMR indicated a strong correlation 
between glyphosate use and AMR development in the environment including soils (Van Bruggen et 
al., 2018). The situation in a conventional dairy farm in Geraldine may be equated to an organic farm 
in some other OECD countries in terms of the intensity of antimicrobials (Jechalke et al., 2014; Levy & 
Marshall, 2004), agrochemicals (Kurenbach et al., 2018; Kurenbach et al., 2015; Mulder et al., 2018), 
and industrialised waste (Graham, Knapp, Christensen, McCluskey, & Dolfing, 2016; Graham et al., 
2011) deposition, which is widely accepted to contribute significantly to AMR development. 
It is traditionally acceptable in the New Zealand dairy farming industry for stock to migrate once a 
year from different areas of a district to the other (Hidano et al., 2019), share contractors, and even 
waterways (McWilliam & Balzarova, 2017). The results of this study indicated the interrelatedness of 
some of the isolates, two of which were from different farms. This shed light on how some of these 
practices may aid the spread of ARGs in the district. This may affect most undertakings on the land 
and the possible spread of ARGs to humans and wildlife. In this study, it was established that the 
more pathogenic and virulent phylogenetic groups A (Blum & Leitner, 2013; Picard et al., 1999) and E 
(Tomazi et al., 2018) may be found in the dairy farm soil, albeit, in lesser quantity. This would mostly 
be caused by the culture of disposing of milk from cows with mastitis into the farm’s sewage system 
and later used for irrigation of the fields. The feeding of such milk to calves (Abb-Schwedler et al., 
2014) could also be a factor as intestinal microbes are easily circulated between the livestock and the 
farm soil on a dairy farm and transfer of genetic material, either vertically or horizontally amongst 
strains of the same species and between species is common (Benz et al., 2021). Further, humans, as 
well as their pets may share microbes with the livestock on a farm. As it is not uncommon for cows 
with subclinical mastitis to shed microbes in their milk that would be consumed by humans, cats, and 
dogs on the farm. In this study, AMR gene variants common to all 20 DfSEC as detected by the 
genomic analysis of sequenced E. coli indicated the presence of intrinsic to Enterobacteriaceae 
family, efflux pump, and the AmpC type β-lactamase was expected of DfSEC (Cox & Wright, 2013; Ma 
et al., 1995; Weston, Sharma, Ricci, & Piddock, 2018). In this study, it can be argued that the two 
isolates out of the 20 isolates that have multi-antimicrobial resistance, belonged to the phylogenetic 
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group A and carried the multi-resistant fimH30 allele (Krekeler et al., 2012; Matsumura et al., 2015; 
Roer et al., 2017) may be of bovine mammary or uterine tissue origin and may have caused mastitis 
or metritis, respectively, in the cow of origin. The pathogenesis of mastitis is such that subclinical 
mastitis caused by E. coli may go undetected for some time (Ruegg, 2017). Milk from such cows if 
consumed by humans without pasteurisation by farm gate sales may cause infection or carriage of 
ARGs from cows to humans (Watts, 2015). Further, secretions from cows with metritis may contain a 
good amount of pathogenic E. coli that may be deposited onto the fields causing such strains of E. 
coli to get established in the soil (Burfeind et al., 2014). 
In this study, the exclusion of any antimicrobial in the isolation media means the method developed 
recovered a diverse range of dairy farm soil E. coli isolates suitable for antimicrobial resistance 
studies. Using a method of isolating environmental bacteria without antimicrobial(s) reduces bias to 
the select strains in an antimicrobial susceptibility/resistant study as the researcher would be naïve 
to the antimicrobial status of the selected strains. In this study, the diversity in the phenotype and 
genotype characteristics of E. coli strains obtained, were indicted by the wide phylogenetic grouping, 
phenotype, and genotype antimicrobial characteristics. This method may easily be applied to the 
isolation of diverse species of bacteria from various environmental niches in a cost-effective manner. 
The method does not require sophisticated equipment and high-cost reagents but results in high 
sensitivity and specificity in isolation. The isolation protocol can be adopted by the simplest of 
microbiological laboratories for high thorough-put results.  
The choice of sampling sites for this study that were geographically closely located eliminated any 
bias that may have resulted from climate/weather, soil-type, vegetable, and agricultural practices 
which would influence the characteristics of the E. coli strains for the study. As it is well established 
that E. coli strains from different niches are affected by the conditions prevailing in these niches. 
More so, the collection of samples from the paddock gate to the nearest watering trough, that was 
adopted in this study, may have increased the chance of isolating diverse E. coli strains that may have 
had interaction with the majority of stock held on the paddock. This is because it is habitual for cows 
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to walk straight to the watering troughs upon returning to the paddock after milking sessions. The 
inclusion of ten paddocks per farm would also have helped. 
In a USA study, a correlation between the human impact of antimicrobial deposition into dairy farm 
soil and AMR development was made when an initial study and a study after 14 years of 
antimicrobial deposition was conducted (Yang et al., 2020). This is the first study of this kind in the 
Geraldine district and similar future studies may indicate a trend as a result of the two different 
farming systems. Further, future studies that would include samples taken from the same farms as 
this study, and other dairy farms from different regions of the country, especially from heavily 
populated towns and cities with heavy industries would help to establish a solid relationship 
between human activities and the development of AMR, its prevalence and mode of spread as has 
been hypothesised by this study. Such a study could also be extended to other agricultural domains 
such as crop and vegetable farms that routinely use agrochemicals. Further, continuous sampling and 
coverage of broader geographical areas in New Zealand would help establish an AMR surveillance 
system.  
Another value of the design of the study was the choice of the widely accepted indicator of AMR 
development, E. coli. E. coli is ubiquitous in most environments. The diversity in its strains, 
characteristics, and quick generation time of approximately 20 min eases its use in studies regarding 
changes in its phenotype and genotype. The information this study provided would be most valuable 
in the control and monitoring of antimicrobial resistance in the dairy industry, as it is possible to 
control acquired resistances, not intrinsic ones. Such findings would alert the relevant bodies such as 
veterinary groups, the Ministry for Primary Industries, and other stakeholders of the industry to not 
only the presence of resistant elements but their prevalence and mode of spread. 
This was a baseline study and similar studies in the future would showcase a trend of AMR 
development by the dairy farming industry. Such a study has been conducted in various regions 
around the globe and has led to the initiation of mitigation programs to control the emergence and 
spread of antimicrobial resistance (De Kraker et al., 2013; Jean, Coombs, et al., 2016). The different 
species of bacteria such as Streptococcus uberis, Streptococcus dysgalactiae, and Staphylococcus 
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aureus commonly associated with bovine mastitis in New Zealand respond differently to the 
antimicrobial groups (McDougall, Hussein, & Petrovski, 2014; Petrovski, Laven, & Lopez-Villalobos, 
2011). Future studies that would compare the phenotype and genotype profiles of these different 
bacteria species may shed more light on the role the use of antimicrobials in conventional dairy 
farms may play in the development of antimicrobial resistance. Further, comparing bacteria isolated 
from the mammary glands (McDougall et al., 2014), respiratory (Bassel, Tabatabaei, & Caswell, 
2020), or digestive (Moriarty, Sinton, Mackenzie, Karki, & Wood, 2008) system of cows to those 
isolated from the bovine external environment. Such a study may also highlight the effect that 
physical features like the differences in temperature, pH, and UV exposure have on the antimicrobial 
susceptibility of different species of bacteria isolated from the environment and different 
mammalian physiological systems.  
In this study, the genomic analysis of the 20 DfSEC isolates, which showed reduced susceptibility to 
especially the broad-spectrum second-generation cefoxitin of cephamycins group and their 
phylogenetic grouping enabled the evaluation of the possible source/cause of AMR E. coli and 
antimicrobial resistance genes (ARGs) on dairy farms. This study may be extended to include other 
animal husbandry systems, vegetable, and crop farms. Secondly, a Swiss study (Roesch et al., 2006) 
suggested that the difference between the influence of the two dairy farming systems may be 
bacteria species-oriented and future studies could be designed to look at other bacteria species such 
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Antimicrobial profile of dairy farm E. coli isolates  
Table A1.1 Antimicrobial susceptibility/resistance profile of DfSEC by the disc diffusion method 
Disc diffusion antimicrobial susceptibility testing 
Clearwaters organic dairy farm. Spring 2017. 




1 CW-16-S17 R S I S S S R S nil B1 
2 CW-35-S17 S S S S S S S S nil B1 
3 CW-46-S17 S S I S S S R S nil B1 
4 CW-60-S17 R S I S S S S S nil B1 
5 CW-1-S17 R S S S S S S S nil B1 
 210 
Disc diffusion antimicrobial susceptibility testing Clearwaters organic dairy farm. Spring 2018 




1 CW-19-S18 S S S S S S S S nil C 
2 CW-33-S18 S S S S S S R S ESBL E 
3 CW-2-S18 S S S S S S S S nil B1 
4 CW-3-S18 S S S S S S S S nil B1 
5 CW-24-S18 S S S S S S S S nil B1 
6 CW-25-S18 S S S S S S S S nil E 
7 CW-20-S18 S S S S S S S S nil E 
8 CW-30-S18 S S S S S S S S nil E 
9 CW-31-S18 S S S S S S S S nil E 
10 CW-32-S18 S S S S S S S S nil E 
11 CW-8-S18 S S S S S S S S nil E 
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12 CW-6-S18 S R S S S S S S nil B1 
13 CW-5-S18 S S S S S S S S nil B1 
14 CW-27-S18 S S S S S S S S nil E 
15 CW-17-S18 S S S S S S S S nil B1 
16 CW-34-S18 S S S S S S S S nil E 
17 CW-29-S18 S S S S S S S S nil B1 
18 CW-18-S18 S S S S S S S S nil E 
19 CW-11-S18 S S S S S S S S nil B1 
20 CW-12-S18 S S S S S S S S nil B1 
21 CW-9-S18 S S S S S S S S nil B1 
22 CW-35-S18 S S S S S S S S nil E 
23 CW-13-S18 S S S S S S S S nil B1 
24 CW-15-S18 S S S S S S S S nil C 
25 CW-14-S18 S S S S S S S S nil C 
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26 CW-7-S18 S S S S S S S S nil C 
27 CW-10-S18 S S S S S S S S nil B1 
28 CW-40-S18 S S S S S S S S nil B1 
29 CW-44-S18 S S S S S S S S nil E 
30 CW-36-S18 S S S S S S S S nil B1 
31 CW-38-S18 S S S S S S S S nil B1 
32 CW-43-S18 S S S S S S S S nil B1 
33 CW-46-S18 S S S S S S S S nil B1 
34 CW-45-S18 S S S S S S S S nil B1 
35 CW-22-S18 S S S S S S S S nil B1 
36 CW-28-S18 S S S S S S S S nil B1 
37 CW-23-S18 S S S S S S S S nil B1 
38 CW-39-S18 S S S S S S S S nil D 
39 CW-42-S18 S S S S S S S S nil B1 
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40 CW-41-S18 S S S S S S S S nil B1 
41 CW-16-S18 S S S S S S S S nil C 
42 CW-26-S18 S S S S S S S S nil E 
43 CW-51-S18 S S I I S S I S nil B1 
44 CW-47-S18 S S R S S S S S nil B1 
45 CW-49-S18 S S S S S S S S nil B1 
46 CW-50-S18 S S S S S S S S nil B1 
47 CW-46-S18 S S S S S S S S nil B1 





Disc diffusion antimicrobial susceptibility testing. Clearwaters organic farm. Autumn 2018 




1 CW-16-A18 R S S S S S S S nil E 
2 CW-15-A18 S S S S S S S S nil Unknown 
3 CW-1-A18 S S S S S S S S nil E 
4 CW-2-A18 S S S S S S S S nil B1 
5 CW-10-A18 S S S S S S S S nil B1 
6 CW-14-A18 S S S S S S S S nil E 
7 CW-3-A18 S S S S S S S S nil B1 
8 CW-9-A18 S S S S S S S S nil B1 
9 CW-31-A18 S S S S S S S S nil A 
10 CW-43-A18 S S S S S S S S nil B1 
11 CW-6-A18 S S S S S S S S nil C 
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12 CW-8-A18 S S S S S S S S nil E 
13 CW-39-A18 S S S S S S S S nil C 
14 CW-44-A18 S S S S S S S S nil E 
15 CW-36-A18 S S S S S S S S nil E 
16 CW-20-A18 S S S S S S S S nil B1 
17 CW-23-A18 S S S S S S S S nil E 
18 CW-48-A18 S S S S S S S S nil B1 
19 CW-4-A18 S S S S S S S S nil B1 
20 CW-33-A18 S S S S S S S S nil B1 
21 CW-50-A18 S S S S S S S S nil B1 
22 CW-40-A18 S S S S S S S S nil B1 
23 CW-13-A18 S S S S S S S S nil B1 
24 CW-32-A18 S S S S S S S S nil B1 
25 CW-37-A18 S S S S S S S S nil E 
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26 CW-29-A18 S S S S S S S S nil B1 
27 CW-21-A18 S S S S S S S S nil B1 
28 CW-18-A18 S S S S S S S S nil E 
29 CW-26-A18 S S S S S S S S nil C 
30 CW-24-A18 S S S S S S S S nil B1 
31 CW-30-A18 S S S S S S S S nil B1 
32 CW-17-A18 S S S S S S S S nil B1 
33 CW-45-A18 S S S S S S S S nil B1 
34 CW-19-A18 S S S S S S S S nil B1 
35 CW-12-A18 R S S S S S S S nil C 
36 CW-47-A18 S S S S S S S S nil B1 
37 CW-49-A18 S S R S S S R S ESBL E 
38 CW-41-A18 S S S S S S S S nil C 
39 CW-11-A18 S S S S S S S S nil B1 
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40 CW-5-A18 S S S S S S S S nil B1 
41 CW-51-A18 S S S S S S S S nil B1 
42 CW-52-A18 S S S S S S S S nil B1 
43 CW-34-A18 S S S R S S S S nil B1 
44 CW-22-A18 S S S S S S S S nil B1 
45 CW-35-A18 S S S S S S S S nil E 
46 CW-42-A18 S S S S S S S S nil C 
47 CW-28-A18 S S R S S S R S ESBL B1 
48 CW-38-A18 S S S S S S S S nil B1 
49 CW-7-A18 S S S S S S S S nil E 




Disc diffusion antimicrobial susceptibility testing. Clearwaters organic dairy farm. Winter 2018 




1 CW-34-W-18 S S S S S S S S nil E 
2 CW-35-W18 S S S S S S S S nil E 
3 CW-37-W18 S S S S S S S S nil B1 
4 CW-29-W18 S S S S S S S S nil E 
5 CW-25-W18 S S S S S S S S nil B1 
6 CW-19-W18 S S S S S S S S nil A 
7 CW-7-W18 S S S S S S S S nil B1 
8 CW-35-W18 S S S S S S S S nil B1 
9 CW-21-W18 S S S S S S S S nil B1 
10 CW-28-W18 S S S S S S S S nil E 
11 CW-23-W18 S S S S S S S S nil C 
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12 CW-22-W18 S S S S S S S S nil B1 
13 CW-30-W18 S S S S S S S S nil B1 
14 CW-31-W18 S S S S S S S S nil B1 
15 CW-32-W18 S S S S S S S S nil B1 
16 CW-24-W18 S S S S S S S S nil B1 
17 CW-8-W18 S S S S S S S S nil B1 
18 CW-27-W18 S S S S S S S S nil E 
19 CW-5-W18 S S S S S S S S nil B1 
20 CW-4-W18 S S S S S S S S nil B1 
21 CW-3-W18 S S S S S S S S nil B1 
22 CW-2-W18 S S S S S S S S nil A 
23 CW-12-W18 S S S S S S S S nil B1 
24 CW-13-W18 S S S S S S S S nil B1 
25 CW-26-W18 S S S S S S S S nil C 
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26 CW-17-W18 S S S S S S S S nil B1 
27 CW-18-W18 S S S S S S S S nil B1 
28 CW-47-W18 S S S S S S S S nil B1 
29 CW-39-W18 S S S S S S S S nil E 
30 CW-41-W18 S S S S S S S S nil D 
31 CW-16-W18 S S S S S S S S nil B1 
32 CW-36-W18 S S S S S S S S nil E 
33 CW-15-W18 S S S S S S S S nil CladeIII+IV +V 
34 CW-48-W18 S S S S S S S S nil E 
35 CW-43-W18 S S S S S S S S nil E 
36 CW-40-W18 S S S S S S S S nil B1 
37 CW-45-W18 S S S S S S S S nil B1 
38 CW-10-W18 S S S S S S S S nil B1 
39 CW-33-W18 S S S S S S S S nil E 
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40 CW-19-W18 S S S S S S S S nil A 
41 CW-44-W18 S S S S R S S S nil A 
42 CW-1-W18 S S S S S S S S nil B1 
43 CW-46-W18 S S S S R S S S nil B1 
44 CW-51-W18 S S S S S S S S nil B1 
45 CW-50-W18 S S S S S S S S nil E 
46 CW-49-W18 S S I S S S R S nil E 




Disc diffusion antimicrobial susceptibility testing. Mill Road conventional dairy farm. Spring 2017 




1 MRD-34-S17 S S S S S S S S nil B1 
2 MRD-37-S17 R S S S S S S S nil B1 
3 MRD-29-S17 S S S S S S S S nil B1 
4 MRD-38-S17 S S S S S S S S nil B1 
5 MRD-19-S17 S S S S R S S S nil B1 
6 MRD-30-S17 S S I S S S S S nil B1 
7 MRD-24-S17 S S S S S S R S ESBL B1 
8 MRD-35-S17 S R S S S S S S nil B1 
9 MRD-18-S17 S S S S S S S S nil B1 
10 MRD-27-S17 S S S S S S S S nil C 
11 MRD-33-S17 S S S S S S S S nil B1 
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12 MRD-46-S17 S S S S S S S S nil B1 
13 MRD-48-S17 S R S S S S S S nil B1 
14 MRD-50-S17 S S S S S S S S nil B1 
15 MRD-16-S17 S S S S S S S S nil A 
16 MRD-13-S17 S S S S S S S S nil B1 
17 MRD-11-S17 S S S S S S S S nil B1 
18 MRD-9-S17 S S S S S S R S nil B1 
19 MRD-1-S17 S S R S R S S S nil E 
20  MRD-17-S17 S R S S S S S S nil B1 
21  MRD-15-S17 S R S S S S I S nil B1 
22  MRD-49-S17 S S S S R S S S nil B1 
23  MRD-40-S17 S S S S S S S S nil B2 
24  MRD-44-S17 S S S S S S S S nil B1 
25  MRD-2-S17 S S S S R S S S nil B1 
 224 
26 MRD-31-S17 S S S S S S S S nil B1 
27 MRD-21-S17 S S S S S S S S nil B1 
28 MRD-22-S17 S S S S S S S S nil B1 
29 MRD-12-S17 S S S S R S S S nil B1 
30 MRD-7-S17 S S S S S S S S nil B1 
31 MRD-5-S17 S S S S S S R S nil B1 
32 MRD-62-S17 S S S S S S S S nil B1 
33 MRD-59-S17 S S S S S S S S nil B1 
34 MRD-47-S17 S S S S S S S S nil B1 
35 MRD-61-S17 S S S S S S S S nil B1 
36 MRD-51-S17 S S I S S S S S nil B1 
37 MRD-60-S17 S S S S S S S S nil B1 
38 MRD-45-S17 S S S S S S S S nil C 
39 MRD-23-S17 S S S S S S S S nil B2 
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40 MRD-58-S17 S S S S S S S S nil B1 
41 MRD-25-S17 S S S S S S S S nil B1 
42 MRD-10-S17 S S S S S S S S nil B1 
43 MRD-42-S17 S I S S R S S S nil B1 
44 MRD-37-S17 S S S S S S S S nil B1 
45 MRD-36-S17 S S S S S S S S nil B1 
46 MRD-57-S17 S S S S S S S S nil B1 
47 MRD-65-S17 S S S S S S S S nil B1 
48 MRD-13-S17 S S S S S S S S nil A 
49 MRD-41-S17 S S S S S S S S nil B1 
50 MRD-43-S17 S I S S R S S S nil B1 
51 MRD-32-S17 S S S S S S S S nil B1 
52 MRD-26-S17 S S S S S S S S nil B1 
53 MRD-35-S17 S S R S S S S S nil B1 
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54 MRD-50-S17 S S S S S S S S nil B1 
55 MRD-54-S17 S S S S S S S S nil B1 
56 MRD-11-S17 S S S S S S S S nil B1 
57 MRD-28-S17 S S S S S S S S nil A 
58 MRD-20-S17 S S S S S S S S nil B1 
59 MRD-56-S17 S S S S S S S S nil B1 
60 MRD-53-S17 S S S S S S S S nil E 
61 MRD-8-S17 S S S S S S S S nil E 
62 MRD-40-S17 S S S S S S S S nil E 
63 MRD-44-S17 S S S S S S S S nil C 
64 MRD-31-S17 S S S S S S S S nil A 
65 MRD-24-S17 S S S S S S R S nil B1 
66 MRD-4-S17 S I S S R S S S nil B1 
Isolates in bold showed ≤10 mm inhibition zone to FOX30 
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Disc diffusion antimicrobial susceptibility testing. Mill Road conventional dairy farm. Spring 2018 




1 MRD-14-S18 S S S S S S S S nil B1 
2 MRD-15-S18 S S S S S S S S nil B1 
3 MRD-25-S18 S S S S S S S S nil C 
4 MRD-35-S18 S S S S S S S S nil B1 
5 MRD-4-S18 S S S S S S S S nil B1 
6 MRD-16-S18 S S S S S S S S nil B1 
7 MRD-18-S18 S S S S S S S S nil B1 
8 MRD-13-S18 S S S S S S S S nil B1 
9 MRD-21-S18 S S S S S S S S nil B1 
10 MRD-22-S18 S S S S S S S S nil B1 
11 MRD-23-S18 S S S S S S S S nil B1 
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12 MRD-24-S18 S S S S S S S S nil B1 
13 MRD-12-S18 S S S S S S S S nil B1 
14 MRD-11-S18 S S S S S S S S nil B1 
15 MRD-19-S18 S S S S S S S S nil B1 
16 MRD-5-S18 S S S S S S S S nil B1 
17 MRD-1-S18 S S S S S S S S nil B1 
18 MRD-8-S18 S S S S S S S S nil unknown 
19 MRD-9-S18 S S S S S S S S nil B1 
20 MRD-10-S18 S S S S S S S S nil B1 
21 MRD-30-S18 S S S S S S S S nil E 
22 MRD-52-S18 S S S S S S S R nil B1 
23 MRD-34-S18 S S S S S S S S nil B1 
24 MRD-36-S18 R S S S S S S S nil B1 
25 MRD-38-S18 S S S S S S S S nil E 
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26 MRD-49-S18 S S S S S S I S nil B1 
27 MRD-53-S18 S S S S S S S R nil A 
28 MRD-54-S18 S I I S S S S I nil B1 
29 MRD-55-S18 S S S S S S S R nil B1 
30 MRD-44-S18 S S S S S S S S nil B1 
31 MRD-47-S18 S S S S S S S S nil C 
32 MRD-45-S18 S S S S S S S S nil B1 
33 MRD-43-S18 S S R S S S S S nil B1 
34 MRD-39-S18 S S S S S S S S nil B1 
35 MRD-40-S18 S S S S S S S S nil A 
36 MRD-32-S18 S S S S S S S S nil B1 
37 MRD-46-S18 S S I S S S R S nil unknown 
38 MRD-29-S18 S S S S S S S S nil B1 
39 MRD-31-S18 S S S S S S S S nil E 
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40 MRD-41-S18 S S S S S S S S nil E 
41 MRD-33-S18 S S S S S S S S nil B1 
42 MRD-42-S18 S S S S R S S S nil B1 
43 MRD-3-S18 S S S S S S S S nil B1 
44 MRD-2-S18 S S S S S S S S nil C 
45 MRD-17-S18 S S S S S S S S nil B1 
46 MRD-48-S18 S S S S S S S S nil B2 
47 MRD-6-S18 S S S S S S S S nil B1 
48 MRD-20-S18 S S S S S S S S nil B1 
49 MRD-27-S18 S S S S S S S S nil B1 
50 MRD-51-S18 S S S S S S S S nil B1 
Isolates in bold showed ≤10 mm inhibition zone to FOX30 
  
 231 
Disc diffusion antimicrobial susceptibility testing. Mill Road conventional dairy farm. Autumn 2018 




1 MRD-61-A18 S S S S S S S S nil A 
2 MRD-43-A18 S S S S S S S S nil B1 
3 MRD-56-A18 S S S S S S S S nil B1 
4 MRD-62-A18 S S S S S S S S nil B1 
5 MRD-63-A18 S S S S S S S S nil B1 
6 MRD-64-A18 S S S S S S S S nil B1 
7 MRD-55-A18 S S S S S S S S nil E 
8 MRD-50-A18 S S S S S S S S nil B1 
9 MRD-44-A18 S S S S S S S S nil B1 
10 MRD-41-A18 S S S S S S S S nil B1 
11 MRD-52-A18 S S S S S S S S nil A 
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12 MRD-59-A18 S S S S S S S S nil B1 
13 MRD-51-A18 S S S S S S S S nil B1 
14 MRD-53-A18 S S S S S S S S nil B1 
15 MRD-33-A18 S S S S S S S S nil B1 
16 MRD-38-A18 S S S S S S S S nil B1 
17 MRD-40-A18 S S R S S S S S nil B1 
18 MRD-37-A18 S S S S S S S S nil E 
19 MRD-47-A18 S S S S S S S S nil B1 
20 MRD-49-A18 S S S S S S S S nil cladeI 
21 MRD-46-A18 S S S S S S S S nil B1 
22 MRD-48-A18 S S S S S S S S nil B1 
23 MRD-45-A18 S S S S S S S S nil B1 
24 MRD-1-A18 S S S S S S S S nil B1 
25 MRD-10-A18 S S S S S S S S nil B1 
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26 MRD-35-A18 S S S S S S S S nil cladeIII+IV+V 
27 MRD-2-A18 S S S S S S S S nil A 
28 MRD-7-A18 S S S S S S S S nil B1 
29 MRD-30-A18 S S S S S S S S nil B1 
30 MRD-31-A18 S S S S S S S S nil B1 
31 MRD-6-A18 S S S S S S S S nil B1 
32 MRD-8-A18 S S S S S S S S nil B1 
33 MRD-3-A18 S S S S S S S S nil A 
34 MRD-18-A18 S S S S S S S S nil B1 
35 MRD-16-A18 S S S S S S S S nil B1 
36 MRD-17-A18 S S S S S S S S nil B1 
37 MRD-19-A18 S S S S S S S S nil B1 
38 MRD-34-A18 S S S S S S S S nil B1 
39 MRD-32-A18 S S S S S S S S nil B1 
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40 MRD-25-A18 S S S S S S S S nil B1 
41 MRD-15-A18 S S S S S S R S nil E 
42 MRD-29-A18 S S S S S S S S nil B1 
43 MRD-26-A18 S S S S S S S S nil E 
44 MRD-27-A18 S S S S S S S S nil D 
45 MRD-22-A18 S S S S S S S S nil B1 
46 MRD-58-A18 S S S S S S S S nil B1 
47 MRD-28-A18 S S S S S S S S nil B1 
48 MRD-21-A18 R S S S S S R S AmpC+ B1 
49 MRD-54-A18 S S S S S S S S nil B2 
50 MRD-39-A18 S S R S S S R S nil B1 
51 MRD-42-A18 S S S S S S R S nil B1 
52 MRD-57-A18 S S S S S S R S nil B1 
53 MRD-5-A18 S S S S S S R S nil E 
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54 MRD-13-A18 S S S S S S R S nil B1 
55 MRD-14-A18 S S S S S S R S nil B1 




Disc diffusion antimicrobial susceptibility testing. Mill Road conventional dairy farm. Autumn 2018 




1 MRD-16-W18 S S S S S S S S nil B1 
2 MRD-19-W18 S S S S S S S S nil A 
3 MRD-6-W18 S S S S S S S S nil unknown 
4 MRD-18-W18 S S S S S S S S nil A 
5 MRD-15-W18 S S S S S S S S nil B1 
6 MRD-36-W18 S S S S S S S S nil B1 
7 MRD-1-W18 S S S S S S S S nil B1 
8 MRD-39-W18 S S S S S S S S nil B1 
9 MRD-50-W18 S S S S S S S S nil B1 
10 MRD-41-W18 S S S S S S S S nil unknown 
11 MRD-55-W18 S S S S S S S S nil B1 
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12 MRD-25-W18 S S S S S S S S nil E 
13 MRD-38-W18 S S S S S S S S nil B1 
14 MRD-44-W18 S S S S S S S S nil B1 
15 MRD-43-W18 S S S S S S S S nil B1 
16 MRD-47-W18 S S S S S S S S nil E 
17 MRD-42-W18 S S S S S S S S nil B1 
18 MRD-46-W18 S S S S S S S S nil E 
19 MRD-30-W18 S S S S S S S S nil B1 
20 MRD-31-W18 S S S S S S S S nil E 
21 MRD-27-W18 S S S S S S S S nil unknown 
22 MRD-48-W18 S S S S S S S S nil B1 
23 MRD-49-W18 S S S S S S S S nil B1 
24 MRD-26-W18 S S S S S S S S nil E 
25 MRD-20-W18 S S S S S S S S nil A 
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26 MRD-29-W18 S S S S S S S S nil B1 
27 MRD-37-W18 S S S S S S S S nil B1 
28 MRD-35-W18 S S S S S S S S nil B1 
29 MRD-13-W18 S S S S S S S S nil A 
30 MRD-9-W18 S S S S S S S S nil B1 
31 MRD-5-W18 S S S S S S S S nil A 
32 MRD-7-W18 S S S S S S S S nil A 
33 MRD-14-W18 S S S S S S S S nil A 
34 MRD-10-W18 S S S S S S S S nil A 
35 MRD-8-W18 S S S S S S S S nil A 
36 MRD-12-W18 S S S S S S R S nil B1 
37 MRD-17-W18 S S S S S S S S nil B1 
38 MRD-11-W18 S S S S S S S S nil B1 
39 MRD-40-W18 S S I S S S I R nil E 
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40 MRD-24-W18 S S I I S S I I nil B1 
41 MRD-22-W18 R S S S S S R S ESBL B1 
42 MRD-45-W18 S S S S S S S S nil B1 
43 MRD-3-W18 S S S S S S R S nil B1 
44 MRD-34-W18 S S I S S S I I nil B1 
45 MRD-4-W18 S S S S S S S S nil B1 
46 MRD-23-W18 S S S S S S R S nil B1 
47 MRD-2-W18 S S S S S S R S nil B1 
48 MRD-32-W18 S S I S S S I S nil B1 
49 MRD-21-W18 S S S S S S R S nil B1 
50 MRD-33-W18 S S I S S S I I nil B1 




Disc diffusion antimicrobial susceptibility testing. Peel Forest conventional dairy farm. Spring 2017 




1 PF-6-S17 S S S S S S S S nil C 
2 PF-9-S17 R S S S S S S R nil C 
3 PF-8-S17 S S S S S S S S nil C 
4 PF-28-S17 S S S S S S S S nil B1 
5 PF-30-S17 S S S R S S S S nil C 
6 PF-31-S17 S S S R S S S S nil B1 
7 PF-29-S17 S S S S S S S S nil C 
8 PF-35-S17 S R S S S S S S nil B1 
9 PF-1-S17 R S S S S S S S nil B1 
10 PF-2-S17 R S S S S S S S nil B1 
11 PF-27-S17 S S S R S S S S nil C 
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12 PF-43-S17 S S S S S S S S nil B1 
13 PF-46-S17 S S S R S S S S nil B1 
14 PF-39-S17 S S S S S S S S nil E 
15 PF-45-S17 S S R S S S S S nil CladeI+II 
16 PF-49-S17 S S S S S S S S nil B1 
17 PF-47-S17 S S S R S S S S nil B1 
18 PF-48-S17 S S S R S S S S nil C 
19 PF-36-S17 S S R S S S S S nil B1 
20 PF-37-S17 S S S S S S S R nil B1 
21 PF-38-S17 S S S S S S S S nil C 
22 PF-25-S17 S S S S S S S S nil B1 
23 PF-44-S17 S S S S S S S S nil B1 
24 PF-22-S17 S R S S S S S S nil B1 
25 PF-19-S17 R S S R S S S S nil C 
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26 PF-18-S17 S R S S S S S S nil A 
27 PF-16-S17 R S S R S S S S nil B1 
28 PF-33-S17 S S S S S S S S nil C 
29 PF-26-S17 S S S S S S S S nil C 
30 PF-24-S17 R S S S S S S S nil C 
31 PF-23-S17 S S S S S S S S nil B1 
32 PF-15-S17 S S S S S S S S nil B1 
33 PF-13-S17 S S S S S S S S nil B1 
34 PF-5-S17 S S R S S S S S nil C 
35 PF-20-S17 S S S S S S R S nil E 
36 PF-41-S17 S S S R S S S S nil E 
37 PF-4-S17 S S S S S S S S nil E 
38 PF-40-S17 R S I I I S S S nil B1 
39 PF-21-S17 R S S S S S S S nil B1 
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40 PF-42-S17 S S S S R S S S nil E 
41 PF-50-S17 S S S S R S S S nil B1 
42 PF-34-S17 S S S S S S S S nil C 
43 PF-17-S17 S S S S S S R S nil C 
44 PF-7-S17 S S S S S S S S nil B1 
45 PF-10-S17 S S R S S S S S nil B1 
46 PF-32-S17 R S S S S S S S nil E 
47 PF-14-S17 S R S S S S S S nil B1 
48 PF-11-S17 S S S S S S S S nil B1 
49 PF-12-S17 S S S S S S S S nil B1 
50 PF-51-S17 S S S S S S S S nil B1 
Isolates in bold showed ≤10 mm inhibition zone to FOX30 
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Disc diffusion antimicrobial susceptibility testing. Peel Forest conventional dairy farm. Spring 2018 




1 PF-49-S18 R S S S S S S S nil B1 
2 PF-48-S18 S S S S S S S S nil E 
3 PF-51-S18 R S S S S S S S nil B1 
4 PF-52-S18 R S I S S S S S nil B1 
5 PF-55-S18 S S S S S S S S nil A 
6 PF-40-S18 S S S S S S S S nil B1 
7 PF-46-S18 R S S S S S S S nil B1 
8 PF-42-S18 R S S S S S S S nil B1 
9 PF-25-S18 R S I S S S R S AmpC B1 
10 PF-36-S18 S S S S S S S S nil B1 
11 PF-56-S18 S S S S S S S S nil C 
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12 PF-1-S18 S S S S S S S S nil B1 
13 PF-4-S18 S S S S S S S S nil B1 
14 PF-15-S18 S S S S S S S S nil B1 
15 PF-2-S18 S S S S S S S S nil B1 
16 PF-3-S18 S S S S S S S S nil B1 
17 PF-7-S18 S S S S S S S S nil B1 
18 PF-10-S18 S S S S S S S S nil B1 
19 PF-14-S18 S S S S S S S S nil B1 
20 PF-13-S18 S S S S S S S S nil B1 
21 PF-16-S18 S S S S S S S S nil B1 
22 PF-11-S18 S S S S S S S S nil B1 
23 PF-12-S18 S S S S S S S S nil B1 
24 PF-6-S18 S S S S S S S S nil B1 
25 PF-5-S18 S S S S S S S S nil A 
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26 PF-8-S18 S S S S S S S S nil B1 
27 PF-17-S18 S S S S S S S S nil B1 
28 PF-24-S18 S S S S S S S S nil B1 
29 PF-23-S18 S S S S S S S S nil B1 
30 PF-22-S18 S S S S S S S S nil B1 
31 PF-21-S18 S S S S S S S S nil B1 
32 PF-18-S18 S S S S S S S S nil B1 
33 PF-19-S18 S S S S S S S S nil E 
34 PF-33-S18 S S S S S S S S nil B1 
35 PF-38-S18 S S S S S S S S nil B1 
36 PF-50-S18 S S S S S S S S nil B1 
37 PF-41-S18 S S S S S S S S nil E 
38 PF-29-S18 S S S S S S S S nil E 
39 PF-27-S18 S S S S S S S S nil A 
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40 PF-45-S18 S S S S S S S S nil B1 
41 PF-37-S18 S S S S S S S S nil E 
42 PF-31-S18 S S S S S S R S nil B1 
43 PF-30-S18 S S S S S S S S nil B1 
44 PF-43-S18 S S S S S S S S nil B1 
45 PF-47-S18 R S S S S S S S nil B1 
46 PF-28-S18 S S S S S S S S nil B1 
47 PF-53-S18 S S S S S S S S nil B1 
48 PF-20-S18 S S S S S S S S nil cladeIII+IV+V 
49 PF-26-S18 S S S S S S S S nil E 




Disc diffusion antimicrobial susceptibility testing. Peel Forest conventional dairy farm. Autumn 2018 




2 PF-29-A18 S S S S S S S S nil B1 
3 PF-34-A18 S S S S S S S S nil B1 
4 PF-1-A18 S S S S S S S S nil B1 
5 PF-3-A18 S S S S S S S S nil B1 
6 PF-28-A18 S S S S S S S S nil B1 
7 PF-27-A18 S S S S S S S S nil B1 
8 PF-8-A18 S S S S S S S S nil B1 
9 PF-54-A18 S S S S S S S S nil C 
10 PF-43-A18 S S S S S S S S nil D 
11 PF-57-A18 S S S S S S S S nil E 
12 PF-55-A18 S S S S S S S S nil E 
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13 PF-38-A18 S S S S S S S S nil B1 
14 PF-47-A18 S S S S S S S S nil B1 
15 PF-52-A18 S S S S S S S S nil B1 
16 PF-49-A18 S S S S S S S S nil B1 
17 PF-51-A18 S S S S S S S S nil C 
18 PF-13-A18 S S S S S S S S nil B1 
19 PF-2-A18 S S S S S S S S nil B1 
20 PF-20-A18 S S S S S S S S nil B1 
21 PF-32-A18 R S I S S S R S ESBL B1 
22 PF-6-A18 S S S S S S S S nil B1 
23 PF-33-A18 S S S S S S S S nil B1 
24 PF-42-A18 S S S S S S S S nil B1 
25 PF-26-A18 S S S S S S S S nil B1 
26 PF-12-A18 S S S S S S S S nil E 
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27 PF-37-A18 S S S S S S S S nil B1 
28 PF-40-A18 S S S S S S S S nil E 
29 PF-7-A18 S S S S S S S S nil B1 
30 PF-56-A18 R S S S S S S S nil B1 
31 PF-5-A18 S S S S S S S S nil B1 
32 PF-11-A18 S S S S S S S S nil E 
33 PF-4-A18 S S S S S S S S nil B1 
34 PF-16-A18 S S S S S S S S nil B1 
35 PF-30-A18 S S I S S S R S AmpC+ B1 
36 PF-60-A18 S S S S S S S S nil B1 
37 PF-10-A18 S S S S S S S S nil cladeIII +IV+V 
38 PF-63-A18 S S S S S S S S nil B1 
39 PF-31-A18 S S S S S S S S nil B1 
40 PF-61-A18 S S S S S S S S nil B1 
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41 PF-62-A18 S S S S S S S S nil B1 
42 PF-15-A18 R S S R S S R S ESBL B1 
43 PF-23-A18 S S S S S S S S nil cladeIII +IV+V 
44 PF-9-A18 S S S S S S R S nil C 
45 PF-58-A18 S S R S S S R S nil B1 
46 PF-24-A18 S S S S S S R S nil B1 
47 PF-19-A18 S S S S S S S S nil E 
48 PF-14-A18 R S S R S S R S AmpC+ B1 
49 PF-22-A18 S S S S S S R S nil E 
50 PF-41-A18 S S S S S S R S nil B1 
51 PF-21-A18 S S S S S S S S nil B1 
52 PF-44-A18 S S S S S S R S nil B1 
53 PF-35-A18 R S I S S S S S nil B1 
Isolates in bold showed ≤10 mm inhibition zone to FOX30 
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Disc diffusion antimicrobial susceptibility testing. Peel Forest conventional dairy farm. Winter 2018 




2 PF-15-W18 S S S S S S S S nil B1 
3 PF-14-W18 S S S S S S S S nil B1 
4 PF-4-W18 S S S S S S R S nil B1 
5 PF-1-W18 S S S S S S S S nil B1 
6 PF-5-W18 S S S S S S S S nil B1 
7 PF-8-W18 S S S S S S S S nil B1 
8 PF-16-W18 S S S S S S S S nil B1 
9 PF-11-W18 S S S S S S S S nil B1 
10 PF-13-W18 S S S S S S S S nil C 
11 PF-10-W18 S S S S S S S S nil B1 
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12 PF-9-W18 S S S S S S R S nil B1 
13 PF-3-W18 S S S S S S S S nil B1 
14 PF-2-W18 S S S S S S S S nil B1 
15 PF-50-W18 S S S S S S S S nil B1 
16 PF-51-W18 S S S S S S S S nil B1 
17 PF-43-W18 S S S S S S S S nil B1 
18 PF-34-W18 S S S S S S S S nil B1 
19 PF-53-W18 S S S S S S S S nil A 
20 PF-56-W18 S S S S S S S S nil A 
21 PF-49-W18 S S S S S S S S nil B1 
22 PF-48-W18 R S S S S S S S nil B1 
23 PF-35-W18 S S S S S S S S nil B1 
24 PF-46-W18 S S S S S S S S nil B1 
25 PF-38-W18 S S S S S S S S nil A 
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26 PF-36-W18 S S S S S S S S nil B1 
27 PF-33-W18 S S S S S S S S nil B1 
28 PF-21-W18 S S S S S S S R nil B1 
29 PF-20-W18 S S S S S S S S nil B1 
30 PF-19-W18 S S S S S S S S nil B1 
31 PF-22-W18 S S S S S S S S nil A 
32 PF-18-W18 S S S S S S S S nil E 
33 PF-25-W18 S S S S S S S S nil B1 
34 PF-29-W18 S S S S S S S S nil A 
35 PF-28-W18 S S S S S S S S nil B1 
36 PF-30-W18 S S S S S S S S nil B1 
37 PF-26-W18 S S S S S S S S nil B1 
38 PF-32-W18 S S S S S S S S nil B1 
39 PF-31-W18 S S S S S S S S nil B1 
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40 PF-63-W18 S S S S S S S S nil B1 
41 PF-27-W18 S S S S S S S R nil B1 
42 PF-45-W18 S S S S S S R S AmpC E 
43 PF-37-W18 S S S S S S R S nil B1 
44 PF-12-W18 S S I S S S I S nil B1 
45 PF-52-W18 S S R S S S R S AmpC B1 
46 PF-42-W18 S S S S S S R S nil B1 
47 PF-39-W18 S S S S S S R S nil B1 
48 PF-55-W18 R S I R S S R S ESBL A 





Disc diffusion antimicrobial susceptibility testing Totara Valley organic dairy farm. Spring 2017 




2 TL-9-S17 S S S S S S S S nil B1 
3 TL-3-S17 S S S S S S S S nil B1 
4 TL-27-S17 S S S S S S S S nil Unknown 
5 TL-29-S17 S S R S S S R S nil B1 
6 TL-31-S17 S S R S S S R S nil B1 
7 TL-46-S17 S S S S S S R S nil B1 
8 TL-49-S17 S S S S S S S S nil B1 
9 TL-35-S17 S S R S S S R S nil B1 
10 TL-34-S17 S S R S S S S S nil E 
11 TL-24-S17 S S S S S S S S nil B1 
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12 TL-12-S17 S S S S S S S S nil B1 
13 TL-21-S17 S S S S S S S S nil B1 
14 TL-17-S17 S S S S S S R S nil B1 
15 TL-4-S17 S S S S S S S S nil B1 
16 TL-7-S17 S S S S S S S S nil B1 
17 TL-32-S17 S S S S S S S S nil E 
18 TL-19-S17 S S R S S S R S nil Unknown 
19 TL-26-S17 S S S S S S S S nil Unknown 
20 TL-22-S17 S S R S S S R S nil Unknown 
21 TL-18-S17 S S S S S S S S nil B1 
22 TL-10-S17 S S S S S S R S nil B1 
23 TL-36-S17 S S S S S S S S nil B1 
24 TL-1-S17 S S R S S S R S nil B1 
25 TL-16-S17 S S S S S S S S nil B1 
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26 TL-44-S17 S S R S S S R S nil Unknown 
27 TL-6-S17 S S S S S S S S nil B1 
28 TL-28-S17 S S S S S S S S nil B1 
29 TL-5-S17 S S S S S S S S nil C 
30 TL-40-S17 S S S S S S S S nil E 
31 TL-45-S17 S S S S S S S S nil B1 
32 TL-23-S17 S S S S S S S S nil B1 
33 TL-14-S17 S S S S S S S S nil C 
34 TL-38-S17 S S S S S S S S nil B1 
35 TL-20-S17 S S S S S S R S nil B1 
36 TL-50-S17 S S S S S S R S nil Unknown 
37 TL-11-S17 S S S S S S S S nil C 
38 TL-41-S17 S S S S S S S S nil B1 
39 TL-49-S17 S S S S S S S S nil B1 
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40 TL-43-S17 S S S S S S S S nil B1 
41 TL-47-S17 R S S S S S R S nil B1 
42 TL-37-S17 S S S S S S R S nil Unknown 
43 TL-42-S17 S S R S S S R S nil E 
44 TL-2-S17 S S R S S S R S nil C 
45 TL-51-S17 S S S S S S R S nil B1 
46 TL-21-S17 S S S S S S S S nil B1 
47 TL-39-S17 S S S S S S S S nil C 
48 TL-25-S17 S S S S S S S S nil B1 
49 TL-8-S17 S S S S S S R S nil unknown 
50 TL-57-S17 S S S S S S S S nil B1 




Disc diffusion antimicrobial susceptibility testing Totara Valley organic dairy farm. Spring 2018 
# DfSEC Te30 Na30 CPD10 CN10 MEM10 CIP30 FOX30 C30 Phenotype screening Phylogenetic 
group 
1 TL-30-S18 S S S S S S S S nil B1 
2 TL-34-S18 S S S S S S S S nil B1 
3 TL-2-S18 S S S S S S S S nil B1 
4 TL-27-S18 S S S S S S S S nil B1 
5 TL-17-S18 S S S S S S S S nil B1 
6 TL-16-S18 S S S S S S S S nil B1 
7 TL-23-S18 S S S S S S S S nil B1 
8 TL-24-S18 S S S S S S S S nil B1 
9 TL-12-S18 S S I S S S S S nil B1 
10 TL-28-S18 S S S S S S S S nil A 
11 TL-26-S18 S S S S S S S S nil B1 
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12 TL-32-S18 S S R S S S S S nil B1 
13 TL-45-S18 S S S S S S S S nil E 
14 TL-46-S18 S S S S S S S S nil B1 
15 TL-47-S18 S S S S S S S S nil B1 
16 TL-31-S18 S S S S S S S S nil CladeIII+IV + V 
17 TL-56-S18 S S I S S S R S ESBL B1 
18 TL-30-S18 S S S S S S S S nil B1 
19 TL-29-S18 S S S S S S S S nil B1 
20 TL-42-S18 S S S S S S S S nil B1 
21 TL-52-S18 S S S S S S S S nil B1 
22 TL-49-S18 S S S S S S S S nil B1 
23 TL-50-S18 S S S S S S S S nil B1 
24 TL-51-S18 S S S S S S S S nil E 
25 TL-41-S18 S S S S S S S S nil B1 
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26 TL-44-S18 S S S S S S S S nil B1 
27 TL-42-S18 S S S S S S S S nil B1 
28 TL-37-S18 S S S S S S S S nil B1 
29 TL-36-S18 S S S S S S S S nil B1 
30 TL-43-S18 S S S S S S S S nil B1 
31 TL-8-S18 S S S S S S S S nil B1 
32 TL-9-S18 S S S S S S S S nil B1 
33 TL-6-S18 S S S S S S S S nil B1 
34 TL-7-S18 S S S S S S S S nil B1 
35 TL-18-S18 S S S S S S S S nil B1 
36 TL-12-S18 S S S S S S S S nil B1 
37 TL-11-S18 S S S S S S S S nil B1 
38 TL-10-S18 S S S S S S S S nil B1 
39 TL-20-S18 S S S S S S S S nil B1 
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40 TL-4-S18 S S S S S S S S nil B1 
41 TL-5-S18 S S S S S S S S nil B1 
42 TL-3-S18 S S S S S S S S nil B1 
43 TL-21-S18 S S S S S S S S nil B1 
44 TL-14-S18 S S S S S S S S nil B1 
45 TL-48-S18 S S S S S S S S nil B1 
46 TL-53-S18 S S R S S S S S nil B1 
47 TL-19-S18 S S S S S S S S nil B1 
48 TL-38-S18 S S S S S S S S nil B1 
49 TL-55-S18 S S S S S S S S nil B1 
50 TL-54-S18 S S I S S S R S ESBL B1 
51 TL-1-S18 S S I S R S R S AmpC+ B1 
Isolates in bold showed ≤10 mm inhibition zone to FOX30 
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Disc diffusion antimicrobial susceptibility testing Totara Valley organic dairy farm. Autumn 2018 




1 TL-31-A18 S S S S S S S S nil B1 
2 TL-29-A18 S S S S S S S S nil B1 
3 TL-22-A18 S S S S S S S S nil unknown 
4 TL-15-A18 S S S S S S S S nil B1 
5 TL-10-A18 S S S S S S S S nil unknown 
6 TL-47-A18 S S S S S S S S nil B1 
7 TL-39-A18 S S S S S S S S nil B1 
8 TL-12-A18 S S S S S S R S ESBL B1 
9 TL-27-A18 S S I S S S S S nil B1 
10 TL-7-A18 S S S S S S S S nil B1 
11 TL-9-A18 S S S S S S S S nil unknown 
12 TL-36-A18 S S S S S S R S nil unknown 
13 TL-40-A18 S S S S S S S S nil unknown 
14 TL-18-A18 S S S S S S S S nil A 
15 TL-38-A18 S S S S S S S S nil B1 
16 TL-20-A18 S S S S S S S S nil B1 
17 TL-34-A18 S S S S S S R S nil unknown 
18 TL-42-A18 S S S S I S S S nil B1 
19 TL-32-A18 S S S R S S S S nil B1 
20 TL-26-A18 S S S S S S R S nil unknown 
21 TL-43-A18 S S S S S S S S nil B1 
22 TL-33-A18 S S S S S S R S nil B1 
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23 TL-19-A18 S S S S S S S S nil B1 
24 TL-25-A18 S S S S S S S S nil B1 
25 TL-1-A18 S S S S S S S S nil A 
26 TL-11-A18 S S S R S S S S nil B1 
27 TL-24-A18 S S S S S S S S nil A 
28 TL-16-A18 S S S S S S S S nil B1 
29 TL-14-A18 S S S R S S S S nil B1 
30 TL-48-A18 S S S S S S S S nil B1 
31 TL-52-A18 S S S S S S S S nil B1 
32 TL-50-A18 S S S S S S S S nil B1 
33 TL-13-A18 S S S S S S S S nil B1 
34 TL-17-A18 S S S S S S R S nil B1 
35 TL-45-A18 S S S S S S S S nil B1 
36 TL-53-A18 S S S S S S S S nil B1 
37 TL-54-A18 S S S S S S S S nil B1 
38 TL-49-A18 S S I S S S R S nil B1 
39 TL-46-A18 S S S S S S S S nil B1 
40 TL-55-A18 S S S S S S S S nil B1 
41 TL-41-A18 S S S S S S S S nil B1 
42 TL-21-A18 S S S S S S S S nil B1 
43 TL-35-A18 S S S S S S S S nil B1 
44 TL-87-A18 S I S S S S R S ESBL B1 
45 TL-28-A18 S S S S S S S S nil CladeI + II 
46 TL-44-A18 S S S S S S R S nil B1 
47 TL-2-A18 S S S I S S R S ESBL B1 
48 TL-56-A18 S S R S S S R S nil CladeI + II 
Isolates in bold showed ≤10 mm inhibition zone to FOX30 
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Disc diffusion antimicrobial susceptibility testing Totara Valley organic dairy farm. Winter 2018 




2 TL-10-W18 S S S S S S S S nil B1 
3 TL-12-W18 S S S S S S S S nil B1 
4 TL-23-W18 S S S S S S S S nil A 
5 TL-3-W18 S S S S S S S S nil A 
6 TL-8-W18 S S S S S S S S nil B1 
7 TL-20-W18 S S S S S S S S nil A 
8 TL-27-W18 S S S S S S S S nil B1 
9 TL-14-W18 S S S S S S R S nil B1 
10 TL-16-W18 S S S S S S S S nil B1 
11 TL-24-W18 S S S S S S S S nil B1 
12 TL-1-W18 S S S S S S S S nil A 
13 TL-25-W18 S S S S S S S S nil unknown 
14 TL-5-W18 S S S S S S S S nil B1 
15 TL-2-W18 S S S S S S S S nil A 
16 TL-18-W18 S S S S S S S S nil B1 
17 TL-50-W18 S S S S S S S S nil unknown 
18 TL-49-W18 S S S S S S S S nil B1 
19 TL-19-W18 S S S S S S S S nil B1 
20 TL-21-W18 S S S S S S S S nil B1 
21 TL-32-W18 S S S S S S S S nil B1 
22 TL-39-W18 S S S S S S S S nil B1 
23 TL-40-W18 S S S S S S S S nil B1 
24 TL-38-W18 S S S S S S S S nil B1 
25 TL-42-W18 S S S S S S S S nil B1 
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26 TL-43-W18 S S S S S S S S nil B1 
27 TL-44-W18 S S S S S S S S nil B1 
28 TL-41-W18 S S S S S S S S nil B1 
29 TL-33-W18 S S S S S S S S nil B1 
30 TL-31-W18 S S S S S S S S nil B1 
31 TL-30-W18 S S S S S S S S nil B1 
32 TL-29-W18 S S S S S S S S nil B1 
33 TL-35-W18 S S S S S S S R nil B1 
34 TL-13-W18 S S S S S S S S nil A 
35 TL-45-W18 S S S S S S S S nil B1 
36 TL-48-W18 S S S S S S S S nil B1 
37 TL-47-W18 S S S S S S S S nil B1 
38 TL-46-W18 S S S S S S S S nil B1 
39 TL-9-W18 S S S S S S S S nil B1 
40 TL-22-W18 S S S S S S S S nil B1 
41 TL-15-W18 S S S S S S S S nil B1 
42 TL-17-W18 S S S S S S S S nil B1 
43 TL-4-W18 S S S S S S S S nil B1 
44 TL-7-W18 S S S S S S S S nil B1 
45 TL-26-W18 S S S S S S S S nil cladeIII +IV+V 
46 TL-28-W18 S S S S S S R S nil A 
47 TL-36-W18 S S S S S S R S nil unknown 






Phylogenetic typing of dairy farm E. coli isolates 
 






S.No  Quadruplex genotype Phylogroup 
 Lane 
number  Strain Name ArpA  chu A yja A TspE4C2   
1 TL-30-S18 + - - +  B1 
2 TL-34-S18 + - - +  B1 
3 CW-19-S18 + - + - A/C 
4 CW-33-S18 + + - + D/E 
5 CW-16-A18 + - + - A/C  
6 Hyper ladder V      
7 CW-15-A18 - - - - not detected 
8 E. coli NCTC 13351 + - + - A/C 
9 E. coli ATCC25922 - + + + B2 
10 Non-Template Control      
11 Non-Template Control      
12 Hyper ladder V      
  








S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1  MRD -34-S17      +       -       -      +  B1 
2  MRD-37-S17      +       -       -      +  B1 
3  MRD-29-S17      +       -      +       - A/C 
4  MRD-38-S17      +       -       -      +  B1 
5  MRD-19-S17      +       -       -      +  B1 
6  MRD-30-S17      +       -       -      +  B1 
7  Hyper ladder V      
8  MRD-24-S17      +       -       -      +  B1 
9  MRD-35-S17      +       -       -      +  B1 
10  MRD-18-S17      +       -       -      +  B1 
11  MRD-27-S17      +       -       -      +  B1 
12 E. coli ATCC25922 - + +       + B2 
13 Non-Template Control      











S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-33-S17 + - - +  B1 
2 MRD-46-S17 + - - +  B1 
3 MRD-48-S17 + - - +  B1 
4 MRD-50-S17 + - - +  B1 
5 MRD-16-S17 + - - - A 
6 Hyper ladder V      
7 MRD-13-S17 + - - +  B1 
8 MRD-14-S17 + - - +  B1 
9 MRD-11-S17 + - - +  B1 
10 MRD-33-S17 + - - +  B1 
11 MRD-9-S17 - - - - not detected 
12 E. coli NCTC 13351 + - + - A/C 
13 Non-template Control - - - -  
14 Hyper ladder V      
 
  





S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-1-S17      +      +       -      + D/E 
2 MRD-17-S17      +       -       -      +  B1 
3 MRD-38-S17       -       -       -       - not detected 
4 MRD-15-S17      +       -       -      +  B1 
5 MRD-49-S17      +       -       -      +  B1 
6 Hyper ladder v (Marker)      
7 MRD-6-S17       -       -       -       - not detected 
8 MRD-40-S17       -      +      +      + B2 
9 MRD-44-S17      +       -       -      +  B1 
10 MRD-2-S17      +       -       -      +  B1 
11 ATCC25922 Positive control       -      +      +      + B2 
12 MRD-9-S17       -       -       -       - not detected 
13 NTC (Non-template control)       -       -       -       -  
14 Hyper ladder v (Marker)      
       
       
1         2            3         4        5         6       7          8       9        10      11       12       13       14 




S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 TL-31-A18      +       -       -      +  B1 
2 TL-29-A18      +       -       -      +  B1 
3 TL-22-A18       -       -       -       - not detected 
4 TL-15-A18      +       -       -      +  B1 
5 TL-10-A18       +       -       -       - A 
6 TL-47-A18      +       -       -      +  B1 
7 Hyper ladder v (Marker)      
8 PF-47-A18      +       -       -      +  B1 
9 ATCC25922 Positive control       -      +      +      + B2 
10 E. coli test 9 sample      +       -       -      +  B1 
11 E. coli test 10 sample      +       -       -      +  B1 
12 E. coli test 11 sample      +       -      +       - A/C 
13 NTC (Non-template control)      
14 Hyper ladder v (Marker)      
 
  
1          2         3          4           5         6         7       8         9        10          11        12         13         14 





S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 PF-49-S18 + - - +  B1 
2 PF-48-S18 + + - -  D/E 
3 PF-51-S18 + - - +  B1 
4 PF-52-S18 + - - +  B1 
5 PF-55-S18 + - - -  A 
6 Hyper ladder v (Marker)      
7 PF-40-S18 + - - +  B1 
8 PF-46-S18 + - - +  B1 
9 TL-2-S18 - - - -  Not detected 
10 TL-27-A18 - - - -  Not detected 
11 PF-39-S18 + - - +  B1 
12 PF-35-S18 - - - -  Not detected 
13 PF-34-S18 + - - +  B1 
14 PF-42-S18 + - - +  B1 
15 NTC (Non-template control)      
       
 
  
1          2          3         4        5          6       7         8         9        10       11      12       13     14       15 







S.No  Quadruplex genotype Phylogroup 
 Lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-33-S17 + - - +  B1 
2 CW-4-S17 + - - +  B1 
3 CW-9-S17 + - - +  B1 
4 CW-33-S17 + - - +  B1 
5 CW-9-S17 + - - +  B1 
6 Hyper ladder v (Marker)      
7 CW-20-S17 + - - +  B1 
8 CW-17-S17 + - - +  B1 
9 CW-39-S17 + + - -  D+E 
10 CW-35-S17 + - - +  B1 
11 CW-5-S17 + - - +  B1 
12 CW-18-S17 + - - +  B1 
13 MRD-50-S17 + - - +  B1 
14 MRD-51-S17 + - - +  B1 
15 MRD-42-S17 + - - +  B1 
16 MRD-40-S17 + - - +  B1 
17 Hyper ladder v (Marker) - - - -  
18 PTC (Positive Template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      




1          2      3          4       5      6      7        8      9     10     11    12    13     14      15    16  17   18   19     20 






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper ladder v (Marker)      
2 CW-16-S17 + - - +  B1 
3 MRD-4-S17 + - - +  B1 
4 CW-86-S17 + - - +  B1 
5 CW-30-S17     
Not 
detected 
6 CW-46-S17 + - - +  B1 
7 Hyper ladder v (Marker)      
8 CW-60-S17 + - - +  B1 
9 CW-1-S17 + - - +  B1 
10 CW-14-S17 + - - +  B1 
11 PTC (Positive template control) ATCC - + + + B2 
12 NTC (Non-template control + - - +  B1 
13 PF-25-S18 + - - +  B1 
14 PF-36-S18 + - - +  B1 




  1         2        3       4       5      6         7        8        9      10     11     12      13     14      15       






Lane order and Quadruplex genotype 
S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-38-S17 + + - - D/E 
2 PF-56-S18     Not detected 
3 CW-37-S17 + - - +  B1 
4 CW-36-S17 + - - +  B1 
5 CW-28-S17     Not detected 
6 Hyper ladder v (Marker)      
7 CW-23-S17 + - - +  B1 
8 CW-48-S17 + - - +  B1 
9 CW-31-S17 + - - +  B1 
10 CW-35-S17 + - - +  B1 
11 CW-14-S17 + - - +  B1 
12 CW-39-S17 + - - +  B1 
13 CW-47-S17 + - - +  B1 
14 CW-42-S17 + - - +  B1 
15 CW-26-S17 + - - +  B1 
16 CW-38-S17 + - - +  B1 
17 PTC (Positive Template control) ATCC - + + + B2 
18 NTC (Non-template control - - - - - 
19 Hyper ladder v (Marker)      
 
  
  1       2      3       4       5        6     7      8     9     10     11     12    13     14    15  16     17     18    19     






S.No  Quadruplex genotype Phylogroup 
 Lane   Strain Name ArpA  chu A yja A TspE4C2   
1 CW-35-W18 + + - + D/E 
2 CW-25-S17     Not detected 
3 CW-34-S17 + - - +  B1 
4 CW-50-S17 + - - +  B1 
5 CW-23-S17 + - - +  B1 
6 CW-47-S17 + - - +  B1 
7 CW-7-S17 + - - +  B1 
8       
9 CW-11-S17 + - - +  B1 
10 CW-34-S17 + - - +  B1 
11 CW-8-S17 + - - +  B1 
12 CW-40-S17 + - - +  B1 
13 CW-49-S17 + + - + D/E 
14 CW-21-S17 + - - +  B1 
15 CW-6-S17 + - - +  B1 
16 CW-10-S17 + - + - A/C  
17 PTC (Positive Template control) ATCC - + + + B2 
18 Hyper ladder v (Marker) - - - - - 




1          2         3       4       5        6      7       8      9     10    11   12    13   14   15  16    17  18  19   20  






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-16-W18 + - - +  B1 
2 MRD-19-W18 + - - - A 
3 CW-15-S17 + - - +  B1 
4 MRD-6-W18 - - - + 
Unknown perform 
MLST 
5 MRD-18-W18 + - - - A 
6 Hyper ladder v (Marker)      
7 CW-52-S17 + - - +  B1 
8 MRD-15-W18 + - - +  B1 
9 MRD-36-W18 + - - +  B1 
10 MRD-1-W18 + - - +  B1 
11 CW-45-S17 + - - +  B1 
12 PTC (Positive template control) ATCC - + + + B2 
13 NTC (Non-template control + - - +  B1 




          1         2          3            4          5         6         7           8          9         10        11        12       13       14              
19     






Lane order and Quadruplex genotype 
S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 MRD-61-A18 + - - - A 
2 MRD-43-A18 + - - +  B1 
3 MRD-39-W18 + - - +  B1 
4 MRD-50-W18 + - - +  B1 
5 MRD-41-W18 - - + + UNKNOWN 
6 MRD-49-W18 + - - +  B1 
7 MRD-55-W18 + - - +  B1 
8 MRD-48-W18 + - - +  B1 
9 MRD-56-A18 + - - +  B1 
10 MRD-57-A18     Not detected 
11 MRD-62-A18 + - - +  B1 
12 MRD-63-A18 + - - +  B1 
13 MRD-64-A18 + - - +  B1 
14 NTC (Non-template control)      




  1         2          3          4          5          6          7          8          9         10        11        12       13         14      15          
19     





Lane order and Quadruplex genotype 
S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 MRD-25-W18 + + - -  D/E 
2 MRD-55-A18 + + - +  D/E 
3 MRD-50-A18 + - - +  B1 
4 MRD-44-A18 + - - +  B1 
5 MRD-41-A18 + - - +  B1 
6 MRD-52-A18 + - - - A 
7 MRD-59-A18 + - - +  B1 
8 MRD-51-A18 + - - +  B1 
9 MRD-53-A18 + - - +  B1 
10 MRD-42-A18      Not detected 
11 MRD-33-A18 + - - +  B1 
12 MRD-38-A18 + - - +  B1 
13 MRD-40-A18 + - - +  B1 
14 PTC (Positive template control) ATCC - + + + B2 
15 NTC (Non-template control)      
 
  
1           2           3           4            5         6        7          8        9        10        11       12       13       14        15          
19     







Lane order and Quadruplex genotype 
S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 MRD-38-W18 + - - +  B1 
2 MRD-44-W18 + - - +  B1 
3 MRD-43-W18 + - - +  B1 
4 MRD-47-W18 + + - -  D/E 
5 MRD-42-W18 + - - +  B1 
6 MRD-46-W18 + + - +  D/E 
7 MRD-30-W18 + - - +  B1 
8 MRD-31-W18 + + - +  D/E 
9 MRD-37-A18 + + - -  D/E 
10 MRD-47-A18 + - - +  B1 
11 MRD-27-W18 - - - -  Unknown* 
12 MRD-48-W18 + - - +  B1 
13 PTC (Positive template control) ATCC - + + + B2 
14 NTC (Non-template control)      
15 Hyper ladder v (Marker)      
 
  
1          2          3           4            5          6         7        8          9        10         11      12      13      14        15          
19     






S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 MRD-49-A18 + + + - E or clade 1 
2 PTC (Positive template control) ATCC - + + + B2 
3 MRD-26-W18 + + - -  D/E 
4 MRD-20-W18 - - - + 
Unknown perform 
MLST 
5 MRD-46-A18 + - - + B1 
6 MRD-48-A18 + - - + B1 
7 MRD-45-A18 + - - + B1 
8 MRD-29-W18 + - - + B1 
9 MRD-37-W18 + - - + B1 
10 MRD-35-W18 + - - + B1 
11 Hyper ladder v (Marker)      
12 CW-25-S17      Not detected 
13 CW-34-S17 + - - + B1 
14 CW-50-S17 + - - + B1 
15 CW-23-S17 + - - + B1 
16 CW-7-S17 + - - + B1 




        1         2       3       4      5        6       7        8      9       10     11         12     13     14     15     16      17    
18         
19     






Lane order and Quadruplex genotype 
S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA 
 chu 
A yja A TspE4C2   
1 MRD-9-A18 - - - - Not detected 
2 MRD-1-A18 + - - + B1 
3 MRD-10-A18 + - - + B1 
4 MRD-35-A18 476 bp - - -  Clade III, IV or V 
5 MRD-2-A18 + - - - A 
6 MRD-5-A18 - - - - Not detected  
7 MRD-7-A18 + - - + B1 
8 MRD-30-A18 + - - + B1 
9 MRD-31-A18 + - - + B1 
10 MRD-6-A18 + - - + B1 
11 MRD-8-A18 + - - + B1 
12 MRD-32-A18 + - - + B1 
13 PTC (Positive template control) ATCC - + + + B2 
14 NTC (Non-template control) - - - -  
15 Hyper ladder v (Marker)      




         1          2         3         4         5          6        7         8          9         10        11       12       13       14      15     
16      17         
19     






S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 MRD-11-A18 - - - - Not detected 
2 MRD-3-A18 + - - - A 
3 MRD-35-A18 476 bp - - -  Clade III, IV or V 
4 MRD-18-A18 + - - + B1 
5 MRD-16-A18 + - - + B1 
6 MRD-17-A18 + - - + B1 
7 PTC (Positive template control) ATCC - + + + B2 
8 Hyper ladder v (Marker)      
9 PF-56-A18 + - - + B1 
10 PF-29-A18 + - - + B1 
11 PF-34-A18 + - - + B1 
12 PF-1-A18 + - - + B1 
13 PF-3-A18 + - - + B1 
14 PTC (Positive template control) ATCC - + + + B2 
15 NTC (Non-template control)      
 
  
   1       2          3         4          5         6        7             8        9       10       11        12        13        14       15     
16      17         
19     





S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 PF-28-A18 + - - + B1 
2 PF-39-A18 - - - - Not detected 
3 PF-27-A18 + - - + B1 
4 PF-53-A18 - - - - Not detected 
5 PF-8-A18 + - - + B1 
6 PF-54-A18 + - + - A/C 
7 PF-43-A18 + + - - D/E 
8 PF-57-A18 + + - - D/E 
9 PF-55-A18 + + - - D/E 
10 PF-38-A18 + - - + B1 
11 PF-47-A18 + - - + B1 
12 PF-52-A18 + - - + B1 
13 PTC (Positive template control) ATCC - + + + B2 
14 NTC (Non-template control)      
15 Hyper ladder v (Marker)      
 
 
   1          2          3        4         5         6         7          8         9        10       11           12       13     14      15      
19     




Lane order and Quadruplex genotype 
S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 PF-49-A18 + - - + B1 
2 PF-51-A18 + - + - A/C 
3 PF-13-A18 + - - + B1 
4 PF-2-A18 + - - + B1 
5 PF-48-A18 + + - + D/E 
6 PF-20-A18 + - - + B1 
7 PF-32-A18 + - - + B1 
8 PF-6-A18 + - - + B1 
9 PF-17-A18 - - - -  Not detected 
10 Hyper ladder v (Marker)      
11 PF-33-A18 + - - + B1 
12 PF-42-A18 + - - + B1 
13 PF-26-A18 + - - + B1 




   1       2        3       4         5        6      7       8        9       10      11     12     13     14           
19     






Lane order and Quadruplex genotype 
S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA chu A yja A TspE4C2   
1 CW-1-A18 + + - + D/E 
2 CW-2-A18 + - - + B1 
3 CW-10-A18 + - - + B1 
4 PF-10-A18 + - - + B1 
5 CW-41-A18 + - + - A/C 
6 PF-12-A18 + + - + D/E 
7 CW-14-A18 + + - - D/E 
8 CW-3-A18 + - - + B1 
9 CW-9-A18 + - - + B1 
10 CW-31-A18 + - + - A/C 
11 CW-43-A18 + - - + B1 
12 PF-37-A18 + - - + B1 
13 NTC (Non-template control)      
14 CW-6-A18 + - - + B1 





   1       2       3        4        5        6       7       8        9       10      11     12     13     14     15         
19     






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 PF-40-A18 + + - + D/E 
2 CW-43-A18 + - + - A/C 
3 CW-87-S17 + - - + B1 
4 CW-8-A18 + + - + D/E 
5 CW-44-A18 + - - + B1 
6 
PTC (Positive template 
control) ATCC - + + + B2 
7 Hyper ladder v (Marker)      






   1       2       3        4        5        6       7       8                
19     







  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-13-W18 + - - - A 
2 CW-36-A18 + + - + D/E 
3 CW-20-A18      Not assignable 
4 CW-35-A18      Not assignable 
5 CW-27-A18      Not assignable 
6 CW-23-A18 + + - - D/E 
7 CW-48-A18 + - - + B1 
8 PF-3-A18 + - - + B1 
9 PF-7-A18 + - - + B1 
10 MRD-9-W18 + - - + B1 
11 CW-5-A18 + - - + B1 
12 PF-4-A18 + - - + B1 
13 MRD-11-W18 + - - - A 
14 NTC (Non-template control)      
15 Hyper ladder v (Marker)      
 
  
  1          2          3          4           5          6      7         8       9       10       11        12      13       14    15     
16     16        
19     





       
 
S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-22-S17 + - - + B1 
2 PF-38-A18 + - - + B1 
3 CW-20-A18      
4 Hyper ladder v (Marker)      
5 CW-4-A18 + - - + B1 
6 PTC (Positive template control) ATCC - + + + B2 
7 Hyper ladder v (Marker)      
8 Hyper ladder v (Marker)      
9 PF-8-A18 + - - + B1 
10 PF-38-A18 + - - + B1 
11 CW-4-A18 + - - + B1 





  1       2       3          4        5       6     7      
7          7           8           9       10         
11        12        13        14      15     16     
16        
19     
16      
  8       9       10      11    12              
12        13        14      15     16     
16        
19     






  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-19-S17 + - - + B1 
2 CW-50-A18 + - - + B1 
3 CW-45-S17 + - - + B1 
4 MRD-5-W18 + - - - A 
5 MRD-7-W18 + - - - A 
6 Hyper ladder v (Marker)      
7 MRD-14-S18 + - - + B1 
8 MRD-15-S18 + - - + B1 
9 TL-13-S18 + - - - A 
10 MRD-25-S18 + - + - A/C 
11 MRD-35-S18 + - - + B1 
12 MRD-4-S18 + - - + B1 
13 MRD-16-S18 + - - + B1 
14 PTC (Positive template control) ATCC - + + + B2 
15 NTC (Non-template control)      
 
  
    1       2            3          4          5          6          7        8          9         10         11      12     13        14        15     
16           
19     






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-40-A18 + - - + B1 
2 MRD-14-W18 + - - - A 
3 CW-34-A18 + - - + B1 
4 MRD-10-W18 + - - - A 
5 CW-13-A18 + - - + B1 
6 CW-46-A18     
 Not 
assignable 
7 CW-32-A18 + - - + B1 
8 CW-37-A18 + + - - D/E 
9 CW-29-A18 + - - + B1 
10 CW-38-W18 + - - + B1 
11 CW-21-A18 + - - + B1 
12 CW-18-A18 + + - + D/E 
13 PTC (Positive template control) ATCC      
14 NTC (Non-template control)      
15 Hyper ladder v (Marker)      
 
  
    1       2        3       4          5            6          7        8        9       10       11      12     13      14        15      
19     








Lane order and Quadruplex genotype 
S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 MRD-18-S18 + - - + B1 
2 MRD-13-S18 + - - + B1 
3 MRD-21-S18 + - - + B1 
4 MRD-8-W18 + - - - A  
5 CW-26-A18 + - + - A/C 
6 CW-24-A18 + - - + B1 
7 CW-30-A18 + - - + B1 
8 CW-17-A18 + - - + B1 
9 TL-25-S18 + - - + B1 
10 CW-45-A18 + - - + B1 
11 MRD-60-A18     Not assignable 
12 Hyper ladder v (Marker)      
13 TL-11-W18 + - - + B1 
14 TL-10-W18 + - - + B1 
15 MRD-22-S18 + - - + B1 
 
  
   1       2          3         4         5        6         7          8         9        10       11        12      13      14         15      
19     






  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-23-S18 + - - + B1 
2 MRD-24-S18 + - - + B1 
3 MRD-12-S18 + - - + B1 
4 MRD-11-S18 + - - + B1 
5 MRD-19-S18 + - - + B1 
6 TL-17-S18 + - - + B1 
7 TL-16-S18 + - - + B1 
8 TL-23-S18 + - - + B1 
9 TL-24-S18 + - - + B1 
10 TL-27-S18 + - - + B1 
11 MRD-5-S18 + - - + B1 
12 TL-12-W18 + - - + B1 
13 PTC (Positive template control) ATCC - + + + B2 
14 NTC (Non-template control)      
15 Hyper ladder v (Marker)      
 
  
1          2          3          4         5        6         7          8       9      10      11        12        13        14        15      
19     






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 TL-23-W18 + - - - A 
2 TL-3-W18 + - - - A 
3 TL-8-W18 + - - + B1 
4 TL-20-W18 + - - - A 
5 TL-12-S18 + - - + B1 
6 TL-7-W18 + - - - A 
7 TL-8*-W18 - - - - Unknown 
8 TL-27-W18 + - - + B1 
9 TL-14-W18 + - - + B1 
10 TL-16-W18 + - - + B1 
11 TL-24-W18 + - - + B1 
12 PTC (Positive template control) ATCC - + + + B2 
13 NTC (Non-template control)      
14 TL-1-W18 + - - - A 




   1       2         3           4        5        6         7        8       9         10     11      12        13      14       15      
19     






  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-19-A18 + - - + B1 
2 TL-28-S18 + - - - A 
3 MRD-1-S18 + - - + B1 
4 TL-26-S18 + - - + B1 
5 TL-25-W18 - - - - Unknown 
6 TL-5-W18 + - - + B1 
7 MRD-8-S18 - - - - Unknown 
8 MRD-17-S18 + - - + B1 
9 TL-2-W18 + - - - A 
10 TL-18-W18 + - - + B1 
11 Hyper ladder v (Marker)      
12 MRD-31-S17 + - - + B1 
13 MRD-21-S17 + - - + B1 
14 TL-50-W18 - - + - Clade IorII 




    1        2        3          4       5         6         7        8         9       10      11       12     13      14        15      
19     







Lane order and Quadruplex genotype 
  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-22-S17 + - - + B1 
2 MRD-12-S17 + - - + B1 
3 MRD-7-S17 + - - + B1 
4 MRD-5-S17 + - - + B1 
5 MRD-62-S17 + - - + B1 
6 MRD-59-S17 + - - + B1 
7 MRD-30-S17 + - - + B1 
8 MRD-9-S18 + - - + B1 
9 MRD-10-S18 + - - + B1 
10 TL-19-W18 + - - + B1 
11       
12 TL-21-W18 + - - + B1 
13 PTC (Positive template control) ATCC - + + + B2 
14 NTC (Non-template control)      




1        2        3        4         5         6       7          8        9        10     11      12      13       14      15      
19     






  Quadruplex genotype Phylogroup 
 Lane   Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-47-S17 + - - + B1 
2 MRD-61-S17 + - - + B1 
3 TL-32-W18 + - - + B1 
4 TL-39*-W18 + - - + B1 
5 TL-40-W18 + - - + B1 
6 TL-38-W18 + - - + B1 
7 TL-42-W18 + - - + B1 
8 MRD-51-S17 + - - + B1 
9 MRD-60-S17 + - - + B1 
10 MRD-45-S17 + - + - A/C 
11 TL-43-W18 + - - + B1 
12 PTC (Positive template control) ATCC - + + + B2 
13 NTC (Non-template control)      





             1           2         3         4         5       6        7         8        9        10       11        12      13    14              
19     




S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 TL-44-W18 + - - + B1 
2 TL-41-W18 + - - + B1 
3 MRD-23-S17 - + + + B2 
4 MRD-58-S17 + - - + B1 
5 MRD-25-S17 + - - + B1 
6 MRD-10-S17 + - - + B1 
7 Hyper ladder v (Marker)      
8 PF-17-W18 + - - + B1 
9 PF-15-W18 + - - + B1 
10 PF-14-W18 + - - + B1 
11 PF-4-W18 + - - + B1 
12 PF-1-W18 + - - + B1 
13 NTC (Non-template control)      
       
14 PTC (Positive template control) ATCC - + + + B2 






1          2       3        4       5       6         7        8       9      10     11     12       13      14      15             
19     






S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 PF-5-W18 + - - + B1 
2 PF-8-W18 + - - + B1 
3 PF-7-W18 + - - + B1 
4 PF-16-W18 + - - + B1 
5 PF-6-W18 + - - + B1 
6 PF-11-W18 + - - + B1 
7 PF-13-W18 + - + - A/C 
8 PF-10-W18 + - - + B1 
9 PF-9-W18 + - - + B1 
10 PF-3-W18 + - - + B1 
11 PF-2-W18 + - - + B1 
12 PF-50-W18 + - - + B1 
13 PF-51-W18 + - - + B1 
14 PF-43-W18 + - - + B1 




1          2          3        4         5         6         7        8        9       10       11       12       13      14      15             
19     







  Quadruplex genotype Phylogroup 
 Lane 
number  Strain Name ArpA  chu A yja A TspE4C2   
1 PF-34-W18 + - - + B1 
2 PF-53-W18 + - - - A 
3 PF-56-W18 + - - - A 
4 PF-49-W18 + - - + B1 
5 PF-48-W18 + - - + B1 
6 PF-35-W18 + - - + B1 
7 PF-46-W18 + - - + B1 
8 PF-47-W18     Unknown 
9 PF-38-W18 + - - - A 
10 PF-36-W18 + - - + B1 
11 PF-33-W18 + - - + B1 
12 CW-4-S18 + - - + B1 
13 CW-1-S18 + - - + B1 
14 NTC      




     1     2          3         4           5       6      7        8            9         10      11       12      13      14      15             
19     






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-2-S18 + - - + B1 
2 CW-3-S18 + - - + B1 
3 PTC (Positive template control) ATCC - + + + B2 
4 CW-24-S18 + - - + B1 
5 CW-25-S18 + + - - D/E 
6 CW-20-S18 + + + - E or clade1 
7 CW-30-S18 + + - - D/E 
8 CW-31-S18 + + - - D/E 
9 CW-32-S18 + + - - D/E 
10 CW-8-S18 + + - - D/E 
11 CW-6-S18 + - - + B1 
12 CW-5-S18 + - - + B1 
13 CW-27-S18 + + + - E or clade1 
14 CW-51-S18 + - - + B1 
15 CW-17-S18 + - - + B1 
16 CW-34-S18 + + + - E or clade1 
17 CW-29-S18 + - - + B1 
18 CW-18-S18 + + + - E or clade1 
19 PTC (Positive template control) ATCC - + + + B2 




    1      2     3       4      5      6      7     8      9     10   11  12   13   14   15     16    17   18     19     20             
19     






  Quadruplex genotype Phylogroup 
 Lane 
number  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-11-S18 + - - + B1 
2 CW-12-S18 + - - + B1 
3 CW-9-S18 + - - + B1 
4 CW-35-S18 + + - + D/E 
5 CW-13-S18 + - - + B1 
6 CW-15-S18 + - + - A/C 
7 CW-14-S18 + - + - A/C 
8       
9 CW-7-S18 + - + - A/C 
10 CW-10-S18 + - - + B1 
11 CW-40-S18 + - - + B1 
12 CW-44-S18 + + - + D/E 
13       
14 CW-36-S18 + - - + B1 
15 CW-38-S18 + - - + B1 
16 CW-43-S18 + - - + B1 
17 CW-46-S18 + - - + B1 
18 CW-45-S18 + - - + B1 
19 CW-29-S18 + - - + B1 




    1     2      3     4      5      6      7     8      9   10    11     12  13     14   15   16     17    18    19   20             
19     






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-22-S18 + - - + B1 
2 CW-28-S18 + - - + B1 
3 CW-23-S18 + - - + B1 
4 Hyper ladder v (Marker)      
5 CW-39-S18 + + - - D/E 
6 CW-42-S18 + - - + B1 
7 CW-41-S18 + - - + B1 
8 CW-16-S18 + - + - A/C 
9 CW-26-S18 + + - - D/E 
10 PTC (Positive template control) ATCC - + + + B2 
11 NTC      





     1          2            3              4         5            6           7           8           9           10           11        12          
19     







S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 TL-39-A18 + - - + B1 
2 TL-12-A18 + - - + B1 
3 TL-31-A18 + - - + B1 
4 TL-27-A18 + - - + B1 
5 TL-7-A18 + - - + B1 
6 TL-9-A18     Unknown 
7 TL-36-A18     Unknown 
8 TL-40-A18     Unknown 
9 TL-18-A18 + - + - A/C 
10 TL-38-A18 + - - + B1 
11 TL-20-A18 + - - + B1 
12 TL-34-A18     Unknown 
13 TL-42-A18 + - - + B1 
14 TL-32-A18 + - - + B1 
15 TL-26-A18 - - + - Clade I+II 
16 TL-43-A18 + - - + B1 
       
18 PTC (Positive template control) ATCC - + + + B2 
19 NTC      




    1    2    3       4      5        6     7      8      9      10    11   12   13    14    15     16   17  18  19     20             
19     






  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-34-W18 + + - + D/E 
2 CW-35-W18 + + - + D/E 
3 CW-37-W18 + - - + B1 





         1        2       3       4         





S.No  Quadruplex genotype Phylogroup 
 Lane 
number  Strain Name ArpA  chu A yja A TspE4C2   
1 TL-33-A18 + - - + B1 
2 TL-19-A18 + - - + B1 
3 CW-51*-S18     Unknown 
4 CW-47-S18 + - - + B1 
5 CW-49-S18 + - - + B1 
6 CW-50-S18 + - - + B1 
7 TL-25-A18 + - - + B1 
8 TL-1-A18 + - + - A/C 
9 TL-11-A18 + - - + B1 
10 TL-24-A18 + - - - A 
11 TL-16-A18 + - - + B1 
12 TL-14-A18 + - - + B1 
13 TL-12*-A18     Unknown 
14 TL-48-A18     Unknown 
15 TL-52-A18 + - - + B1 
16 TL-50-A18 + - - + B1 
17 TL-13-A18 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 NTC      
20 Hyper ladder v (Marker)      
 
  
  1      2      3      4      5      6     7    8       9      10     11     12    13    14   15   16   17   18     19     20             
19     





  Quadruplex genotype Phylogroup 
 Lane 
number  Strain Name ArpA  chu A yja A TspE4C2   
1 CW-6-W18     Unknown 
2 CW-29-W18 + + - + D/E 
3 CW-25-W18 + - - + B1 
4 CW-19-W18 + - - - A 
5 CW-7-W18 + - - + B1 
6 CW-100-S17 + - - + B1 
7 TL-19-A18 + - - + B1 
8 CW-20-W18     Unknown 
9 CW-21-W18 + - - + B1 
10 CW-28-W18 + + - + D/E 
11 CW-23-W18 + - + - A/C 
12 CW-22-W18 + - - + B1 
13 CW-30-W18 + - - + B1 
14 CW-31-W18 + - - + B1 
15 CW-32-W18 + - - + B1 
16 CW-24-W18 + - - + B1 
17 CW-9-W18     Unknown 
18 CW-8-W18 + - - + B1 
19 PTC (Positive template control) ATCC - + + + B2 
20 Hyper ladder v (Marker)      
  1       2       3       4       5     6    7      8      9      10    11    12    13      14    15     16   17  18 19     20             
19     




  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 PF-6-S17 + - + - A/C 
2 CW-27-W18 + + - - D/E 
3 CW-14-W18     Unknown 
4 PF-9-S17 + - + - A/C 
5 PF-8-S17 + - + - A/C 
6 TL-11-A18 + - - + B1 
7 PF-5-S17 + - + - A/C 
8 CW-5-W18 + - - + B1 
9 CW-4-W18 + - - + B1 
10 CW-3-W18 + - - + B1 
11 TL-33-A18 + - - + B1 
12 TL-17-A18 + - - + B1 
13 CW-2-W18 + - - - A 
14 CW-12-W18 + - - + B1 
15 CW-13-W18 + - - + B1 
16 CW-26-W18 + - + - A/C 
17 CW-17-W18 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 NTC      




  1       2       3       4     5       6      7      8      9     10    11    12    13     14    15     16   17   18    19     20             
19     











Lane order and Quadruplex genotype 
S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 CW-18-W18 + - - + B1 
2 NTC      





  1       2       3        
19     






S.No  Quadruplex genotype Phylogroup 
 lane  Strain Name ArpA  chu A yja A TspE4C2   
1 PF-23-S17 + - - + B1 
2 PF-35-S17 + - + - A/C 
3 PF-37-S17 + - - + B1 
4 f + - + - A/C 
5 PF-34-S17 + - + - A/C 
6 CW-21-W18 + - - + B1 
7 PF-18-S17 + - + - A/C 
8 PF-13-S17 + - - + B1 
9 PF-15-S17 + - - + B1 
10 PF-16-S17 + - - + B1 
11 PF-21-S17 + - - + B1 
12 PF-19-S17 + - + - A/C 
13 PF-22-S17 + - - + B1 
14 CW-49-W18 + + - + D/E 
15 CW-51-W18 + - - + B1 
16 CW-10-W18 + - - + B1 
17 CW-11-W18 + - - + B1 
18 CW-1-W18 + - - + B1 
19 PTC (Positive template control) ATCC - + + + B2 
20 Hyper ladder v (Marker)      
 
  
     1       2      3       4      5       6      7       8     9     10    11     12    13   14    15    16     17  18    19     20             
19     










































  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 CW-47-W18 + - - + B1 
2 PF-28-S17 + - - + B1 
3 CW-39-W18 + + - + D/E 
4 CW-41-W18 + + - + D/E 
5 PF-30-S17 + - + - A/C 
6 PF-31-S17 + - - + B1 
7 CW-16-W18 + - - + B1 
8 PF-29-S17 + - + - A/C 
9 PF-35-S17 + - - + B1 
10 CW-36-W18 + + - + D/E 
11 CW-15-W18 - 476 - - 
 Clade III, IV 
or V 
12 CW-48-W18 + + - + D/E 
13 PF-1-S17 + - - + B1 
14 PF-2-S17 + - - + B1 
15 CW-43-W18 + + - + D/E 
16 CW-40-W18 + - - + B1 
17 PF-27-S17 + - + - A/C 
18 PTC (Positive template control) ATCC - + + + B2 
19 Negative template control(NTC)      
       
20 Hyper ladder v (Marker)      
       
  1       2      3      4      5       6     7        8     9    10    11   12    13  14     15     16    17   18    19   20             
19     





































S.No  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 TL-32-S18 + - - + B1 
2 TL-48-S17 + - - + B1 
3 TL-45-S18 + + - - D/E 
4 TL-46-S18 + - - + B1 
5 TL-47-S18 + - - + B1 
6 TL-34-S18 + - - + B1 
7 TL-31-S18 - 476 - - 
 Clade III, IV 
or V 
8 TL-33-S18 + - - + B1 
9 TL-30-S18 + - - + B1 
10 TL-29-S18 + - - + B1 
11 TL-42-S18 + - - + B1 
12 TL-52-S18 + - - + B1 
13 TL-49-S18 + - - + B1 
14 TL-50-S18 + - - + B1 
15 TL-51-S18 + + - - D/E 
16 TL-41-S18 + - - + B1 
17 TL-44-S18 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
1      2      3      4      5      6        7    8      9     10     11   12   13   14     15    16  17    18    19                      
20             
19     













  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 PF-43-S17 + - - + B1 
2 PF-46-S17 + - - + B1 
3 PF-39-S17 + + + - E or clade I 
4 PF-45-S17 + + + - E or clade I 
5 PF-49-S17 + - - + B1 
6 PF-47-S17 + - - + B1 
7 PF-48-S17 + - + - A/C 
8 PF-36-S17 + - - + B1 
9 TL-38-S18 + - - + B1 
10 PF-37-S17 + - - + B1 
11 PF-38-S17 + - + - A/C 
12 PF-35-S17 + - - + B1 
13 MRD-30-S18 + + - - D/E 
14 TL-42-S17 + + + - E or clade I 
15 TL-37-S18 + - - + B1 
16 TL-36-S18 + - - + B1 
17 TL-43-S18 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
  1     2      3      4      5      6      7      8       9      10     11       12    13     14      15     16    17  18  19     20             
19     















  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 PF-25-S17 + - - + B1 
2 CW-45-W18 + - - + B1 
3 CW-42-W18     Unknown 
4 Hyper V ladder      
   1       2      3      4       
19     






S.No  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-52-S18 + - - + B1 
2 MRD-34-S18 + - - + B1 
3 MRD-36-S18 + - - + B1 
4 MRD-38-S18 + + - - D/E 
5 MRD-49-S18 + - - + B1 
6 MRD-53-S18 + - - - A 
7 MRD-54-S18 + - - + B1 
8 MRD-55-S18 + - - + B1 
9 MRD-44-S18 + - - + B1 
10 MRD-47-S18 + - + - A/C 
11 MRD-45-S18 + - - + B1 
12 MRD-43-S18 + - - + B1 
13 MRD-39-S18 + - - + B1 
14 MRD-40-S18 + - - - A 
15 MRD-32-S18 + - - + B1 
16 MRD-46-S18     Unknown 
17 MRD-29-S18 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
  1       2       3      4        5       6    7      8     9       10   11   12    13     14   15  16    17      18     19     20             
19     
16      
 317 
 
  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-42-S17 + - - + B1 
2 MRD-10-S17 + - - + B1 
3 MRD-37-S17 + - - + B1 
4 MRD-29-S17 + - - + B1 
5 MRD-47-S17 + - - + B1 
6 MRD-36-S17 + - - + B1 
7 MRD-41-S18 + + - - D/E 
8 MRD-57-S17 + - - + B1 
9 MRD-65-S17 + - - + B1 
10 MRD-13-S17 + - - - A 
11 MRD-41-S17 + - - + B1 
12 MRD-43-S17 + - - + B1 
13 MRD-30-S17 + - - + B1 
14 MRD-18-S17 + - - + B1 
15 MRD-32-S17 + - - + B1 
16 MRD-26-S17 + - - + B1 
17 MRD-35-S17 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
 1      2      3      4      5      6      7     8      9    10    11    12    13      14      15     16    17     18     19     20             
19     
















S.No  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-31-S18 + + - - D/E 
2 MRD-50-S17 + - - + B1 
3 Hyper ladder v (Marker)      
    1       2       3                     
19     







S.No  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 MRD-54-S17 + - - + B1 
2 MRD-26-S17 + - - + B1 
3 MRD-5-S17 + - - + B1 
4 MRD-15-S17 + - - + B1 
5 MRD-11-S17 + - - + B1 
6 MRD-8-S17 + + - - D/E 
7 MRD-55-S18 + - - + B1 
8 MRD-27-S17 + - + - A/C 
9 MRD-28-S17 + - - - A 
10 MRD-20-S17 + - - + B1 
11 MRD-56-S17 + - - + B1 
12 MRD-53-S17 + + - + D/E 
13 MRD-7-S17 + - - + B1 
14 MRD-8-S17 + + - - D/E 
15 MRD-40*-S17 + + - - D/E 
16 MRD-44-S17 + - + - A/C 
17 MRD-31-S17 + - - - A 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
1     2     3      4       5     6     7      8       9    10    11    12    13      14     15   16    17   18   19     20             
19     





  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 TL-9-S17 + - - + B1 
2 TL-3-S17 + - - + B1 
3 TL-27-S17     Unknown 
4 TL-29-S17     Unknown 
5 TL-31-S17     Unknown 
6 TL-46-S17 + - - + B1 
7 TL-49-S17 + - - + B1 
8 TL-35-S17 + - - + B1 
9 TL-34-S17 + + - - D/E 
10 TL-24-S17 + - - + B1 
11 TL-12-S17 + - - + B1 
12 TL-21-S17 + - - + B1 
13 TL-17-S17 + - - + B1 
14 TL-8-S17     Unknown 
15 TL-4-S17 + - - + B1 
16 MR-33-S17 + - - + B1 
17 MR-9-S17 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
1      2       3       4      5        6      7     8        9     10    11   12    13     14    15   16    17    18     19     20             
19     

















  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 MR-51-S17 + + - + D/E 
2 MR-2-S17 + - - + B1 
3 Hyper ladder v (Marker)      
       1       2       3        4                      
19     









  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 TL-7-S17 + - - + B1 
2 TL-32-S17 + + - - D/E 
3 TL-25-S17     Unknown 
4 TL-19-S17     Unknown 
5 TL-26-S17     Unknown 
6 TL-22-S17     Unknown 
7 TL-18-S17 + - - + B1 
8 TL-10-S17 + - - + B1 
9 TL-36-S17 + - - + B1 
10 TL-1-S17 + - - + B1 
11 TL-16-S17 + - - + B1 
12 TL-35-S17 + - - + B1 
13 TL-44-S17     Unknown 
14 TL-6-S17 + - - + B1 
15 TL-28-S17 + - - + B1 
16 TL-5-S17 + - + - A/C 
17 TL-40-S17 + + - - D/E 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
1        2       3      4        5     6      7      8     9    10    11     12     13     14   15     16    17     18   19     20             
19     








  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 TL-45-S17 + - - + B1 
2 TL-23-S17 + - - + B1 
3 TL-14-S17 + - + - A/C 
4 TL-38-S17 + - - + B1 
5 TL-46-S17 + - - + B1 
6 TL-20-S17 + - - + B1 
7 TL-50-S17     Unknown 
8 TL-11-S17 + - + - A/C 
9 TL-41-S17 + - - + B1 
10 TL-49*-S17 - + - - F 
11 TL-43-S17 + - - + B1 
12 TL-36*-S17     Unknown 
13 TL-35-S17 + - - + B1 
14 TL-47-S17 + - - + B1 
15 TL-37-S17     Unknown 
16 TL-5-S17 + - + - A+C 
17 TL-42*-S17     Unknown 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
1        2       3      4        5     6      7      8     9    10    11     12     13     14   15     16    17     18   19     20             
19     






































  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 TL-8-S18 + - - + B1 
2 TL-9-S18     Unknown 
3 TL-6-S18     Unknown 
4 TL-7-S18     Unknown 
5 TL-18-S18     Unknown 
6 TL-17-S18 + - - + B1 
7 TL-12-S18     Unknown 
8 TL-11-S18 + - - + B1 
9 TL-10-S18     Unknown 
10 TL-16-S17     Unknown 
11 TL-48-S17 + - - - A 
12 TL-20-S18 + - - + B1 
13 TL-2-S17 + - + - A/C 
14 TL-12-S17 + - - + B1 
15 TL-24-S17 + - - + B1 
16 TL-41-S17 + - - + B1 
17 TL-51-S17 + - - + B1 
18 PTC (Positive template control) ATCC - + + + B2 
19 Hyper ladder v (Marker)      
20 NTC      
1       2        3         4        5        6       7    8    9   10   11    12    13    14   15   16     17     18    19    20             
19     





































  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 PF-1-S18 + - - + B1 
2 PF-4-S18 + - - + B1 
3 PF-15-S18 + - - + B1 
4 PF-2-S18 + - - + B1 
5 PF-3-S18 + - - + B1 
6 PF-7-S18 + - - + B1 
7 PF-10-S18 + - - + B1 
8 PF-14-S18 + - - + B1 
9 PF-13-S18 + - - + B1 
10 PF-16-S18 + - - + B1 
11 PF-11-S18 + - - + B1 
12 PF-12-S18 + - - + B1 
13 PF-9-S18 + - + - A/C 
14 PF-6-S18 + - - + B1 
15 PF-5-S18 + - - - A 
16 PF-8-S18 + - - + B1 
17 TL-4-S18 + - - + B1 
18       
19 PTC (Positive template control) ATCC - + + + B2 
20 Hyper ladder v (Marker)      
1       2        3         4        5        6       7    8      9 10     11    12    13    14   15   16   17    18    19   20             
19     



































  Quadruplex genotype Phylogroup 
 lane   Strain Name ArpA  chu A yja A TspE4C2   
1 PF-17-S18 + - - + B1 
2 PF-24-S18 + - - + B1 
3 PF-23-S18 + - - + B1 
4 PF-22-S18 + - - + B1 
5 PF-21-S18 + - - + B1 
6 PF-18-S18 + - - + B1 
7 PF-19-S18 + + - - D/E 
8 PF-32-S18     Unknown 
9 PF-33-S18 + - - + B1 
10 PF-38-S18 + - - + B1 
11 PF-50-S18 + - - + B1 
12 PF-41-S18 + + - + D/E 
13 PF-29-S18 + + - + D/E 
14 PF-27-S18 + - - - A 
15 PF-45-S18 + - - + B1 
16 PF-37-S18 + + - - D/E 
17 PF-31*-S18     Unknown 
18 PF-31-S18 + - - + B1 
19 PF-30-S18 + - - + B1 
20 Hyper ladder v (Marker)      
1     2       3       4      5      6      7     8      9     10     11    12    13    14   15    16     17   18   19     20             
19     






































  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 PF-43-S18 + - - + B1 
2 PF-47-S18 + - - + B1 
3 PF-28-S18 + - - + B1 
4 PF-53-S18 + - - + B1 
5 PF-56-S18 + - + - A/C 
6 PF-28-S18 + - - + B1 
7 PF-26-S18     Unknown 
8 PF-25-S18 + - - + B1 
9 PF-20-S18 - 476 - - 
 Clade III, IV 
or V 
10 
PTC (Positive template control) 
ATCC - + + + B2 
11 NTC      
12 Hyper ladder v (Marker)      
13 TL-21-S17 + - - + B1 
14 TL-51-S17 + - - + B1 
15 TL-16-S17 + - - + B1 
16 TL-5-S18 + - - + B1 
17 TL-3-S18 + - - + B1 
18 TL-1-S18 + - - + B1 
19 Hyper ladder v (Marker)      
1       2        3         4        5        6       7    8      9 10     11    12    13    14   15   16     17     18    19       20             
19     





































  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
Hyper v 
ladder Kb+ladder      
2 PF-56*-A18 - - - - unknown 
3 PF-5-A18 + - - + B1 
4 PF-22-A18 + + - + D/E 
5 PF-4-A18 + - - + B1 
6 PF-16-A18 + - - + B1 
7 PF-50-A18 + + - - D/E 
8 PF-60-A18 + - - + B1 
9 PF-10-A18 - - + - Clad I or II 
10 PF-63-A18b + - - + B1 
11 PF-31-A18 + - - + B1 
12 PF-61-A18 + + - - D/E 
13 PF-62-A18 + - - + B1 
14 PF-15-A18 + - - + B1 
15 PF-34-A18 + - - + B1 
16 PF-23-A18 - - + + unknown 
17 Contaminant - - + - unknown 
18       
19       
1       2        3         4        5        6       7    8      9 10     11    12    13    14   15   16     17     18    19       20             
19     














  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 TL-22-W18 + - - + B1 
3 TL-19-W18 + - - + B1 
4 TL-21-S18 + - - + B1 
5 TL-14-S18 + - - + B1 
6 TL-39-S17 + - + - A/C 
7 TL-46-S17 + - - + B1 
8 TL-48-S18 + - - + B1 
9 TL-15-W18 + - - + B1 
10 TL-17-W18 + - - + B1 
11 TL-4-W18 + - - + B1 
12 TL-7-W18 + - - + B1 
13 TL-11-S17 + - - + B1 
14 TL-52-S17 + - - + B1 
15 TL-54-S17 + - - + B1 
16 TL-53-S17 + - - + B1 
17 TL-53-S18 + - - + B1 
18 TL-26-W18 - 476 - - 
 Clade III, IV 
or V 
19 E. coli ATCC25922 - + + + B2 
20 dH2O      
1       2        3         4        5        6       7    8      9 10     11    12    13    14   15   16     17     18    19       20             
19     










































  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 TL-45-W18 + - - + B1 
3 TL-48-W18 + - - + B1 
4 TL-47-W18 + - - + B1 
5 TL-46-W18 + - - + B1 
6 TL-9-W18 + - - + B1 
7 TL-19-S18 + - - + B1 
8 TL-27-S17 + - - + B1 
9 TL-30-S17 + - - + B1 
10 TL-33-W18 + - - + B1 
11 TL-31-W18 + - - + B1 
12 TL-30-W18 + - - + B1 
13 TL-29-W18 + - - + B1 
14 TL-35-W18 + - - + B1 
15 TL-38-S18 + - - + B1 
16 TL-55-S18 + - - + B1 
17 TL-13-W18 + - - - A 
18 TL-54-S18 + - - + B1 
19 E. coli ATCC25922 - + + + B2 
20 dH2O      
1        2      3      4       5       6      7       8      9      10    11    12    13     14    15    16    17     18   19       20           
19     































  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 CW-37-S18 + + - + D+E 
3 CW-47-A18 + + - + D+E 
4 CW-56-A18 + - - + B1 
5 CW-38-A18 + - - + B1 
6 CW-14-S17 + - - + B1 
7 CW-55-A18 + - - + B1 
8 CW-53-A18 + - - + B1 
9 CW-52-S18 + - - + B1 
10 CW-1-S18 + - - + B1 
11 CW-21-W18 + - - + B1 
12 CW-4-S18 + - - + B1 
13 CW-49-S17 + + - + D+E 
14 CW-54-A18 + + - + D+E 
15 CW-3-S17 + + - + D+E 
16 CW-41-A18 + - + - A+C 
17 CW-27-S17 + - - + B1 
18 CW-25-A18 - - + - Clade I or II 
19 E. coli ATCC25922 - + + + B2 
20 dH2O      
1        2      3      4       5       6      7     8      9      10    11    12    13    14    15    16    17    18    19    20           
19     











  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 CW-23-S17 + - - + B1 
3 CW-48-A18 + - - + B1 
4 CW-51-A18 + - - + B1 
5 CW-42-A18 + - + - A/C 
6 CW-21-S18 + - - + B1 
7 CW-59-A18 + - + - A/C 
8 CW-31-S18 + + - - D/E 
9 CW-28-S17 + - - + B1 
10 CW-29-S17 + - - + B1 
11 CW-49-A18 + + - - D/E 
12 CW-62-A18 + - - + B1 
13 CW-5-A18 + - - + B1 
14 CW-38-A18 + - - + B1 
15 CW-44-S17 + - - + B1 
16 CW-57-A18 - - - - unknown 
17 CW-7-A18 + + - + D/E 
18 E. coli ATCC25922 - + + + B2 
19 CW-22-A18      
20 dH2O      
1     2     3     4      5      6      7     8      9    10   11    12   13   14    15   16    17  18     19    20           
19     











  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 PF-63-W18 + - - + B1 
3 PF-20-W18 + + - - D+E 
4 MRD-23-W18 + - - + B1 
5 MRD-21-W18 + - - + B1 
6 PF-21-W18 + - - + B1 
7 PF-19-W18 + - - + B1 
8 MRD-45-W18 + - - + B1 
9 PF-24-W18 + - - + B1 
10 MRD-3-W18 + - - + B1 
11 MRD-34-W18 + - - + B1 
12 MRD-3-W18 + + - + D+E 
13 MRD-2-W18 + - - + B1 
14 MRD-4-W18 + - - + B1 
15 PF-32-W18 - - - - unknown 
16 E. coli ATCC25922 - + + + B2 
17 dH2O      
18       
19       
       
1         2        3        4        5       6        7        8        9      10       11     12     13      14      15    16       17  
18     19    20           
19     









  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 PF-31-W18 + - - + B1 
3 PF-26-W18 + - - + B1 
4 PF-23-W18 + + - + D/E 
5 MRD-40-W18 + + - + D/E 
6 MRD-24-W18 + - - + B1 
7 MRD-12-W18 + - - + B1 
8 PF-63-W18 + - - + B1 
9 MRD-22-W18 + - - + B1 
10 PF-25*-W18 + - + + UNKNOWN 
11 PF-23*-W18 + + - + D+E 
12 PF-18-W18 + + - + D+E 
13 MRD-11-W18 + - - + B1 
14 PF-28-W18 + - - + B1 
15 PF-29-W18 + - - - A 
16 PF-27-W18 + - - + B1 
17 MRD-17-W18 + - + - A/C 
18 MRD-34-W18 + - - + B1 
19 E. coli ATCC25922 - + + + B2 
20 dH2O      
1       2      3      4       5       6      7      8       9      10    11   12     13    14    15     16     17   18     19   20 
2020           
19     









  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 PF-5-A18 + - - + B1 
3 PF-16-A18 + - - + B1 
4 PF-58-A18 + - - + B1 
5 PF-31-A18 + - - - A 
6 PF-11-A18 + + - + D+E 
7 PF-15-A18 + - - + B1 
8 PF-4-A18 + - - + B1 
9 PF-61-A18 + - - + B1 
10 MRD-2-W18 + - - + B1 
11 MRD-4-W18 + - - + B1 
12 PF-23-A18 + - - - A 
13 PF-60-A18 + - - + B1 
14 PF-62-A18 + - - + B1 
15 PF-3-A18 + - - + B1 
16 PF-63-A18 + - - + B1 
17 PF-14-A18 + - - + B1 
18 E. coli ATCC25922 - + + + B2 
19 dH2O      
20 MM      
1     2       3       4        5       6        7        8       9      10      11     12     13     14     15     16      17     18     
19   20 2020           
19     












  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 HyperV ladder      
2 PF-21-W18 + - - + B1 
3 PF-20-W18 + - - + B1 
4 PF-19-W18 + - - + B1 
5 PF-22-W18 + - - - A 
6 PF-18-W18 + + - + D+E 
7 PF-25-W18 + - - + B1 
8 PF-25*-W18 + - - + B1 
9 PF-29-W18 + - - - A 
10 PF-28-W18 + - - + B1 
11 PF-30-W18 + - - + B1 
12 PF-26-S18 + + - - D+E 
13 PF-32-W18 + - - + B1 
14 PF-31-W18 + - - + B1 
15 PF-34-W 18 + + - + D+E 
16 MRD-12-W18 + - - + B1 
17 MRD-17-W18 + - - + B1 
18 E. coli ATCC25922 - + + + B2 
19 dH2O      
20 MM      
1     2       3      4      5       6      7       8     9     10    11    12   13    14    15     16    17   18     19   20 
2020           
19     












S.No  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 HyperV ladder      
2 PF-34-A18 + - - + B1 
3 PF-34-A18 + - - + B1 
4 PF-3-A18 + - - + B1 
5 PF-2-A18 + - - + B1 
6 PF-19-A18 + + - + D+E 
7 PF-22-A18 + + - + D+E 
8 PF-25-A18 - - - - unknown 
9 PF-24-A18 + - - + B1 
10 PF-32-A18 + - - + B1 
11 PF-13-A18 + - - + B1 
12 PF-44-A18 + - - - A 
13 PF-9-A18 + - - + B1 
14 PF-58-A18 + - - + B1 
15 PF-30-A18 + - - + B1 
16 PF-21-A18 + - - + B1 
17 PF-30-A18 + - - + B1 
18 PF-46-A18 + - - + B1 
19 E. coli ATCC25922 - + + + B2 
20 dH2O - - - -  
1       2        3         4        5        6       7    8      9 10     11    12    13    14   15   16     17     18    19       20             
19     










  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 1Kb+ladder      
2 PF-56-A18 - - - - unknown 
3 PF-5A-18 + - - + B1 
4 PF-11-A18 + + - + D+E 
5 PF-4A-18 + - - + B1 
6 PF-16A-18 + - - + B1 
7 PF-50A-18 + + - - D+E 
8 PF-60A-18 + - - + B1 
9 PF-10A-18 476    III +IV+V 
10 PF-63A-18 + - - + B1 
11 PF-31A-18 + - - + B1 
12 PF-61A-18 + + - - D+E 
13 PF-62A-18 + - - + B1 
14 PF-15A-18 + - - + B1 
15 PF-34A-18 - - - - unknown 
16 PF-23-A18 476    III +IV+V 
17 PF-63+-A18 - - + - I+II 
18       
19       
20       
1         2      3      4        5         6       7         8          9      10     11      12      13    1 4      15      16       17   
18       19   20           
19     










S.No  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 TL-45-A18 + - - + B1 
3 TL-50-A18 + - - + B1 
4 TL-53-A18 + - - + B1 
5 TL-54-A18 + - - + B1 
6 TL-49-A18 + - - + B1 
7 TL-46-A18 + - - + B1 
8 TL-55-A18 + - - + B1 
9 TL-41-A18 + - - + B1 
10 TL-26-W18 - - - - unknown 
11 TL-47-A18 + - - + B1 
12 TL-48-A18 + - - + B1 
13 TL-21-A18 + - - + B1 
14 CW-61-A18 + - - + B1 
15 CW-38-W18 + - - + B1 
16 E. coli ATCC25922  + + + B2 
17 dH2O - - - -  
18       
19       
20       
1      2      3      4        5       6     7       8     9      10     11    12    13    1 4    15    16    17   18       19   20           
19     











  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 MRD-33-S17 + - - + B1 
3 MRD-49-S17 + - - + B1 
4 MRD-26-S17 + - - + B1 
5 MRD-35-S17 + - - + B1 
6 MRD-29-S17 + - + - B1 
7 MRD-14-S17 + - + - A or C 
8 MRD-24-S17 + - - + B1 
9 MRD-38-S18 + + - - D or E 
10 MRD-18-S17 + - - + B1 
11 MRD-46-S17 + - - + B1 
12 MRD-30-S17 + - - + B1 
13 MRD-50-S17 + - - + B1 
14 MRD-33-S17 + - - + B1 
15 MRD-27-S17 + - + - A or C 
16 MRD-17-S17 + - - + B1 
17 MRD-40-S17 + - - + B1 
18 MRD-40-S18 - + + + B2 
19 E. coli ATCC25922 - + + + B2 
20 DH20      
1      2     3      4       5       6      7      8       9     10     11   12     13   1 4    15    16    17   18      19    20           
19     









  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 MRD-4-S17 + - - + B1 
3 MRD-13-S17 + - - + B1 
4 MRD-33-S18 + - - + B1 
5 MRD-42-S18 + - - + B1 
6 MRD-3-S18 + - - + B1 
7 MRD-2-S18 + - + - A or C 
8 MRD-17-S18 + - - + B1 
9 MRD-48-S18 - + + - B2 
10 MRD-6-S18 + - - + B1 
11 MRD-20-S18 + - - + B1 
12 MRD-55-S17 + - - + B1 
13 MRD-27-S18 + - - + B1 
14 MRD-24-S18 + - - + B1 
15 MRD-51-S18 + - - + B1 
16 MRD-29-S17 + - + - A or C 
17 MRD-38-S17 - - - - unknown 
18 E. coli ATCC25922 - + + + B2 
19 DH20      
20 PCR MM      
1      2     3      4       5       6      7      8       9     10     11   12     13   1 4    15    16    17   18      19    20           
19     











S.No  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 MRD-15-A18 + + - - D+E 
3 MRD-29-A18 + - - + B1 
4 MRD-26-A18 + + + - E or CLAD1 
5 MRD-27-A18 + + - - D +E 
6 MRD-22-A18 + - - + B1 
7 MRD-58-A18 + - - + B1 
8 MRD-28-A18 + - - + B1 
9 PF-23-S17 + - - + B1 
10 PF-40-S17 + - - + B1 
11 PF-21-S17 + - - + B1 
12 PF-42-S17 + + + - E or CLAD1 
13 PF-50-S17 + - - + B1 
14 PF-34*-S17 + - + - A+C 
15 PF-34-S17 + - + - A+C 
16 PF-35*-S17 + - - + B1 
17 PF-35-S17 + - - + B1 
18 PF-35-S17 + - - + B1 
19 E. coli ATCC25922 - + + + B2 
20 DH2O      
1      2      3      4       5       6      7     8      9    10     11   12    13    1 4   15    16    17    18    19   20  
19     











  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 PF-44-S17 + - - + B1 
3 PF-22-S17 + - - + B1 
4 PF-19-S17 + - + - A+C 
5 PF-18-S17 + - + - A+C 
6 PF-16-S17 + - - + B1 
7 PF-33-S17 + - + - A+C 
8 PF-26-S17 + - + - A+C 
9 PF-24-S17 + - + - A+C 
10 PF-23-S17 + - - + B1 
11 PF-15-S17 + - - + B1 
12 PF-13-S17 + - - + B1 
13 PF-35-S17 + - - + B1 
14 PF-5-S17 + - + - A+C 
15 PF-20-S17 + + - + D+E 
16 PF-16-S17 + - - + B1 
17 PF-41-S17 + + - - D+E 
18 PF-4-S17 + + - - D+E 
19 E. coli E. COLI ATCC25922 - + + + B2 
20 DH2O      
1      2      3       4       5      6     7       8       9      10    11   12    13    14    15    16   17    18    19     20  
19     












  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder + - - +  
2 MRD-19-A18 + - - + B1 
3 MRD-34-A18 + - - + B1 
4 MRD-32-A18 + - - + B1 
5 MRD-25-A18 + - - + B1 
6  E. coli ATCC25922 - + + + B2 
7 DH2O      
8       
9       
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1     2      3      4      5      6     7       8       
9      10    11   12    13    14    15    
16   17    18    19     20  
19     
16       
 347 
Phylo A+C typing 
 
 




S.No  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpC   
1 Hyper V ladder   + +  
2 MRD-2-S18   + + C 
3 MRD-47-S18   + + C 
4 MRD-44-S17   + + C 
5 MRD-27-S17   + + C 
6 TL-18-A18   + - A 
7 CW-19-S18   + + C 
8 CW-26-A18   + + C 
9 CW-7-S18   + + C 
10 CW-6-A18   + + C 
11 PF-30-S17   + + C 
12 PF-26-S17   + + C 
13 PF-9-S17   + + C 
14 PF-8-S17   + + C 
15 PF-56-S18   + + C 
16 PF-6-S17   + + C 
17 PF-9-S18   + + C 
18 PF-5-S17   + + C 
19 PF-25*-W18   + + C 
20 PF-33-S17   + + C 
1       2       3       4      5      6      7      8       9     10   11     12    13     14    15    16   17     18    19   20  
19     




Phylo A+C typing 
 
 




   A+C typing Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpC   
1 Hyper V ladder      
2 PF-27-S17   + + C 
3 PF-13-W18   + + C 
4 PF-38-S17   + + C 
5 PF-51-A18   + + C 
6 PF-54-A18   + + C 
7 CW-15-S18   + + C 
8 CW-16-S18   + + C 
9 CW-14-S18   + + C 
10 CW-26-W18   + + C 
11 CW-39-A18   + + C 
       
       
       
       
       
       
       
       
       
1       2        3       4         5       6       7         8       9       10      11     
12    13     14    15    16   17     18    19   20  
19     
16       
 349 







S.No  A+C typing Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpC   
1 Hyper V ladder      
2 PF-19-S17   + + C 
3 PF-24-S17   + + C 
4 PF-26-S17   + + C 
5 PF-34-S17   + + C 
6 PF-33-S17   + + C 
7       
8       
       
       
       
       
       
       
       
       
       
       
       
       
1    2      3      4      5      6      7       8       
9       10      11     12    13     14    15    
16   17     18    19   20  
19     
16       
 350 
 
Phylo A+C typing 
 
 





S.No  A+C typing Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpC   
1 Hyper V ladder      
2 TL-14-S17   - + C 
3 TL-14-S17   + -  
4       
5       
6       
7       
8       
       
       
       
       
       
       
       
       
       
       
       
       
1      2     3      4      5      6      7       8       
9       10      11     12    13     14    15    
16   17     18    19   20  
19     






lincoln 2019-09-06_15h33m26s phyloD+E.tif 
 
  








E   
1 Hyper V ladder      
2 CW-10-S18   + + E 
3 CW-43-W18   + - D 
4 CW-25-S18   + + E 
5 CW-39-W18   + + E 
6 CW-31-S18   + + E 
7 CW-20-S18   + + E 
8 CW-33-S18   + + E 
9 CW-30-S18   + + E 
10 CW-36-W18   + + E 
11 CW-1-A18   + + E 
12 CW-44-A18   + + E 
13 CW-34-W18   + + E 
14 CW-44-S18   + + E 
15 CW-49-S17   + + E 
16 CW-33-S18   + + E 
17 CW-48-W18   + + E 
18 CW-43-W18   + - D 
19 CW-27-S18   + + E 
20 CW-16-A18   + + E 
1     2       3       4       5       6       7      8       9      10    11     12    13    14     15     16    17    18    19     20  
19     
16       
 352 









  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpE   
1 Hyper V ladder      
2 CW-23-A18   + + E 
3 CW-41-W18   + - D 
4 CW-32-S18   + + E 
5 CW-29-W18   + + E 
6 CW-39-S18   + - D 
7 CW-35-S18   + + E 
8 CW-27-W18   + + E 
9 PF-41-S18   + + E 
10 PF-18-W18   + + E 
11 PF-41-S17   + + E 
12 PF-55-A18   + + E 
13 PF-11-A18   + + E 
14 PF-20-S17   + + E 
15 PF-29-S17   + + E 
16 PF-42-S17   + + E 
17 PF-29-W18   + + E 
18 PF-43-A18   + - D 
19 PF-26-S18   + + E 
20 PF-23-W18   + + E 
1      2      3       4       5       6       7      8       9      10    11     12    13     14    15     16    17    18    19     20  
19     




Phylo D+E typing 
 
 





  D+E typing Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpE   
1 Hyper V ladder      
2 MRD-30-S18   + + E 
3 MRD-27-A18   + + D 
4 MRD-41-S18   + + E 
5 MRD-53-S17   + + E 
6 CW-18-A18   + + E 
7 TL-42-S17   + + E 
8 MRD-38-S18   + + E 
9 MRD-31-S18   + + E 
10 TL-51-S18   + + E 
11 PF-29-S18   + + E 
12 MRD-44-S17   + + E 
13 MRD-47-W18   + + E 
14 MRD-46-W18   + + E 
15 MRD-8-S17   + + E 
16 MRD-40*-S17   + + E 
17 MRD-25-W18   + + E 
18 MRD-26-W18   + - D 
19 TL-45-S18   + + E 
20 dH20   - -  
1      2      3       4       5       6       7      8       9      10    11     12    13     14    15     16    17    18    19     20  
19     






Phylo D+E typing 
 
 
lincoln 2019-09-07_15h29m33s phyloE gel2.tif 






S.No  Quadruplex genotype Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpE   
1 Hyper V ladder      
2 TL-1-S17   + + E 
3 TL-40-S17   + + E 
4 TL-32-S17   + + D 
5 TL-32*-S17   + + E 
6 PF-57-S17   + + E 
7 PF-34-S17   + + E 
 dH20   - -  
       
       
       
       
       
       
       
       
       
       
       
       
1      2      3     4     5      6       7      8       
9      10    11     12    13     14    15     
16    17    18    19     20  
19     












  D+E typing Phylogroup 
 Lane 
number   Strain Name    trpBA trpAgpE   
1 Hyper V ladder   + + E 
2 CW-8-A18   + + E 
3 CW-14-A18   + + E 
4 CW-28-W18   + + E 
5 PF-40-A18   + + E 
6 CW-14-A18   + + E 
7 CW-37-A18   + + E 
8 CW-35-W18   + + E 
9 PF-37-S17   + + E 
10 PF-12-A18   + + E 
11 CW-26-S18   + + E 
12 DH20      
13       
14       
15       
16       
17       
18       
19       
20       
1       2          3           4          5          6          7         8          9        10       11        12    13     14    15     16    
17    18    19     20  
19     











  Multiplex genotyping Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 CW-41-S17 + - + - A+C 
3 CW-33-S17 + - - + B1 
4 CW-5-S17 + - - + B1 
5 CW-10-W18 + - - + B1 
6 CW-4-S17 + - - + B1 
7 CW-17-S17 + - - + B1 
8 CW-33-W18 + + - + D+E 
9 CW-29-S17 + - - + B1 
10 CW-19-W18 + - - - A 
11 CW-18-S17 + - - + B1 
12 CW-44-W18 + - - - A 
13 CW-27-S17 + - - + B1 
14 CW-1-W18 + - - + B1 
15 CW-25-S17 + - - + B1 
16 CW-20-S17 + - - + B1 
17 CW-51-S17 + - + - A+C 
18 CW-20-A18 + - - + B1 
19 CW-46-W18 + - - + B1 
20 E. coli ATCC25922 + - - + B2 
1      2       3       4       5       6      7       8       9     10    11    12    13     14    15     16    17     18     19     20  
19     












  Multiplex genotyping Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 CW-13-S17 + - - + B1 
3 CW-3-S17 + + - + D+E 
4 CW-2-S17 + - - + B1 
5 CW-51-W18 + - - + B1 
6       
7       
8       
9       
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1      2      3     4       5     6      7       8       
9     10    11    12    13     14    15     
16    17     18     19     20  
19     













  D+E typing Phylogroup 
 Lane 
number   Strain Name   trpBA trpAgpE   
1 Hyper V ladder      
2 PF-45-W18   + + E 
3 PF-32-S17   + + E 
4 PF-41-S18   + + E 
5 PF-45*-W18   + + E 
6 PF-29-S18   + + E 
7 PF-20-S17   + + E 
8 PF-41-S17   + + E 
9 PF-48-S18   + + E 
10 PF-57-S18   + + E 
11 PF-61-A18   + + E 
12 PF-50-A18   + + E 
13 MRD-1-S17   + + E 
14 MRD-31-W18   + + E 
15 MRD-40-W18   + + E 
16 TL-51-S18   + + E 
17 CW-36-A18   + + E 
18 PF-57-A18   + + E 
19 DH20      
20 blank      
1      2      3       4      5        6       7       8       9     10     11    12     13     14    15    16     17     18    19    20  
19     











  A+C typing Phylogroup 
 Lane 
number   Strain Name   trpBA trpAgpC   
1 Hyper V ladder      
2 TL-11-S17   + + C 
3 TL-5-S17   + + C 
4 MRD-27-S17   + + C 
5 PF-28-S17   + + C 
6 PF-29-W18   + + C 
7 CW-39-A18   + + C 
8 CW-10-S17   + - A 
9 CW-31-A18   + - A 
10 CW-39*-A18   - - CONTAMINANT 
11 PF-18-S17   - - A 
12 DH20   - -  
MULTIPLEX GENOTYPING 
  ArpA  chu A yja A TspE4C2  
1 CW-20-A18 + - - + B1 
2 CW-50-W18 + + - + D+E 
3  E. coli ATCC25922 - + + + B2 
       
       
       
1        2         3           4         5          6          7         8          9        10       11       12       13        14       15     16     
17     18    19    20  
19     













  Multiplex genotyping Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 CW-47-A18 + - - + B1 
3 CW-49-A18 + + - - D+E 
4 CW-41-A18 + - + - A+C 
5 CW-11-A18 + - - + B1 
6 CW-5-A18 + - - + B1 
7 CW-51-A18 + - - + B1 
8 CW-52-A18 + - - + B1 
9 CW-34-A18 + - - + B1 
10 CW-22-A18 + - - + B1 
11 CW-25-A18 - - + - Clade I or II 
12 CW-35-A18 + + + - E or clade I 
13 CW-42-A18 + - + - A+C 
*14 CW-38-A18 + - - + B1 
15 CW-38-A18 + - - + B1 
16 CW-7-A18 + + - + D+E 
17 E. coli ATCC25922 - + + + B2 
18 DH20      
19 PRIMER MIX      
20       
1       2        3       4        5        6       7       8        9     10     11     12     13      14     15     16     17     18    19    
20  
19     







































  Multiplex genotyping Phylogroup 
 Lane 
number   Strain Name ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 MRD-23-W18 + - - + B1 
3 MRD-32-W18 + - - + B1 
4 MRD-15-S17 + - - + B1 
5 MRD-4-S17 + - - + B1 
6 MRD-20-W18 + - - - A 
7 MRD-21-A18 + - - + B1 
8 MRD-15-S17 + - - + B1 
9 MRD-24-S17 + - - + B1 
10 TL-35-A18 + - - + B1 
11 TL-2-A18 + - - + B1 
12 TL-25-S17 + - - + B1 
13 TL-36-S17 + - - + B1 
14 TL-56-A18 - - + - Clade I or II 
15 TL-44-A18 + - - + B1 
16 TL-23-A18 + - - + B1 
17 TL-8-S17 + - + + unknown 
18 PF-47-S17 + - - + B1 
19 E.coli E. COLI ATCC25922 - + + + B2 
20 DH20      
1       2       3      4       5       6      7       8       9     10     11    12    13     14    15    16    17     18    19    20  
19     






































S.No  PHYLO C TYPING Phylogroup 
 Lane 
number   Strain Name   trpBA trpAgpC   
1 Hyper V ladder      
2 PF-17-S17   + + C 
3 CW-12-A17   + + C 
4 PF-9-A18   + + C 
    trpBA trpAgpE  
5 PF-22-A18   + + E 
7       
8       
9       
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1         2     3      4      5      6      7       8       
9     10     11    12    13     14     15    16    
17     18    19    20  
19     







































S.No Strain Name Multiplex genotyping Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 PF-45-W18 + + + - E or clade I 
3 PF-37-W18 + - - + B1 
4 PF-12-W18 + - - + B1 
5 TL-29-S17 + - - + B1 
6 TL-31-S17 + - - + B1 
7 TL-2-S17 + - + - A+C 
8 PF-38-S18 + - - + B1 
9 PF-17-S17 + - - + B1 
10 PF-51-S17 + - - + B1 
11 PF-38-S18 + - - + B1 
12 PF-12-S17 + - - + B1 
13 PF-10-S17 + - - + B1 
14 PF-3-S17 + - - + B1 
15 PF-11-S17 + - - + B1 
16 PF-4-S17 + - - + B1 
17 MRD-36-A18 + - - + B1 
18 MRD-39-A18 + - - + B1 
19 E. coli E. COLI ATCC25922 - + + + B2 
20 DH20 - - - -  
1      2      3       4      5       6      7       8       9     10     11    12    13    14    15    16    17     18    19    20  
19     





































S.No Strain Name Multiplex genotyping Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 MRD-54-A18 - + + - B2 
3 MRD-50-S18 + - - + B1 
4 CW-2-S17 + - - + B1 
5 CW-9-S17 + - - + B1 
6 CW-47-S18 + - - + B1 
7 E. coli E. COLI ATCC25922 - + + + B2 
8 DH20 - - - -  
9       
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1       2      3      4      5      6      7       8       
9     10     11    12    13    14    15    16    
17     18    19    20  
19     








































S.No Strain Name Multiplex genotyping Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 CW-24-S17 + - - + B1 
3 CW-5-S17 + - - + B1 
4 CW-35-W18 + + - + D+E 
5 CW-49-W18 + + - + D+E 
6 CW-51-A18 + - - + B1 
7 CW-38-W18 + - - + B1 
8 CW-8-S18 + + - + D+E 
9 MRD-42-A18 + - - + B1 
10 MRD-57-A18 + - - + B1 
11 MRD-5-A18 + + - + D+E 
12 E. coli ATCC25922 - + + + B2 
13 DH20      
 A+C GENOTYPING 
    trpBA trpAgpC  
14 TL-2-S17   + - A 
15 TL-5-S17   + + C 
16 TL-39-S17   + + C 
17 CW-41-S17   + - A 
18 DH20      
19 VICKY PLASMID      
20 VICKY PLASMID      
1      2      3      4      5      6      7       8       9     10    11    12    13    14    15    16    17      18       19  20  
19     







































S.No Strain Name Phylo E genotyping Phylogroup 
      trpBA trpAgpE   
1 Hyper V ladder      
2 CW-33-W18   + + E 
3 CW-49-W18   + + E 
4 CW-8-S18   + + E 
5 CW-50-W18   + + E 
6 MRD-5-A18   + + E 
7 DH20      
8       
9       
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1      2      3      4      5        6      7       8       
9     10    11    12    13    14    15     
16     17    18    19    20  
19     




































S.No Strain Name Multiplex genotyping Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 TL-7-S18 + - - + B1 
3 TL-9-S18 + - - + B1 
4 TL-10-S18 + - - + B1 
5 TL-6-S18 + - - + B1 
6 TL-12-S18 + - - + B1 
7 TL-18-S18 + - - + B1 
8 PF-25-W18 + - - + B1 
9 PF-26-W18 + - - + B1 
10 PF-52-W18 + - - + B1 
11 PF-37-W18 + - - + B1 
12 PF-42-W18 + - - + B1 
13 PF-39-W18 + - - + B1 
14 E. coli ATCC25922 - + + + B2 
15 DW - - - -  
16       
17       
18       
19       
20       
1      2        3       4        5        6        7       8        9      10    11      12      13    14      15     
16     17    18    19    20  
19     







































S.No Strain Name Multiplex genotyping Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 MRD-3-W18 + - - + B1 
3 MRD-21-W18 + - - + B1 
4 MRD-33-W18 + - - + B1 
5 MRD-13-A18 + - - + B1 
6 MRD-14-A18 + - - + B1 
7 MRD-15-A18 + + - + D+E 
8 E. coli ATCC25922 - + + + B2 
9       
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1      2      3    4        5      6      7       8        
9      10    11      12      13    14      15     
16     17    18    19    20  
19     







lincoln 2019-09-27_15h26m46smultilex &D+E.tif 
 
  
S.No Strain Name Multiplex genotyping Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 Hyper V ladder      
2 TL-39-S18 + + - - D+E 
3 MRD-40-S17 + - - + B1 
4 MRD-38-S18 + + - - D+E 
5 PF-55-W18 + - - - A 
6 MRD-51-S17 + - - + B1 
7 PF-52-W18 + - - + B1 
8 E. coli ATCC25922 - + + + B2 
9 DW      
 D+E TYPING trpBA trpAgpE PHYLOGROUP 
11 MRD-15-A18   + + E 
12       
13       
14       
15       
16       
17       
18       
19       
20       
1      2        3        4         5       6       7        8        9      10    
11      12      13    14      15     16     17    18    19    20  
19     












S.No Strain Name Multiplex genotyping Phylogroup 
    ArpA  chu A yja A TspE4C2   PHYLOGROUP 
1 Hyper V ladder      
4 TL-28-W18 + - - - A 
5 TL-36-W18 - - - - UNKNOWN 
 A+C typing trpBA trpAgpC  
7 CW-23-W18   + + C 
8 E. coli NCTC13352   + + C 
11 MRD-45-S17   + + C 
12 MRD-25-S18   + + C 
13 CW-51-S17   + + C 
 D+E TYPING trpBA trpAgpE  
2 PF-19-S18   + + E 
3 CW-34-S18   + + E 
6 PF-39-S17   + + E 
9 PF-45-S17   + - Clade I 
10 CW-18-S18   + + E 
14 E. coli ATCC25922 - + + + B2 
15 E. coli NCTC13352 + - + - A+C 
       
       
       








































S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 HYPER V LADDER      
2 TL-87-A18 + - - + B1 
3 TL-59-S17 + - - + B1 
4 TL-76-S17 + - - + B1 
5 TL-82-S17 + - - + B1 
6 TL-69-S17 + - - + B1 
7 TL-87-A18 + - - + B1 
8 TL-75-S17 + - - + B1 
9 DW - - - -  
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
  1        2      3      4        5       6       7      8        9   
10  11  12 13   14  15  16   17  18  19  20  
19     






































S.No Strain Name Quadruplex genotype Phylogroup 
    ArpA  chu A yja A TspE4C2   
1 HYPER V LADDER      
2 TL-60-S17 + - - + B1 
3 TL-71-S17 + - - + B1 
4 TL-72-S17 + - - + B1 
5 TL-64-S17 + - - + B1 
6 TL-58-S17 + - - + B1 
7 TL-75-S17 + - - + B1 
8 TL-61-S17 + - - + B1 
9 TL-63-S17 + - - + B1 
10 46 + + - - D+E 
11 10 + - + - A+C 
12 4 - + + + B2 
13 A7 - + + + B2 
14 A5 + + - + D+E 
15 A2 + + - + D+E 
16 B10 - + + + B2 
17 E. coli ATCC25922 - + + + B2 
18 DW      
19       
20       
1      2       3       4      5       6      7      8      9      10     11   12    13    14     15    16    17    18   19   
20  
19     






































S.No Strain Name Phylo E genotyping Phylogroup 
      trpBA trpAgpE   
1 Hyper V ladder      
2 CW-35-A18   + + E 
3 CW-27-A18   + + E 
4 CW-3-S17   + + E 
5 CW-20-S17   + + E 
6 MRD-55-A18   + + E 
7 MRD-37-A18   + + E 
8 MRD-49-A18   + - Clade I 
9 MRD-26-A18   + + E 
10 DW      
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1          2           3         4           5         6           7         8          9       10     11     12     13     14   15   
16  17  18   19   20  
19     
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S.No Strain Name Phylo D+E genotyping Phylogroup 
      trpBA trpAgpE   
1 Hyper V ladder      
2 46   + - D 
3 A5   + + E 
4 A2   + + E 
5 Phylo A+C genotyping 
6 B10   + + C 
7       
8       
9       
10       
11       
12       
13       
14       
15       
16       
17       
18       
19       
20       
1     2     3      4       5      6      7     8        
9       10     11     12     13     14   15   
16  17  18   19   20  
19     
16       
